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CHAPTER 1
General introduction
 
Chronic non-specifi c back pain
In the Netherlands, the annual incidence of back pain in the general population is 
estimated at 10-15%.1 In Canada, the annual (cumulative) incidence of low back pain 
in the general population is 18.6%.2 In 1999, in the Netherlands, chronic non-specifi c 
low back pain was reported by 16.0% of working men, by 23.1% of non-working men, 
by 17.9% of working women and by 27.4% of non-working women.3 In 2009, 33.2 per 
1,000 patients Registered in general practice contacted the general practitioner (GP) 
because of low back pain.4 On average, these patients had contact with their GP two 
times in the form of a consultation (42.4%). Of these patients, over 15% were referred 
to another healthcare discipline, mainly to a physiotherapist (63.8%).4
 The clinical guidelines recommend to focus on identifi cation of ’red fl ags’ to 
determine whether the patient is suffering from non-specifi c back pain or whether 
there is a suspicion of serious pathology.5,6 The GP and physiotherapist are advised 
to initially treat patients with non-specifi c back pain in a conservative way, which 
includes informing the patient about the expected course, prescription of (pain) 
medication (by the GP) and the general recommendation that the patient should 
remain as active as possible.5,6 After 12 weeks, low back pain is labelled as chronic 
non-specifi c low back pain and the Dutch GP Guideline6 recommends to consider 
cognitive behavioural therapy; this is because it is increasingly likely that psycho-
logical factors (e.g. fear of movement, illness perception) and/or the workplace, play 
a role. In this case, referral by a GP to multidisciplinary treatment is then advised. If 
there is suspicion of a specifi c (physical) cause, this should fi rst be excluded by an 
orthopaedic surgeon, neurologist or rheumatologist, before the patient is referred 
to a multidisciplinary centre.6
 In this thesis, chronic ‘non-specifi c low back pain’ is defi ned as low back pain 
without a specifi c physical cause, such as nerve root compression (the radicular 
syndrome), trauma, infection, or the presence of a tumour. 
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Pain in the lumbosacral region is the most common symptom in patients with non- 
specific low back pain. Pain may also radiate to the gluteal region to the thighs, 
or to both. The duration of this type of back pain is defined as lasting longer than 
3 months.5 
Course of (chronic) non-specific back pain
The term ‘course’ can refer to both the natural and the clinical course of low back 
pain.7 The natural course (in contrast to the clinical course) refers to the ‘normal’ 
course of low back pain without any intervention. We expect that the natural and 
clinical course will differ for each phase, starting with acute (< 12 weeks) and 
progressing to chronic (> 12 weeks) non-specific low back. We also expect different 
prognostic factors for the natural and clinical course of non-specific low back 
pain.8 A systematic review on the prognosis and long-term course of low back 
pain indicates that, after an episode of low back pain, 44% to 78% of the patients 
suffer from a relapse of back pain, and that 26% to 37% suffer from recurrent 
sick leave.9 
 Furthermore, after 3 months the pain and disability level decrease, although 
disability tends to persist for at least 12 months or patients will have at least one 
recurrence within 12 months.7 Cassidy et al. describe similar results, indicating 
that low back pain is a common, chronic and recurrent condition in the general 
population.2 Younger people are less likely to have persistent low back pain and 
more likely to have complete resolution of symptoms.2 A recent meta-analysis 
confirms earlier findings describing the course for patients with acute (< 12 weeks) or 
persistent (> 12 weeks to 12 months) low-back pain for the outcome pain, disability, 
or recovery.10 
 After an intervention, both acute and persistent low back pain improve in the 
first 6 weeks and, thereafter, improvement slows down. Low to moderate levels 
of pain and disability may still be present at 12 months, especially in cohorts with 
persistent pain. Other studies show that the course can differ per patient or group: 
some improve more rapidly, some more slowly, whereas others may fluctuate.11 
This difference might be explained by the inclusion of different study populations 
and/or the use of different outcomes to define recovery.8,10,11
 
Prognosis of (chronic) non-specific back pain
Chronic non-specific low back pain is assumed to be a multi-factorial affliction, 
implying that a number of different risk factors contribute to its development 
and persistence.8,10,12,13 After onset, prognostic factors can potentially predict 
the future course. 
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Risk factors for the development of chronic pain (i.e. transition from acute to 
chronic pain) are well documented in the literature.8,12,14,15 However, when pain 
becomes persistent, less knowledge is available on the risk factors for future 
outcome. Increased knowledge on the prognostic factors for chronic complaints 
will allow to better inform and advise patients, by supporting clinical decisions 
about the type of treatment and identifying patients at risk of a poor outcome.8,14 
A study from Australia reported that the prognosis is less favourable for those 
who: a) have taken previous sick leave for low back pain, b) have more disability 
or severe pain intensity at onset of chronic non-specific low back pain, c) have a 
lower education level, d) perceive themselves as having a high risk of persistent 
pain, and e) were born outside Australia.12 
Outcome of (chronic) non-specific back pain
The objective of this thesis is to describe the clinical course of chronic non-specific 
low back pain in patients referred to a rehabilitation centre in tertiary care, to identify 
prognostic factors for recovery, and to analyse the influence of various outcomes and 
statistical techniques on the development of a prognostic model. We used outcome 
measures that are similar to those utilised since 2000, when an international panel 
of experts on low back pain agreed on a core set of outcome measures. This core set 
includes five domains: 1) low back pain intensity, 2) low-back-pain-specific disability, 
3) return to work, 4) generic functional status, and 5) patient’s satisfaction with the 
process of care and treatment outcome.16 
 Ostelo et al. stated that, when measuring outcomes in patients, there is no 
consensus in the literature on the most appropriate technique to use to determine 
the ‘minimal clinically important change’ (MCIC).17,18 Two adequate and frequently 
used methods to estimate the MCIC are the smallest change possible to detect 
improvement (between baseline and follow-up) and to estimate the optimal 
cut-off point. For example, the Quebec Back Pain Disability Scale (QBPDS; range 
0-100) was dichotomised into “no improvement in disability” and “improvement 
in disability,” using a reduction of 30% at follow-up compared to baseline as a 
clinically relevant difference17-19 and ’absolute recovery’ was defined as a QBPDS 
score of  20 points at follow-up.13,17,20,21 Ostelo et al. reported that the change from 
baseline to follow-up can be defined as ‘clinically important’ (e.g. a 30% improvement) 
because individual patients determine their own health status.17 For each outcome, 
except for generic functional status, an indicator is suggested to determine the 
MCIC between baseline and follow-up.17,18,20-22 However, an ongoing discussion is 
whether the MCIC is better expressed as a percentage of improvement (e.g., > 30% 
improvement on the scale) or as a cut-off point (dichotomisation) in order to 
determine recovery.17,18,20-22 
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In our study, recovery as assessed with various outcome measures was operationalised 
according to two definitions: 1) a 30% improvement compared to baseline scores 
with regard to the outcomes back pain intensity, disability, work participation and 
quality of life (SF-36; 10% improvement)17-19 and 2) ’absolute recovery’ was defined 
with a Visual Analogue Scale score of pain intensity  10 mm, disability with the 
QBPDS score of  20 points, work participation (0-100% working)  90% at follow-up, 
and global perceived effect (GPE) on a 5-point scale dichotomised into ‘clinically 
improved’ vs. ‘clinically not improved’.13,17,20,21,23 
Multidisciplinary treatment in the Spine & Joint Centre
Management of chronic non-specific low back pain in the sense of treatment after 
a lack of successful recovery in primary care (e.g. GP, physiotherapist) consists of 
behavioural treatment and/or multidisciplinary rehabilitation.5,6,24,25 A systematic 
review showed moderate quality of evidence that, for pain relief on the short-term, 
operant therapy is more effective than a waiting list and that behaviour therapy is 
more effective than usual care.25 However, no specific type of behaviour therapy 
has been shown to be more effective than another. On the long term, there appears 
to be little difference between behaviour therapy and group exercises for pain or 
depressive symptoms.25
 Another systematic review using the same core set of outcomes as used in this 
thesis, reported moderate evidence that intensive multidisciplinary bio-psycho-
social rehabilitation with functional restoration is more effective in reducing pain 
compared with outpatient non multidisciplinary rehabilitation or usual care.24
 There is contradictory evidence regarding vocational outcomes of an intensive 
multidisciplinary bio-psychosocial intervention. Some trials report improvements in 
work readiness, whereas others shows no significant reduction in sick leave. Less 
intensive outpatient psychophysical treatments did not improve pain, function or 
vocational outcomes when compared with non multidisciplinary outpatient therapy 
or usual care. Few trials have reported on the effects on quality of life or global 
assessments.24
 In the cohort study presented in this thesis, all patients received multidisci-
plinary treatment at the Spine & Joint Centre (Rotterdam) using a bio-psychosocial 
approach to stimulate patients to adopt adequate (movement) behaviour aimed 
at physical and functional recovery. The therapy program consisted of 16 sessions 
of 3 hours each during a 2-month period (a total of 48 hours), coached by a 
multi disciplinary team (physical therapist, physician, health scientist, psychologist). 
Behavioural principles were applied to encourage patients to adopt adequate 
normal behavioural movement aimed at physical recovery. 
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Five months after the start of the therapy program (2 months twice a week at 
the rehabilitation centre + 3 months self-supporting activity) the patients were 
measured again. At 12 months the follow-up measurement was performed by postal 
questionnaires sent to all participating patients.
Aim of thesis
This thesis was conducted to describe and gain insight into: 1) the characteristics 
and clinical course of patients with non-specific low back pain treated in a tertiary 
rehabilitation centre, and 2) the prognostic factors for recovery (including internal 
validation) of patients with chronic non-specific low back pain treated in a tertiary 
rehabilitation centre. 
Content of the thesis
Chapter 2 presents the results of a systematic review on the prognostic factors for 
recovery in chronic non-specific low back pain.
Chapter 3 describes the study design, the multidisciplinary treatment at the Spine & 
Joint Centre, and the baseline characteristics of patients in the prospective cohort 
study on chronic non-specific low back pain.
Chapter 4 presents the 2-, 5- and 12-months course of back pain intensity and the 
identified prognostic factors for the outcome ‘back pain intensity’ at 5- and 12-months 
follow-up. 
Chapter 5 presents the 2-, 5- and 12-months course of back pain disability and the 
identified prognostic factors for the outcome ‘back pain disability’ at 5- and 12-months 
follow-up.
Chapter 6 reports the 5- and 12-months course of work participation and the 
identified prognostic factors for the outcome ‘work participation’ at 5- and 12-months 
follow-up.
Chapter 7 describes the 2-, 5- and 12-months course of quality of life and global 
perceived effect, and the identified prognostic factors for the outcomes ‘quality of 
life’ and ‘global perceived effect’ at 5- and 12-months follow-up. 
Chapter 8 addresses the main results of this thesis, discusses implications for daily 
practice, and makes some recommendations for further research. 
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CHAPTER 2
Prognostic factors 
for recovery in chronic 
non-specifi c low back 
pain: a systematic review
Verkerk K., Luijsterburg P.A.J., Miedema H.S., Pool-Goudzwaard A.L., Koes B.W.
Phys Ther 2012, 92(9):1093-1108
  
Abstract
Background. Few data are available on predictors for a favorable outcome in 
patients with chronic non-specifi c low back pain (CNLBP).
Purpose. The aim of this study was to assess prognostic factors for pain intensity, 
disability, return to work, quality of life, or global perceived effect in patients with 
CNLBP at short-term (  6 months) and long-term (> 6 months) follow-up. 
Data Sources. Relevant studies evaluating the prognosis of CNLBP were searched 
in PubMed, CINAHL and EMBASE (through March 2010).
Study Selection. Articles with all types of study design were included. Inclusion 
criteria were: participants were patients suffering from CNLBP (  12 weeks’ duration), 
participants were older than 18 years of age; and the study was related to prognostic 
factors for recovery. Fourteen studies met the inclusion criteria.
Data Extraction. Two reviewers extracted the data and details of each study.
Data Synthesis. A qualitative analysis using ‘’level of evidence’’ was performed for 
all included studies. Data was summarized in tables and critically appraised.
Limitations. The results of the studies reviewed were limited by their  methodo logical 
weaknesses.
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Conclusion. At short-term follow-up, no association was found for the factors age 
and sex with the outcomes of pain intensity and disability. At long-term follow-up, 
smoking had the same result. At long-term follow-up, pain intensity and fear of 
movement had no association with disability. At short-term follow-up, conflicting 
evidence was found for the association between the outcomes pain intensity and 
disability and the factor fear of movement. At long-term follow-up, conflicting 
evidence was found for the factors age, sex and physical job demands. At long-term 
follow-up, conflicting evidence was also found for the association between return 
to work and age, sex and activities of daily living. At baseline, there was limited 
evidence of a positive influence of lower pain intensity and physical job demands on 
return to work. No high-quality studies were found for the outcomes quality of life 
and global perceived effect.
Keywords: chronic low back pain; prognosis; systematic review
 
Introduction
Prognostic factors are important in providing clinicians information related to clinical 
decision-making, understanding of the disease process, defining the risk groups 
based on prognosis, and allowing more accurate prediction of disease outcome.1 
Prognostic factors are suspected to differ between acute nonspecific low back pain 
(NLBP) and chronic nonspecific low back pain (CNLBP) because the natural course 
of these 2 conditions also differs.2 
 Some data are available (based on systematic reviews) on prognostic factors 
from acute NLBP and the transition from acute to CNLBP, but not for the course 
of CNLBP.3-8 Given its high rate of prevalence, investigation of the course of CNLBP 
and possible prognostic factors is needed for effective patient management, 
especially when modifiable prognostic factors can be identified. However, little 
information is available about CNLBP. One review found consistent evidence that 
in patients with CNLBP, expectations regarding recovery were a predictor for the 
decision to return to work.9 
 There is growing interest in the course and prognostic factors of CNLBP and 
in the various outcomes related to the recovery of patients with CNLBP.6,10
 The aim of this systematic review was to determine prognostic factors for the 
outcomes pain intensity, disability, return to work, quality of life, and global perceived 
effect in patients with CNLBP at short-term and long-term follow-ups. 
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Materials and Method
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 
statement) was used for this systematic review.11 
Data sources and searches
Using the strategy of broad search terms for systematic reviews on prognostic 
research,12 one reviewer (K.V.) searched for eligible studies in PubMed/MEDLINE 
(1966 through March 2010), CINAHL (1984 through March 2010), EMBASE (1950 
through March 2010), Cochrane Library (Cochrane Central Register of Reviews and 
Trials through March 2010) and PEDro (1929 through March 2010). Appendix 1 
shows the full search strategy with the key words used (MeSH, EMTREE and text 
words). Full-text articles published in English, Danish, Norwegian, Swedish and 
Dutch were eligible. The inclusion criteria for this review were applied independently 
by 2 reviewers (K.V., P.A.J.L.). First, they screened the title, key words and abstract 
for eligibility. Secondly, they assessed the selected full-text papers with regard to the 
inclusion criteria (i.e., design, participants, and reported outcomes and prognostic 
factors). In case of disagreements, the consensus method was used to discuss and 
resolve disagreement. When disagreement persisted a third independent reviewer 
(B.W.K.) was consulted for a final decision. The reference lists of all full-text articles 
were checked for eligibility.
Study selection
Only randomized cohorts designs, including randomised controlled trials that 
reported regarding prognostic factors on targeted outcomes, were eligible. The 
studies had to meet the following criteria: (1) the focus was on patients with CNLBP 
(  12 weeks’ duration), defined as low back pain that has no specified physical cause 
(e.g., nerve root compression, trauma, infection or the presence of a tumor), and 
(2) participants were older than 18 years of age. Pain in the lumbosacral region is 
the most common symptom in patients with NLBP. Pain may radiate to the gluteal 
region or to the thighs, and/or to both.13 
 A study was excluded when the study population had a specific pathology 
(e.g., lumbar radicular syndrome, oncological disease, arthritis, rheumatoid arthritis, 
systemic impairments, fractures, dislocation of the lumbar or sacral spine) or the 
primary aim of the study was to identify etiological factors. 
 Outcomes of interest were: (1) pain intensity, (2) disability, (3) return to work, 
(4) quality of life, and (5) global perceived effect. All reported prognostic factors 
(measured at baseline) on these outcomes at short-term (  6 months) and long-term 
(> 6 months) follow-up were reviewed. 
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Data extraction and quality assessment 
Two reviewer (K.V., P.A.J.L.) extracted data on study population, design, setting, 
follow-up period, loss to follow-up, prognostic factors, outcomes, and strength of 
association using a standardized form. The associations at short-term and long-term 
follow-up (reported by odds ratios or relative risk values, with corresponding 
P value or 95% confidence interval) between the prognostic factors and the 
outcomes were extracted or calculated by the reviewers.
 The methodological quality of the studies was assessed using the Quality 
In Prognosis Studies (QUIPS) with a list of issues or considerations.4,12,14 Detailed 
information about the issues or considerations can be retrieved by the first 
author. We adjusted the criteria list aimed at our population, establishing criteria 
for follow-up en dropout percentage15,16 and scoring each item with ‘’yes’’, ‘’no’’, 
or ‘’don’t know’’, which led to the overall scoring of low, moderate or high risk of bias 
per domain. 
 The quality assessment considered 6 domains of potential biases: (1) study 
participation, (2) study attrition, (3) measurement of prognostic factors, (4) 
measurement of and controlling for confounding variables, (5) measurement of 
outcomes, and (6) analysis approaches (Appendix 2).14 All criteria were first scored 
as follows: ‘’yes’’ (Y) for informative description of the criterion at issue and study 
meets the criterion; ‘’no’’ (N) for informative description, study does not meet the 
criterion, or there is no information; or ‘’don’t know’’ (U) for information that is 
lacking or insufficient. The issues were not rated or scored individually, but taken 
together to create an overall judgement for each of the domains of potential bias. 
For each of the 6 potential biases, a study was rated as having low, moderate or 
high risk of bias per domain. All criteria were weighted equally. We considered 
a study to be of high quality when the methodological risk of bias score was rated 
with low or moderate risk on all of the 6 important domains.
 Two reviewers independently assessed the methodological quality of the 
included studies. Discrepancies were resolved by discussion until consensus was 
reached. The reviewers were not blinded to the authors or the journal name. 
The interobserver agreement of the quality assessment and data extraction was 
calculated using percentage agreement.
Data synthesis and analysis
Because of the many different potential prognostic factors that were presented actors 
in the included studies, the methodological heterogeneity, and the low response 
rate (one author responded, but incorrectly), we refrained from statistical pooling.
 The strength of evidence for the reported prognostic factors associated with 
recovery for the outcomes pain intensity, disability, return to work, quality of life, 
and global perceived effect was assessed by 4 levels of evidence17: (1) consistent 
evidence: consistent findings in 2 or more studies or at least 75% of the studies 
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reporting similar conclusions (1 of the studies should be of high quality); (2) limited 
evidence: findings in 1 study of high quality or 2 or more of low quality; (3) conflicting 
evidence: < 75% of available studies reported similar findings, or contradictory 
findings present within 1 study; and (4) no evidence: no associations with an 
outcome of interest.9
Results
Search strategy and selection criteria
The search identified 6,755 citations (Figure 1). In the first round, 2 reviewers 
(K.V., P.A.J.L.) included 123 studies. Finally, 14 studies met all inclusion criteria and 
were included in the review.18-31 
Study characteristics
Table 1 presents the characteristics of the included studies.
Design of the studies 
Of the 14 included studies, 8 were prospective cohort studies18,23,24,26-29,31 and 3 were 
randomised controlled trials.20,25,30 Of 3 the remaining studies, 1 was a prospective 
case series21, 1 was a retrospective correlation study,22 and the 1 a retrospective case 
series.19 
The follow-up period ranged from 6 weeks22 to 4 years.29 The percentage loss to 
follow-up ranged from 0% to 23%18-20,24,26-31 or was unclear.21-23,25
Study population 
Seven studies19-21, 24, 28, 30, 31 included patients from either rehabilitation or specialized 
back centers, 2 included patients from an orthopedic outpatient clinic,25,27 and 4 
included patients from other rehabilitations settings such as a primary care clinic23, 
hospital,22 or general practice.29 The setting of recruitment was not specified by 
Hanson and Hanson26 and Anema et al.,18 both reporting on the same multinational 
study. 
 Sample size ranged from 5024 to 5,03529 patients, with 10 studies enrolling 
more than 100 patients. Mean age of the patients ranged from 36 to 46 years, 
and the male-female ratio ranged from 10:1 to 1:1.
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Initial electronic search 
(conducted by one reviewer)
MEDLINE 2,529
EMBASE 2,984 
CINAHL 742 
Cochrane Library      79 
PEDro 421 
Excluded (n= 6,321)
Not a study of CNSLBP
Not studying prognosis factors
A systematic review 
Excluded by language 
(articles could be excluded for more  
than one reason) 
Duplicates removed (n=311)
Excluded (n=98)
Not a study of CNSLBP
Not studying prognosis factors
Excluded by language 
No full text available  
(articles could be excluded for more  
than one reason) 
Excluded (n=11)
Not a study of CNSLBP (n=7)
Not studying prognosis factors or an 
outcome for recovery (n=4)
Screening of titles & abstract (1)
(independently conducted by 2 reviewers) 
6,444  articles retrieved
Included articles (4) 
(independently conducted by 2 reviewers) 
n=14
Review of retrieved articles (2)
(independently conducted by 2 reviewers);  
full article screen 
n=123 articles 
Review of retrieved articles (3)
(independently conducted by 2 reviewers);  
full article screen 
n=25
Figure 1. Flowchart showing the search strategy
CNLBP= chronic nonspecific low back pain 
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Methodological quality
The overall interobserver agreement was 80% for the methodological quality and 
90% for the data extraction.
 Table 2 presents the methodological quality scores (risk of bias) of all included 
studies. Ten studies were considered to be of low quality19-21,23,25,27-31 and 4 studies 
were considered to be of high quality.18,22,24,26 The methodological shortcoming 
most frequently noted were: no information about nonresponders versus responders, 
(item D) and no specified confounding measurement and no appropriate accounting 
of confounders (items J,K, and L) (Appendix 2). Nine of the 14 studies had no 
(or unclear) information about the presence of a prognostic model (item N).19-25,28,29 
Three studies18,22,26 clearly defined one or more confounders (item J). Only 2 studies30,31 
provided information on the methods used to measure the confounders in a 
valid and reliable way (item K), and only 3 studies18,22,24 applied appropriate accounting 
for confounding (item L). In addition to the score on prognostic factors and outcomes 
defined in the studies (item H and I), the reliability and validity of the instruments 
used to measure the prognostic factors and outcomes also were scored positive 
(low risk of bias) when consensus was reached by the reviewers.19, 24, 25, 27, 28 
Prognostic factors and outcome measures 
Table 3 presents the prognostic factors that were reported in only one study.18,20-31 
The level of evidence for these prognostic factors was limited, or there was no 
evidence. A large number of different prognostic factors (n=77) were studied 
in relation to the outcomes of interest. A few prognostic factors showed some 
influence on improving or delaying the recovery, but most showed no association. 
Nine studies20,22-27,30,31 had more than one outcome of interest. 
Table 4 shows the 14 prognostic factors that were reported in at least 2 studies 
evaluating associations with the outcomes of pain intensity, disability, return to 
work, and quality of life.18-31
 For 8 of the factors,20,22-24,30,31 there was consistence evidence for no association. 
For 15 factors18,20-28,30,31 there was conflicted evidence, and for 6 factors,18,20,21,23,26 
there was limited evidence for no association or positive influence. Seven out of 14 
prognostic factors were reported by low quality studies.20,21,23,25,27,30 The 4 high-quality 
studies reported either positive significance value or no significance value of factors 
on outcomes.18,22,24,26
 It was not possible to present the strength and confidence interval of the 
associations due to poor presentation of the results in the studies. Contacting 
the authors did not provide additional information because the low response rate 
(one responded, but incorrectly). 
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Table 2. Results of the methodological assessment of the 14 reviewed studiesa 
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r
A
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alysis
Q
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ality
Anema et al (2009)18 Low Low Moderate Low Moderate Low High
Costa et al (2009)23 Low Low Low Low High Low Low
Van der Hulst et al 
(2008)30
Low Moderate Low Low High Low Low
Keeley et al (2008)27 Moderate Low Low Low High Low Low
Chan and Chin 
(2008)22
Low Moderate Low Low Moderate Low High
Grotle et al (2006)24 Low Moderate Low Low Moderate Low High
Koopman et al 
(2005)28
Moderate Moderate Low Moderate High Low Low
Woby et al (2004)31 Low High Low Low High Low Low
Casso et al (2004)21 Low Low Low Low High Low Low
Smith et al (2004)29 Moderate High Moderate Moderate High Moderate Low
Hagg et al (2003)25 Low Moderate Low Low High Low Low
Hansson and Hansson 
(2000)26
Low Moderate Low Low Moderate Low High
Bendix et al (1998)20 Low Moderate Moderate Low High High Low
Barnes et al (1989)19 Moderate Moderate Low High High Low Low
a   A study was rated for each of the 6 potential biases as low (Y,YYY, YYYY, YYYU, NYYY, NYYU), moderate  
(U, YUU,NYUU,NYYU,NNYY,NNYU), or high (N, NNU, NNUU, NNNY, NNNU NNNN) risk of bias per domain.
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The results are described for each outcome of interest for those prognostic factors 
whereby minimal one study of high quality was involved (table 4):
Pain intensity. In 7 studies,20,22-24,26,29,31 pain intensity was the primary outcome. Six 
different instruments were used in these studies: visual analog scale (0-100mm),22,31 
numeric rating scale (0-10),24 Von Korff pain score,26 6-point Likert scale,23 a measure 
of pain severity of the back or leg. (0-10),20 and the Chronic Pain Grade question-
naire.29 Three studies were of high quality.22,24,26 
Overall, the studies show consistent evidence that at short-term follow-up, age22,31 
and sex22,31 were not predictive for pain decrease. The high-quality study by Chan 
and Chin22 demonstrated a significant improvement for the change in pain at the 
6- week follow-up associated with the baseline Fear-Avoidance Beliefs Questionnaire 
score (mean 27.73, SD 15.93), although accounting for only 3% of the variance in 
outcome. This finding was inconsistent with the findings at 8 weeks31 and 12 weeks.22 
 Long-term follow-up provided consistent evidence that smoking20,23,24 was 
not a predictive factor. Conflicting evidence was found for age,20,24,26 sex,20,24,26,29 
and physical job demands20,26 in association with pain intensity at the long-term 
follow-up; these studies were of low and high quality. Conflicting evidence also 
were found for sick leave20,23,25,30 and work status,20,23 but these studies were of 
low quality. 
Disability. The Roland-Morris Disability Questionnaire30,31 and the Oswestry 
Disability Index24,25 were each used in 2 studies. Four studies20,22,23,26 used other 
instruments to measure disability, including a 5-point Likert scale,23 a physical 
impairment score (0-33),22 a change in level of activities of daily living,20 and the 
Hannover Activities of Daily Living Scale (0-100).26 Three studies were of high 
quality.22, 24, 26
 Consistent with the finding for the outcome pain for the short term, there was 
no association between the factors age and sex and the disability outcome.24,31
At short-term follow-up, conflicting evidence was found that fear-avoidance 
beliefs22,30,31 were associated with disability. The study by Woby et al.31 and the 
high-quality study by Chan and Chin22 showed a positive association between the 
Fear-Avoidance Beliefs Questionnaire score and disability, although accounting 
for only 3% of the variance in outcome at 6 weeks. The positive association 
between the Fear-Avoidance Beliefs Questionnaire score and disability accounted 
for 12% of the variance in outcome at 12 weeks in the study by Chan and Chin.22 
Van der Hulst et al.30 found no association between the Tampa Scale for Kinesio-
phobia-Dutch Version score and disability.
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 The study by Hagg et al.25 had a 2-year follow-up period and demonstrated no 
association for improvement in all the assessed factors, but they did not present 
the data. The high-quality study by Hansson and Hansson26 demonstrated that in 
6 countries a lower age was associated with more improvement in disability scores 
over a longer follow-up period (> 1 year). In 4 out of 6 countries, male sex showed a 
positive association with improvement in disability scores.26 The high-quality study 
by Grotle et al.24 and the low quality studies by Bendix et al.20 and Hagg et al.,25 
however, demonstrated no associations with age or sex for the long-term follow-up. 
Also, at long-term follow-up, conflicting evidence was found for an association 
between physical job demands20,26 and disability. There was consistent evidence that 
smoking,20,23-25 pain intensity at baseline,24,30 and fear-avoidance beliefs24,30 were not 
associated with more improvement in disability scores on long-term follow-up. 
Return to work. The work-related variables included work status,23,25 work 
resumption,26 return-to-work,18,19,21,28 and ability to work.20 Two studies were of high 
quality.18,26 All studies reported on prognostic factors at the long-term follow-up, but 
these were scored with different instruments. 
In 2 out of the 3 studies of high quality, lower pain intensity18,21,26 and lower physical 
job demands18,20,26 at baseline showed limited evidence of returning to work earlier. 
 Conflicting evidence was found for age,20,21,26,28 sex,20,25,26,28 and daily activities,18,20,26 
with at least one high-quality study represented. 
 Three studies reported that younger age predicted return to work.20,26,28
Quality of life. The low-quality studies by van der Hulst et al.30 and Keeley et al.27 
used the Physical Component Scale of the 36-Item Short-Form Health Survey 
questionnaire (SF-36) but investigated different prognostic factors. Therefore, each 
factor was limited to no evidence (table 3). For the factor fear-avoidance beliefs, 
both studies27, 30 showed conflicted evidence for the long term follow-up (Table 4). 
Patient global assessment. Because only one study25 of low quality included 
patient global assessment, the evidence was restricted (Table 3).
Discussion
This systematic review aimed to present potential prognostic factors that can 
influence relevant outcomes such as pain intensity, disability, return to work, quality 
of life and global perceived effect in patients with CNLBP.
 The evidence for each association of a prognostic factor with any outcome 
variable was weak, and most studies were of poor methodological quality. Only 
2 to 5 studies reported on the same prognostic factors. 
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Moreover, the confidence intervals of the odds ratios (if reported) were generally 
widespread, indicating uncertainty in the estimation of association. Therefore, 
caution is needed in the interpretation of these results. 
Prognostic factors and outcomes
In the included studies, pain intensity, disability, and return to work were the most 
frequently reported outcomes, similar to the reviews on acute NLBP and the 
transition from acute to chronic NLBP.4,5,15,32,33 Comparison with these studies is 
difficult because few studies are available and the clinical course of CNLBP can 
differ between acute and subacute NLBP.9,15,34 However, criticisms of the use of 
different instruments for the same prognostic factors, the timing of follow-up 
measurements, and unclear definitions of outcomes were similar between the 
available systematic reviews4,6,7,15,32 and the present review.
 For the outcomes of pain and disability, several studies20,22,24,25,30,31 implied that 
there can be a correlation or interaction between these 2 outcomes and the investi-
gated prognostic factors. Different kinds of possible bias were present, including 
lack of a control group to reflect the natural course,24,31 small sample size,24,25,31 
no blinded measurements,23 and self-reporting by the patient.23 Therefore, the 
possible relation between pain en disability, the quality of the instruments, and 
the various biases in the studies indicated that the results should be interpreted 
as a direction for further research. 
 For the outcome return to work, aspects such as small sample size21,25 
and self-reported sick leave absence28 can reduce the validity of the results. 
The outcomes quality of life and patient global assessment were not 
investigated in any studies of high quality. The available studies suffered 
from difficulties with the results due to a small percentage of patients at work 
(20%)30 and the possible interaction with pain intensity and disability27 that 
could influence the results. Therefore, future research needs to have a sufficiently 
large sample size, measure the potential prognostic factors with similar 
instruments, and use well-defined outcomes of interest. 
 Researchers should incorporate the quality assessments of the 6 bias 
domains into their synthesis of evidence about prognosis. The inclusion and 
exclusion criteria for patients with CNLBP should be clearly defined, and there 
should be several follow-up periods (at least 1 year). These suggestions will 
provide the opportunity to investigate the course of CNLBP and to identify 
modifiable prognostic factors on outcomes. To improve the quality of the 
prognostic studies the following conside rations are important: (1) precisely 
defining the study objectives, (2) presenting the study methods and data, and 
(3) interpreting and applying the results of the study.35
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Limitations and methodological quality 
An important strength of this review is that the evidence regarding prognostic 
factors in outcomes of CNLBP is now systematically summarised, showing evidence 
available and the areas in which further research is needed.
 In the present review, problems arose in identifying the prognostic factors and 
associations with outcomes and in reporting the predictive strength of associations 
due to: (1) searches made in different databases, (2) variation in the study design 
(heterogeneity), (3) inadequate description of the selection criteria; and (4) 
insufficient methodological quality of most of the studies.1,4 
 Haynes et al.4 suggest that at least MEDLINE and EMBASE should be used in 
a search for articles of prognostic value. Although we used MEDLINE, CINAHL, 
EMBASE, the Cochrane Library, and PEDro some relevant studies may not have 
been included in these databases. Therefore, the possibility of publication bias 
cannot be ruled out.1 
 We chose to include randomized cohort study designs, which gave a large 
variety of prognostic factors and outcome measures. Some results were based on 
data from study designs (e.g., randomized controlled trails) that initially were not 
designed to identify prognostic factors for CNLBP improvement. Another form of 
heterogeneity could lie with the definition of the study population; all 14 studies 
described their selection criteria, but no study provided a clear definition or 
diagnostic labeling of patients with CNLBP.
 The criteria list we used for quality assessment was based on the QUIPS low 
back pain tool by Hayden.14 The main reasons for modifying the QUIPS list was the 
length of the list and the items we considered most relevant for the current topic; 
however, the 6 domains for risk of bias are presented. A specific cutoff point for 
high quality or low quality is difficult to define (even when based on theoretical 
considerations) and thus remains arbitrary. The most frequent topic of discussion 
between the present authors was whether the included studies clearly or 
completely described the reliability and validity of the method of measurement 
of the prognostic factors, outcomes, and confounders. A second major topic was 
which factors can be described as prognostic and which factors can be described 
as confounders, because they were seldom explicitly defined in the included studies. 
These matters may have influenced the quality scores and the interpretation 
of the results.
 Apart from the low methodological quality of most of the studies, it was difficult 
to report the qualitative results of the studies due to problems with different 
measures of prognostic factors and confounders, poor statistical methods, and 
different ways of reporting the outcomes. 
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Implication for clinical practice
This systematic review revealed that there is little consistent evidence as to which 
prognostic factors are of value in the recovery from CNLBP. There is no consistent 
evidence that any positive prognostic factors are associated with one of the 
investigated outcomes. 
 At short-term (  6 months) follow-up there was consistent evidence for no 
association regarding the prognostic factors age22,31 and sex22,31 for pain intensity 
and disability. Smoking20,23,24 had the same result on the long-term (> 6 months) 
follow-up. Pain intensity24,30 and fear of movement24,30 had no association on the 
long term with the outcome disability. 
 Conflicting evidence was found for the association between the outcomes pain 
intensity and disability at the short term follow-up for the prognostic factor fear of 
movement.22,30,31 On the long-term follow-up, conflicting evidence was found for the 
factors age20,24-26, sex20,24-26,29 and physical job demands.20,26  
 Conflicting evidence was found for the association between return to work 
and age,20,21,26,28, sex,20,25,26,28 and activities daily lives18,20,26 at long-term follow-up. 
At baseline, limited evidence of a positive influence on return to work was found for 
lower pain intensity18,21,26 and physical job demands.18,20,26 No studies of high quality 
were found for the outcome of quality of life and global perceived effect.25,27,30 
 This review provides evidence-based information that may be valuable to 
clinicians and policymakers in guiding their professional practice and suggest that 
more studies are needed to further clarify these unclear and conflicting results on 
prognostic variables in patients with CNLBP, especially those prognostic factors 
that can be influenced by the clinicians or the patients. 
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Appendix 1
Full Search Strategy for Prognostic Factors in Chronic Nonspecific Low Back Pain 
for Recovery in MEDLINE/PUBMED (1966-March 2010)a
Phase 1: Sensitive search for low back pain
1. Back pain 
2. Low back pain
3. Simple back pain 
4. Nonspecific low back pain
5. #1 OR #2 OR #3 OR #4
Phase 2: Sensitive search for prognosis
6.  Prognosis
7.  Prediction
8.  Course
Phase 3: Sensitive search for outcome
9.  Outcome assessment
10.  Outcome treatment
11.  Recovery
Phase 4: Sensitive search for design
12.  Cohort studies
13.  Follow-up studies
14.  Longitudinal studies
15.  Prospective studies
16.  Controlled clinical trials
17.  Randomized controlled trials
18. Case-control studies
19.  Retrospective studies
20.  Case studies
21.   Search #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR 
#15 OR #16 OR #17 OR #18 OR #19 OR #20 
Phase 5: Exclude criteria and limits
22.  Intervertebral disk displacement
23.  Infection
24.  Neoplasm
25.  Neoplasm metastasis
26.  Cancer
27.  Arthritis
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28. Arthritis rheumatoid
29.  Arthritis juvenile rheumatoid
30.  Fibromyalgia
31.  Fracture
32.  Osteoporosis
33.  Pregnancy
34.  Reiter disease
35.  Diskectomy
36.   #22 OR #23 OR #24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 
OR #32 OR #33 OR #34 OR #35 
37.  #5 NOT #36
38.  #37 AND #21
39.  #38 AND chronic
40.  #39 Limits: Humans, English, Danish, Dutch, Norwegian, Swedish
MEDLINE: 2,529, CINAHL: 742, EMBASE: 2984, Cochrane Library: 79, PEDro: 421
a   Search Stategies were modified appropriately by reviewer (K.V.) for EMBASE (1950-March 2010), CINAHL 
(1984-March 2010), Cochrane Library (Cochrane Central Register of Reviews, trials to March 2010) and 
PEDro (1929-March 2010).
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Appendix 2   
Criteria List for Assessing Methodological Quality 
1.1 Study participation
A.  Description of study population
B.  Description of inclusion and exclusion criteria
C.  Description of baseline study population
1.2 Study attrition, Follow–up (extent and length)
D.  Information about nonresponders versus responders
E.  Follow-up of at least  3 months
F.  Drop-outs/loss to follow-up  20%
G. Information completers versus loss to follow-up/drop-outs
1.3 Prognostic factors measurement
H.   Clearly defined constructs of what is measured was provided, standardised 
assessment of patient characteristics and potential clinical prognostic factors
1.4 Outcome measurement
I.   Clearly defined and standardised assessment of relevant outcome criteria: 
pain, disability, quality of life, return to work, global perceived effect
1.5 Confounding measurement and account
J.  Important confounders measured
K.  Valid and reliable measurement of confounders
L.  Appropriate accounting for confounding
1.6 Analysis
M.  Appropriate analysis techniques
N.  Prognostic model presented
O.  Frequencies of most important prognostic factors
P.  Frequencies of most important outcome
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CHAPTER 3
Course and prognosis of 
recovery for chronic non-
specifi c low back pain: 
design, therapy program 
and baseline data of a 
prospective cohort study
Verkerk K., Luijsterburg P.A.J., Ronchetti I., Miedema H.S., Pool-Goudzwaard A.L., 
van Wingerden J.P., Koes B.W.
BMC Musculoskelet Disord 2011,12:252
 
 
Abstract
Background. There has been increasing focus on factors predicting the develop-
 ment of chronic musculoskeletal disorders. For patients already experiencing 
chronic non-specifi c low back pain it is also relevant to investigate which 
prognostic factors predict recovery. We present the design of a cohort study that 
aims to determine the course and prognostic factors for recovery in patients 
with chronic nonspecifi c low back pain.
Methods/ Design. All participating patients were recruited (Jan 2003-Dec 2008) 
from the same rehabilitation centre and were evaluated by means of (postal) 
questionnaires and physical examinations at baseline, during the 2-month therapy 
program, and at 5 and 12 months after start of therapy. The therapy protocol at the
rehabilitation centre used a bio-psychosocial approach to stimulate patients to 
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adopt adequate (movement) behaviour aimed at physical and functional recovery. 
The program is part of regular care and consists of 16 sessions of 3 hours each, 
over an 8-week period (in total 48 hours), followed by a 3-month self-management 
program. The primary outcomes are low back pain intensity, disability, quality 
of life, patient’s global perceived effect of recovery, and participation in work. 
Baseline characteristics include information on socio-demographics, low back pain, 
employment status, and additional clinical items status such as fatigue, duration 
of activities, and fear of kinesiophobia. Prognostic variables are determined for 
recovery at short-term (5 months) and long-term (12 months) follow-up after start 
of therapy.
Discussion. In a routine clinical setting it is important to provide patients suffering 
from chronic non-specific low back pain with adequate information about the 
prognosis of their complaint.
 
Background
In the Netherlands, the annual incidence of back pain in the general population 
is estimated at 10-15%.1 In 1999, chronic non-specific low back pain (CNLBP) was 
reported by 16.0% of Dutch working men, by 23.1% of non-working men, by 17.9% of 
working women and 27.4% of non-working women.2 CNLBP has consequences for 
daily activity, use of health care services and ability to work. Most people with acute 
low back pain recover from their pain and/or disability and return to work within 
a few weeks.3 Up to 3 months the self-limiting condition improves at a slower 
pace compared to the first month of recovery, and after 3 months the chance of 
recovery diminishes for patients with CNLBP.1,3-5 However, CNLBP can fluctuate over 
time with (frequent) recurrences or exacerbations.6,7 Identifying the factors that 
predict the prognosis of CNLBP can help physicians in the management of patients 
with CNLBP. Prognostic factors are suspected to differ between acute and chronic 
non-specific low back pain since the course of these two conditions differs.4,8 The 
transition from acute non-specific low back pain to CNLBP has been well investi-
gated9-12, whereas studies on prognostic factors for recovery from CNLBP are scarce. 
 A recent systematic review investigating which outcome measurements 
were used to define recovery of low back pain in the past 10 years, concluded that 
almost every study defined recovery differently.13 Although pain and disability 
were the outcome measurements most often used for defining recovery, a broader 
perspective may provide a more comprehensive health profile of the patient.14-16
 Therefore, we present the design of a cohort study that investigates the course 
of patients with CNLBP undergoing treatment in an outpatient rehabilitation centre. 
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Also investigated are prognostic factors for recovery using the outcomes low back 
pain intensity, low back pain specific disability, generic health status, patient’s global 
perceived effect of recovery and work participation on both the short (5-month) and 
long (12-month) term. 
Methods/Design
Design
This study is a prospective cohort study. Patients were recruited (from January 
2003 – December 2008) in a multidisciplinary outpatient rehabilitation clinic the 
‘Spine & Joint Centre’ (SJC) in Rotterdam. The Medical Ethics Committee of SJC 
approved the study and all participants provided informed consent. 
Participants
In the present study, low back pain is defined as ‘non-specific low back pain’, i.e. 
low back pain without a specified physical cause, such as nerve root compression 
(the radicular syndrome), trauma, infection or the presence of a tumour. Pain in the 
lumbosacral region is the most common symptom in patients with non-specific low 
back pain. Pain may also radiate to the gluteal region or to the thighs, or to both.17 
 Patients with CNLBP (low back pain duration > 3 months) not recovering after 
primary and/or secondary care were referred by their general practitioner (GP) 
or specialist to the SJC for a diagnostic consultation. 
The inclusion criteria for this study are:
• Men and women aged 18 years or over;
• Having CNLBP (i.e., a duration of low back pain for  3 months);
•  Previous and insufficient treatment in primary and secondary care (e.g., physio-
therapy);
• Signed informed consent.
Exclusion criteria are:
• Insufficient knowledge of the Dutch language;
•  Signs indicating radiculopathy: asymmetric Achilles tendon reflex and/or 
(passive) straight leg raise test restricted by pain in the lower leg; positive 
magnetic resonance imaging findings for disc herniation;
•  Recent (< 6 months) fracture, neoplasm or recent previous surgery 
(< 6 months) of the lumbar spine, the pelvic girdle, the hip joint, or the femur;
•  Specific causes such ankylosing spondylitis and systemic disease of the 
locomotor system;
• Being pregnant or  6 months post-partum at the moment of consultation.
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Procedure in the SJC
Based on a bio-psychosocial understanding of CNLBP the following steps are 
followed (Figure 1):
Intake (diagnostic consultation). 
The intake is a 3-hour session in which: 1) the patient fills in psychometric 
questionnaires by computer; 2) a recording is made of the patient’s strength 
(Isostation B200), a motion analysis of forward bending of the lumbar pelvic 
rhythm (video registration) of the trunk, and 3) the patients sees a physician for 
history taking and physical examination. The physician may request an additional 
consultation with a psychologist and/or manual physiotherapist before deciding 
on treatment management.
Patients meeting the inclusion criteria for the SJC are invited to participate in 
the multidisciplinary treatment program. Those not wishing to participate in this 
program are referred to their GP with a letter containing appropriate recom -
mendations. 
Therapy program. 
In the therapy protocol, behavioural principles are applied to stimulate patients 
to adopt adequate normal behavioural movement aimed at physical recovery. 
The program consists of 16 sessions of 3 hours each, over a 2-month period (a total 
of 48 hours) located in the SJC. During the program patients are educated to be 
self-supporting and to become ‘their own therapist’. After this 2-month period, 
patients are stimulated to continue the training program independently for at least 
3 months, twice a week, in a local, regular health centre located near their home 
environment. Five months after the start of the therapy program (2 months at SJC 
+ 3 months self-supporting activity) the patient has a follow-up meeting. 
5-month follow-up after start of therapy.
At the 5-month follow-up the patient fills in questionnaires, and discusses the 
recovery process with a focus on personal targets with regard to physical training, 
and psychological and social factors. A physical examination takes place and 
(if required) personal advice is provided by one of the therapists of the SJC.
12-month follow-up after start of therapy. 
Via postal correspondence the patient is asked to fill in the 12-month questionnaires. 
At the SJC a small group of patients follow treatment once a week for 4 months 
(instead of twice a week for 2 months). After the program is completed they are 
encouraged to continue their training program for at least 3 months in a regular 
health centre. At 7 and 14 months after start of therapy the same follow-up procedure 
is performed. The reason for the ‘once a week’ program is that some patients 
are unable to visit twice the SJC a week due travelling and/or physical problems. 
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Consulting with a physician
Patient history and a physical 
examination:
ASLR, PPPP, LDL, load transfer 
abduction and adduction strength, and 
neurological research
VAS pain and ‘fatigue’, QBPDS,TSK, 
Work participation,
Duration of standing, walking,  
bicycling, sitting and lying  
(in minutes)
In therapy for 2 months at SJC  
and 3 months self-management:
Start therapy: SF-36
VAS pain and ‘fatigue’, QBPDS
TSK, GPE therapist and client 
Duration of standing, walking,  
bicycling, sitting and lying  
(in minutes)
VAS pain and ‘fatigue’
QBPDS
Work participation
GPE client 
Duration of standing, walking,  
bicycling, sitting and lying  
(in minutes)
VAS pain and ‘fatigue’
QBPDS
SF-36
Work participation
GPE client
Duration of standing, walking,  
bicycling, sitting and lying  
(in minutes)
Diagnostic consultation     
(n=2,545)
12 months follow-up after start 
of therapy (n=965) 
Figure 1. Study design 
ASLR= Active Straight Leg Raise test; PPPP= Posterior Pelvic Pain Provocation test; LDL= long dorsal  
sacro-iliac ligament; VAS= Visual Analogue Scale; QBPDS= Quebec Back Pain Disability Scale; SF-36=Short 
Form; TSK= Tampa Scale Kinesiophobia.
Not in therapy (n=785)    
In therapy (n=1,760) 
Two months after therapy 
(n=1,696) 
5 months follow-up after start 
of therapy (n=1,564)
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SJC treatment program 
Patients are treated in groups of 6 accompanied by 3 therapists. In the first session 
a personal treatment goal/plan is established with agreement from the patient. 
During the 9th and 16th sessions there is a 1:1 patient/therapist evaluation (in 
addition to the regular training program). The remainder of the treatment 
sessions consist of 1-hour training, a 1-hour group lesson, followed by another 
1-hour training. The training consists of group training and/or individual coaching. 
Figure 2 presents the treatment protocol. The therapists (e.g., a physiotherapist, 
Mensendieck therapist, psychologist, health scientist, physician) are trained in the 
bio-psychosocial aspects of CNLBP. 
 The aim of the program is to normalise motion behaviour. This is done by 
modifying the patient’s experience of movements and increasing the experienced 
quality of movements by learning about and training the reduction of compensatory 
mechanisms of a physical nature, e.g. increasing intra-abdominal pressure at low 
loads, breathing cessation during loading tasks, and extreme activity in all superficial 
muscles. During the program it is explained that the above-described compensatory 
mechanisms are present due to an interaction between biophysical and psychosocial 
factors (multidimensional) such as stress, psychological status and social factors. 
All these factors are treated by a multidisciplinary team. 
 The training starts to increase awareness of excessive tension of the muscles in 
trunk and extremities. The patient is stimulated to take breaks during daily activities 
by using tools like time contingent management and learning about his/her physical 
load and physical capacity.18,19 Breathing techniques are used in combination with a 
stabilisation program to normalise the activity of the m. Multifidus, m. Transversus 
abdominis20-25, diaphragm and pelvic floor (the ‘inner tube system’). In a later stadium 
different coordination patterns of the lumbar-pelvic rhythm by sitting, standing, 
stooping and walking are experienced by the patient, and through strengthening 
exercises of the ‘global muscles’ (the ‘outer tube system’) the local load of the trunk 
is increased.26-28 Cardiovascular endurance is trained by a cardio program. The daily 
activities of the patients are built up, depending on the physical load that the patient 
can bear. 
 The lessons aim to modify the patient’s cognitions with respect to their 
complaints, thus reinforcing well behaviour.29 The group lessons include information 
on the patient’s activities, functional anatomy of the spine, principles of chronic 
pain, the role and impact of emotions, communication, and finding the balance 
between the load of daily life and physical capacity. 
Individual coaching focuses on the specific needs/problems of the patient. The 
training is performed in a progressive sequence adjusted to the patient’s situation 
and the clinical experience (estimation) of the therapist. Additional assistance (as 
required) is provided by a manual therapist, psychologist or therapist specialised in 
body awareness. 
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Session 1
1. Intake consultation between patient and therapist:
 a. screening by questionnaires, and patient’s goals
 b. patient receives an information map
 c. screening if there is a problem with the pelvic floor
 d. patient is informed of the time contingent load
 e.  personal goals are created for the patient and his/her motivation  
for the  ther apy
2.  Introductory lesson (1 hour), a video is made of the patient’s activities  
and his/her strength (rotation and extension) is measured
Sessions 2-8
1. Target: training the patient’s cognitions and physical aspects 
2. Parts of the therapy: (2 x 45 min)
 a. physical awareness and relaxation
 b. stabilization program
 c. cardio program (walking, bicycling, rowing)
 d. strength exercises (force closure)
3.  Lessons on: anatomy (2x), pain and pain experience, physical load, attitude and 
movement in daily life (2x), emotions 
4. The multi-dimensional load-carrying capacity model and behaviour change 
Session 9: Evaluation at SJC
1. Target: evaluation therapy 
 a. questionnaires (QBPDS and TSK, VAS pain and fatigue)
 b. personal goals of the patient and their motivation 
2. Parts of the therapy: (2 x 45 min)
 a. physical awareness and relaxation
 b. stabilization program
 c. cardio program (walking, bicycling, rowing)
 d. strength exercises (force closure)
3. Lesson: group evaluation and relaxation exercises 
4. Patient thinks about the phase after the program has ended
Sessions 10-15
1. Target: patient becomes own coach 
2. Parts of the therapy: (2 x 45 min)
 a. physical awareness and relaxation
 b. stabilization program
 c. cardio program (walking, bicycling, rowing)
 d. strength excises (force closure)
 e. daily activities are built up 
3.  Lessons on: pelvic floor and a second pregnancy, preparing oneself for self-training, 
movement in daily life, communication, intimacy and sexuality, anatomy, pain and how 
to handle recidivism
4. Building-up daily activities
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Prognostic factors
Prognostic factors are assessed at intake and at start of therapy by means 
of an interview focusing on the patient’s history, a physical examination, and on 
questionnaires. After the 2-month therapy program at SJC, post-treatment follow-up 
measure ments are scheduled at 5 and 12 months after start of therapy. In the 
present study, the classification into domains as proposed by Pincus et al., with 
one additional domain ‘Physical characteristics’, is used to order the prognostic 
factors.30 
 Table 1 lists the prognostic factors. The prognostic factors include: a) 
demographic characteristics such as educational level, marital status, weight, 
alcohol, smoking and drug consumption; b) clinical status such as body mass 
index (BMI), pain below the knee, cause and duration of complaints, previous 
rehabilitation, degree of fatigue31, low back pain intensity (VAS)32,33 and disability 
Session 16: Evaluation at SJC
1. Target: evaluation of therapy program and personal goals
2. Parts of the therapy: (1 x 45 min)
 a. physical awareness and relaxation
 b. stabilization program
 c. cardio program (walking, bicycling, rowing, cross trainer)
 d. strength excises (force closure)
 e. daily activities are built up 
3. Lesson: group and individual evaluation
4.  Testing patient’s strength; filling in and discussing questionnaires  
(QBPDS, TSK, VAS pain and fatigue, GPE patient) 
Self-management for 3 months
1.  Target: continuing therapy program and personal goals twice a week  
in a local ‘fitness’ centre
2. Parts of the therapy: 
 a. physical awareness and relaxation
 b. stabilization program
 c. cardio program (walking, bicycling, rowing, cross trainer)
 d. strength excises (force closure)
 e. daily activities are built up 
3.  Evaluation at the SJC 5 months after start of therapy (2 months SJC  
and 3 months self-management); filling in/discussing questionnaires 
(QBPDS, TSK, VAS pain and fatigue, GPE patient). 
4.  Physical examination: ASLR, PPPP, LDL, load transfer abduction and  
adduction str ength.
Figure 2. Flow chart of the therapy program
VAS= Visual Analogue Scale; QBPDS= Quebec Back Pain Disability Scale; SF-36=Short Form; TSK= Tampa 
Scale Kinesiophobia; GPE=Global Perceived Effect; ASLR= Active Straight Leg Raise ; PPPP= Posterior Pelvic 
Pain Provocation test; LDL= Long Dorsal sacro-iliac Ligament.
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(QBPDS).34,35; c) psychological characteristics such as fear avoidance (TSK)36-42 
and quality of life (SF-36)43; d) work-related characteristics such as employment 
benefits and work participation in relation to back complaints, and e) physical 
characteristics such as the mobility of lumbar pelvic rhythm (video registration)44, 
strength (B-200 isostation)45,46 and activities of daily living (ADL) consisting 
of walking, sitting, bicycling and lying. Figure 1 shows the physical tests that are 
measured at intake, evaluated at the end of therapy, and at 5 months after start of 
therapy. The reliability and validity of these tests have been established. The Active 
Straight Leg Raising (ASLR) test47-49 (0= not difficult at all, 1= minimally difficult, 
2= somewhat difficult, 3= fairly difficult, 4= very difficult, 5= unable to do) is 
positive when the bilateral sum score is  2 (score range 0-10). The posterior pelvic 
pain provocation (PPPP) test (0= no pain, 1= pain unilateraal, 2= pain bilateral), 
is positive when the bilateral sum score is  2 (0-2). For the longum dorsal sacro-
iliacale ligament (LDL) test27 (0= no pain, 1= complaint of pain without grimace, 
flinch, or withdrawal (mild), 2= pain plus grimace or flinch (moderate), 3= the 
examiner is not able to complete the test because of withdrawal (unbearable), the 
score is positive when the bilateral sum score bilateral is  2 (score range 0-6). The 
load transfer adduction test (score best to worse > 129-0 Newton) and abduction 
(score best to worse > 196-0 Newton)50 is measured with a Microfet in Newtons.
 The choice to include these specific variables in the analyses as potential 
prognostic factors is based on a literature review30, the quality of tests, and clinical 
experience in the SJC. 
Outcomes
Outcomes are assessed at intake, at the start and end of therapy, and at 5 and 
12 months after start of therapy using questionnaires (Figure 1). An international 
group of back pain researchers recommended a standard battery of outcome 
measures to represent the multiple dimensions of outcome in the field of back 
pain.14,16 We measured improvement of the patient with various measures: 1) pain 
intensity measured with a visual analogue scale (VAS; at the moment, minimum 
and maximum)51,52, 2) low-back-pain-specific disability is measured with the Quebec 
Back Pain Disability Scale (QBPDS)53, 3) generic health status. The Short Form 
(SF-36) is measured at start of therapy.54-58 The three instruments have shown to 
be reliable, valid and responsive for a minimal important change (MIC).32-35,51,53,59-64 
4) Global Perceived Effect (GPE) of the patient is measured with a 5-point scale 
(1= much improved, 2= slightly improved, 3= no change, 4= slightly worsened, 5= 
much worsened).16 The GPE is proven valid16,65, and 5) work participation. Work partici-
pation is measured by dividing ‘current work hours’ by ‘former work employment 
hours’ prior to CNLBP. No psychometric values are known for this instrument.
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Analyses
Baseline characteristics of the patients are presented as descriptive statistics. Data 
on the course of CNLPB recovery during treatment are presented in graphs and 
tables at 5 and 12 months after start of therapy. The development of a multi variate 
prognostic model is based on principles and methods described by Moons and 
Altman et al..66-69 The relationship between potential prognostic factors and 
outcome is evaluated using bivariate and multivariate analyses. For all outcome 
measurements, separate analyses are conducted to investigate prognostic 
factors at 5 and 12 months after start of therapy. Differences between baseline 
and follow-up scores are analysed using repeated measures analysis of variance. 
Logistic regression is used to determine odds ratios (ORs) of recovery, initially for 
each variable independently and then in a multiple regression model.
 Recovery is operationalised into two definitions: ‘improvement in’16,33,70 and 
’absolute’16,71-73 recovery for each outcome measurement. All analyses are conducted 
with SPSS for Windows (version 18.0).
Results 
Baseline measurements
A total of 2,545 patients [mean age 40.4 (10.9) years; 73.3% women] visited 
the SJC for an intake consultation between January 2003 and December 2008. 
Of these, 1,760 patients [mean age 40.1 (10.6) years; 74.3% women] with CNLBP 
met the inclusion criteria, completed the 2-month therapy program, and were 
followed up at 5 and 12 months after start of therapy. Of this latter group, 
96 followed the ‘once a week’ therapy program (with a duration of 4 months). 
A total of 785 patients [mean age 41.3 (11.5) years; 70.3% women] had the intake 
consultation but decided not to start therapy: reasons given for this included, 
only wanting the consultation and/or a diagnosis and/or some advice, referred to 
another specialist (e.g., psychologist, orthopaedic surgeon), decided not to come, 
travel distance too far, and unknown reasons.
 The distribution of prognostic factors were similar in both the excluded and 
included groups regarding demographic characteristics, clinical status, psycho-
logical status, work-related parameters, and physical examination. Table 1 presents 
the baseline characteristics of the 1,760 patients; 74.3% is female with a (mean) 
duration of LBP complaints of 7.8 (SD 8.8) years. Of all patients, 90.2% had stable 
or increased low back pain intensity in the 3 months prior to intake. Pain intensity 
and disability showed moderate to severely impaired patients; 43.9% worked less 
because of their complaints. Of the 1,760 patients, 1,696 (96.4%) completed the 
2-month therapy program, 1,564 (88.9%) participated in the 5-month follow-up and 
965 (54.8%) completed the 12-month follow-up after start of therapy. 
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Table 1. Baseline characteristics of the study population (n=1,760)a  
Variables Population (n=1,760) Missing value
Number of female participants 1,307(74.3) 0
Age in years: M (SD) 40.1(10.6) 0
Weight (kg): M (SD)* 75.3(14.8) 81(4.6)
Height (cm): M (SD)* 172.2(8.8) 70(4.0)
Demographic factors
Low education* 716(40.7) 71(4.0)
Marital status/living with one adult* 1,515(86.1) 46(2.6)
Lifestyle 
Alcohol consumers; more than 2 per day* 73(4.1) 326(18.5)
Smoking ‘yes’* 413(23.5) 326(18.5)
No drug consumers* 1,399(79.5) 313(17.8)
Clinical status
Patients with BMI > 25* 783(44.5) 88(5.0)
Duration of complaints in years: M (SD) 7.7(8.8) 0
   1 gradual emergence of NLBP 1,167(66.3) 30(1.7)
   2 sudden emergence of NLBP 563(32.0)
Cause 23(1.3)
   1 accident/wrong movement 374(21.3)
   2 after physical overload 73(4.1)
   3 during pregnancy or after delivery 586(33.3)
   4 surgery pelvis/back or after HNP 32(1.8)
   5 unknown 672(38.2)
Previous revalidation program* 186(10.6) 101(5.7)
Comorbidity 275(15.6) 88(5.0)
VAS Pain intensity LBP in mm: M (SD)
   1 present pain intensity 55.5(23.0) 5(0.3)
   2 minimal pain intensity 34.6(21.7) 13(0.7)
   3 maximal pain intensity 80.0(16.2) 13(0.7)
Pain intensity due to CNLBP in the previous 3 months 52(3.0)
   1 stable pain intensity 865(49.1)
   2 increased pain intensity 723(41.1)
   3 decreased pain intensity 120(6.8)
VAS degree of fatigue LBP in mm: M (SD)
   1 present fatigue 56.5(26.6) 118(6.7)
   2 minimal fatigue 32.2(23.3) 169(9.6)
   3 maximal fatigue 77.8(20.4) 169(9.6)
Disability (QBPDS): M (SD) 51.7(15.6) 8(0.5)
Psychological factors
Fear avoidance (TSK): M (SD) 36.7(7.3) 50(2.8)
SF-36 (health-related quality of life)
   PCS  31.8(7.1) 493(28.0)
   MCS 46.5(10.3) 493(28.0)
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Variables Population (n=1,760) Missing value
Work-related factors
Employment status benefit 924(52.5) 353(20.1)
Work participation 161(9.1)
   1 100% working 391(22.2)
   2 1-99% working 488(27.7)
   3 not working 689(39.1)
   4 retired 31(1.8)
Less work due to 460(26.1)
   1 complaints 772(43.9)
   2 unemployed 19(1.1)
   3 different reasons 177(10.1)
   4 fully working 332(18.9)
Physical examination
LDL positive 
   1 left 1,373(78.0) 29(1.6)
   2 right 1,336(75.9) 31(1.8)
Mobility (VR) (degrees in flexion): M (SD) 
   1 pelvis in flexion 40.7(15.7) 154(8.8)
   2 low back in flexion 47.3(14.3) 154(8.8)
   3 pelvis+low back in flexion (ROM) 88.0(24.6) 154(8.8)
ASLR positive (sum score  3)
   1 by general practitioner 1,442(81.9) 16(0.9)
   2 by patient 1,217(69.1) 8(0.5)
ADL function – duration > 31 min without pain increase 
   1 walking 410(23.3) 10(0.6)
   2 cycling 312(17.8) 287(16.3)
   3 sitting 432(24.5) 13(0.7)
   4 lying 1,017(57.8) 15(0.9)
   5 standing 106(6.1) 9(0.5)
PPPP positive (uni or bilateral) 1,110(63.1) 50(2.8)
Load transfer Abduction (Newton): M (SD) 224.9 (96.4) 137 (7.8)
Load transfer Adduction (Newton): M (SD) 172.5 (87.2) 136 (7.7)
B200 Isostation (strength) (Newton): M (SD)
   1 extension 81.6(45.8) 107(6.1)
   2 flexion 65.2(45.0) 106(6.0)
   3 lateroflexion left 68.1(41.2) 106(6.0)
   4 lateroflexion right 74.2(39.4) 106(6.0)
   5 rotation left 34.6(23.1) 107(6.1)
   6 rotation right 33.4(22.5) 108 (6.1)
 Values are numbers (percentages) unless stated otherwise.
a*  these factors were reported when therapy started, or gathered from the personal status; M = mean; SD 
= standard deviation; BMI = Body Mass Index; NLBP = non-specific low back pain; VAS = Visual analogue 
scale; QBPDS = Quebec Back Pain Disability Scale; TSK = Tampa Scale Kinesiophobia ;SF-36 = Short Form; 
PCS = Physical Component Summary; MCS = Mental Component Summary; SCL-90 = Symptom Checklist; 
GPE = Global Perceived Effect; ADL= activities of daily living; VR = video registration; ASLR = Active 
Straight Leg Raise; PPPP = Posterior Pelvic Pain Provocation test; LDL = long dorsal sacro-iliac ligament. 
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Discussion
Little information is available on the prognostic factors for recovery in patients with 
chronic non-specific low back pain. The present study is designed to provide insight 
into the course and prognostic factors for recovery in patients with CNLBP who are 
managed in a rehabilitation centre. 
 The study population was recruited from a multidisciplinary outpatient rehabili-
tation clinic (part of regular care), which leads to a more pragmatic approach 
regarding the prognosis of patients with CNLBP. In the 6 years during which patients 
have been followed for 12 months after start of therapy, the procedure of data 
recording and the follow-up period has been consistent. This limits information bias 
for the outcome recovery. Another strength of this study is that use of five domains 
of recovery allows to describe and analyse a broader perspective of relevant health 
outcomes for patients with CNLBP. 
 The study also has some limitations. First, we are unable to present the natural 
(untreated) course of CNLBP, because all patients receive multidisciplinary 
treatment during rehabilitation.74,75 Also, most changes in outcome measurements 
are reported by the patients themselves, which might lead to some bias. The existing 
SJC procedure was maintained with regard to the follow-up. This probably decreased 
the response rate (especially at 12 months after start of therapy) because some 
patients were no longer motivated or were not approached to provide a response 
if they did not respond to the postal requests. 
Impact of this study
This study provides information on relevant prognostic factors for recovery, and 
presents data on the course of patients with CNLBP following a multidisciplinary 
rehabilitation program. 
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CHAPTER 4
Prognosis and course 
of pain in patients with 
chronic non-specifi c 
low back pain: a 1-year 
follow-up cohort study
Verkerk K., Luijsterburg P.A.J., Heymans M.W., Ronchetti I., Pool-Goudzwaard A.L., 
Miedema H.S., Koes B.W.
under revision 
 
Abstract
Background. It remains unclear to what extent patients recover from chronic 
non-specifi c low back pain (NSLBP). The study objectives were to determine a) the 
course of CNLBP in tertiary care and b) which factors predicted 5 and 12 month 
outcomes.
Methods. This prospective study includes 1,760 CNLBP patients from a rehabilitation 
clinic (mean age 40.1 years, SD 10.6). After baseline measurement patients 
followed a 2-month multidisciplinary therapy program; evaluation took place at 
2, 5 and 12-months post-baseline. Recovery was defi ned as: 1) relative recovery 
(30% improvement on the pain, Visual Analogue Scale (VAS) compared to baseline), 
and 2) absolute recovery (VAS pain  10 mm). The multivariate logistic regression 
analysis included 23 baseline characteristics.
Results. Patient-reported intensity of back pain decreased from 55.5 (SD 23.0) at 
baseline to 37.0 (SD 23.8), 35.3 (SD 26.1) and 32.3 (SD 26.9) at 2, 5 and 12-months 
follow-up, respectively. Younger age, back pain at baseline, no psychological/
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physical dysfunction (Symptom Check List-90, item 9) and higher baseline scores 
on the physical (PCS) and mental component scale (MCS) of quality of life (Short 
Form-36) were positively associated with recovery at 5 and 12 months. At 5-months 
follow-up, higher work participation at baseline was also a prognostic factor for both 
definitions of recovery. At 12-months follow-up, having comorbidity was predictive 
for both definitions. 
Conclusion. The results of this study indicate that in CNLBP patients bio-psycho- 
 social prognostic factors may be important for clinicians when predicting recovery 
in back pain intensity during a 1-year period.
Keywords. chronic non-specific low back pain; course; prognosis; cohort study; 
logistic regression
 
Introduction 
A recent study in the Lancet1 reported that low back pain stands out as the leading 
musculoskeletal disorder because of a combination of similarly high prevalence and 
a greater disability weight associated with this health state. Low back pain was one of 
the four most common disorders in all regions, and was the leading cause of years 
lived with disabilities (YLDs) in all developed countries. Low back and neck pain 
accounted for 70% of all YLDs from musculoskeletal disorders, and for every YLD due 
to neck pain there were 2.5 YLDs related to low back pain. The burden as estimated in this 
study is substantially higher than previously assessed 20 years ago. Across all countries 
surveyed, respondents consistently recorded high levels of health loss caused by pain. 
These findings combined with the 33.3% increase in YLDs from 1990 to 2010 driven 
largely by population growth and ageing have important implications for health systems. 
 Non-specific low back pain (NSLBP) is defined as pain and discomfort, localised 
below the costal margin and above the inferior gluteal folds, with or without leg. 
pain.2,3 Because this pain often leads to medical consultations and/or sick leave, 
there is considerable medical and socioeconomic impact on the individual, family 
and society.2,3 In the Netherlands, about 40-50% of the population experiences low 
back pain during a 12-month period. Also, about one-fifth of the adult population 
has reported CNLBP, i.e. symptoms present for  3 months4, and about 14% of the 
Registered disabled is incapacitated due to spine-related disorders.4 Therefore, 
the economic burden of CNLBP is particularly high and is compounded by the 
psychological burden on patients. Given the high prevalence, it is important to 
study risk factors for development, as well as the course of CNLBP and factors 
that influence its prognosis. Such information is important for patient education/ 
management and to develop interventions for CNLBP, especially if modifiable 
prognostic factors are identified. However, few data are available on the clinical 
course of CNLBP and the prognostic factors related to outcomes at follow-up.5
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 Therefore, this prospective cohort study aims to 1) describe the course of back 
pain intensity in patients with CNLBP after receiving multidisciplinary therapy, 
and 2) develop a prognostic model predicting recovery in these patients at 5- and 
12-months follow-up. 
Methods 
Study design and population 
Patients were recruited (January 2003-December 2008) in a multidisciplinary 
outpatient rehabilitation clinic the ‘Spine & Joint Centre’ (SJC) in Rotterdam, the 
Netherlands. Patients were evaluated by means of physical examinations and/
or questionnaires at baseline and at 2, 5- months at the location SJC and postal 
at 12-months follow-up. The Medical Ethics Committee of SJC approved the study 
protocol and all patients provided informed consent. Details on the study design of 
this prospective cohort study and intervention are published elsewhere.6
 Patients with CNLBP, not recovering after primary and/or secondary care were 
referred by their general practitioner (GP) or specialist to the SJC for a diagnostic 
consultation. Inclusion criteria for this study were: 1) men and women aged  18 years; 
2) with CNLBP (i.e., duration of low back pain for  3 months); 3) previous and 
insufficient treatment in primary and/or secondary care (e.g., physiotherapy); and 
4) signed informed consent. Exclusion criteria were insufficient knowledge of the 
Dutch language; signs indicating radiculopathy, asymmetric Achilles tendon reflex 
and/or (passive) straight leg raise test restricted by pain in the lower leg; positive 
magnetic resonance imaging findings for disc herniation; recent (< 6 months) fracture, 
neoplasm or recent previous surgery (< 6 months) of the lumbar spine, the pelvic 
girdle, the hip joint, or the femur; specific causes such ankylosing spondylitis and 
systemic disease of the locomotor system; and being pregnant or  6 months 
post-partum at the moment of consultation.
Outcome measures and defining recovery 
The outcome pain intensity is one of the 5 outcomes (back pain intensity, disability 
due back pain, work participation, quality of life and patients’ perceived recovery) 
measured in this prospective cohort study. The choice for the outcome pain intensity 
is because this is important to the patient and also the most published outcome 
measurement in prognostic studies,7 but the main objective of the rehabilitation 
program is normal behaviour of movements.8,9 To determine the course of back 
pain intensity in patients with CNLBP, the Visual Analogue Scale (VAS) was used 
(range 0 mm=no back pain to 100 mm=unbearable back pain). Recovery was 
defined in two ways based on a minimally clinical important change (MCIC) in low 
back pain (LBP) as described by Ostelo et al.10 and Helmhout et al.11 for intensity 
of LBP. 
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First, ‘relative recovery’’ was defined as a 30% or more improvement compared 
to baseline (considered a clinically relevant difference) on the VAS back pain at 
follow-up measurements.10,12 Second, ’absolute recovery’ was defined as a VAS score 
of  10 mm at follow-up measurement. 
Potential prognostic factors
Initially, 47 prognostic factors were considered relevant for inclusion in the analyses. 
However, to comply with the rule of at least 10 events per variable in the analysis, 
we had to restrict the number of potential prognostic factors.13 The choice for 
eligible factors was made using the policy Delphi procedure in which the factors 
were independently scored (on a 4-point Likert scale ranging from 1=very important 
to 4=not important) by 8 experts.5,14,15 The panel has experience in patients with 
CNLBP by research and/or working in the field, we consider them as experts. 
There were 3 rounds and each time the responses were aggregated, tabulated, 
summarized, and returned to the experts. In the third round the experts were asked 
to decide whether to keep or remove the factor from the list, through consensus 
meeting. The final list of consisted of 23 potential factors that were included by at 
least 80% consensus.9 The following continuous variables (measured at baseline) 
were used in the analysis: age, duration of back pain in years, present back pain 
intensity (VAS: 0-100 mm), degree of present fatigue (VAS 0-100 mm), Quebec Back 
Pain Disability Scale (QBPDS: 0-100), Tampa Scale for Kinesiophobia (TSK, 17-68), 
Short-Form Health survey 36 [SF-36, Physical Component Scale (PCS) and Mental 
Component Scale (MCS)], Symptom Checklist 90 (SCL-90; item 9; psychoneurosis), 
work participation (0-100%), and the B200 Isostation (strength of back extension 
in Newton). The following categorical variables (split into  2 categorical variables) 
were included: body mass index (BMI;  24.9, 25-29.9,  30 kg/m2), cause of back 
pain (accident movement; after physical load; during pregnancy or after delivery; 
unknown; surgery pelvis/back or herniated nucleus pulposus), pain in the previous 
3 months (stable; increased; decreased), and the duration of walking, sitting, 
standing (0-15, 16-30, 31-60, 61 min) during daily activities. Dichotomized variables 
were: gender, comorbidity (none vs. having one of more comorbidity), level of 
education (< high school vs.  high school/university), married/living with one 
adult (yes/no), previous rehabilitation treatment (no vs. one or more previous 
rehabilitation treatment) and employment status benefit (no vs. different types of 
government welfare benefits). For the excluded factors we refer to Verkerk et al..9
Treatment at the Spine & Joint Centre
The multidisciplinary treatment at the SJC centre used a bio-psychosocial approach 
consisting of 16 sessions of 3 h each during a 2-month period (total of 48 h). Patients 
were coached by a multidisciplinary team (e.g., a physical therapist, physician, health 
scientist, psychologist).6 
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After this 2-month period, patients are encouraged to continue the training program 
independently for at least 3 months, twice a week, in a local, regular health center 
located near their home environment.
Data analysis
Course of pain
Descriptive statistics were used to describe the patients course of back pain intensity 
at baseline, and at 2, 5 and 12-months follow-up. The percentage of patients with 
CNLBP defined as recovered based on a 30% improvement of the back pain 
intensity and absolute recovered (VAS pain  10 mm) at 2, 5 and 12 months follow- 
up was calculated.
Model development
Data from all patients with CNLBP receiving a multidisciplinary treatment were 
used to develop a prognostic model for back pain intensity recovery at 5 and 
12 months. 
Step 1. Using a correlation matrix, eligible prognostic factors were identified which 
were highly correlated (r > 0.8). This was the case for the B200 Isostation (strength in 
flexion, extension, lateroflexion, rotation) and the SCL-90 (item 1-8). Only the B200 
extension and the total score item 9 of the SCL-90 were included in the analysis.16
Step 2. The continuous factors were checked for linearity using spline regression 
curves; this revealed a non-linear relationship between BMI and the score on VAS 
pain for back pain. Therefore, BMI was changed into a categorical variable.17
Step 3. Imputation of missing values in the data was carried out by multiple imputa-
tions. A total of 5 imputed datasets were used.17-19 To develop our prognostic model 
a multivariable logistic regression analysis was performed.16,20-22 Results of 5 
imputed datasets were compared when 40 imputated datasets are used to see 
if the results would change; this number was used because in the initial model 
selection about 40% of the patients at 12 months was missing. Because the 
results were similar, 5 imputed datasets were used as primary analysis method. We 
also compared the results with complete case analysis (CCA), i.e. all patients with 
missing data were excluded from the analyses.16,18,19
Step 4. The most important prognostic variables were selected using a 
multi variable logistic regression analysis (stepwise method, backward likelihood 
ratio p < 0.157).16,23 The selection of variables was performed over all the imputed 
datasets using Rubin’s rules.24 To assess whether the level of significance 
influenced the final prognostic model for all models, the selection of variables 
was repeated with p-values of 0.05 and 0.157. 
Step 5. A sensitivity analysis was also performed using VAS cut-off values of  20 mm 
for absolute recovery and the same p-values.12,25,26 
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Missing data and the impact of nonresponders at baseline and 12 months follow-up 
was analysed by comparing patients’ with response status, using summary measures.
All analyses were done using SPSS version 18.0 (SPSS Inc., USA) and R software 
(R Foundation for Statistical Computing, Vienna, Austria). 
Performance of the prognostic model 
We checked the performance of the model with regard to the goodness of fit 
(Hosmer-Lemeshow test), the explained variation, and the discriminative ability 
of the model. The explained variation is the extent to which the outcome can be 
predicted by (the predictors in) the model in current dataset(s). The discriminative 
ability is reflected by the area under the receiver operating characteristics curve 
(AUC). The AUC represents the ability of the prognostic model to identify the patient 
who will recover from back pain intensity in two patients with different outcomes, 
and ranges from 0.5 (chance) to 1.0 (perfect discrimination).27 Bootstrapping 
techniques were used to internally validate our models, i.e. to simulate the perfor-
mance with respect to the explained variance and the AUC in comparable patient 
datasets.21,22,28,29
All analyses were done with SPSS version 18.0 (SPSS Inc., USA) and R software 
(R Foundation for Statistical Computing, Vienna, Austria). 
Results 
Population
A total of 1,760 patients [mean age 40.1 (10.6) years; 74.3% women] with CNLBP 
participated in the study. Of these, 1,695 (96.3%) completed the 2-month 
multidisciplinary treatment, 1,564 (88.9%) completed the 5-months follow-up and 
960 (54.5%) completed the 12-months follow-up. Table 1 presents the baseline 
characteristics of the 1,760 patients and the distribution of the possible prognostic 
factors . Responders at 12 months were likely to be female (77.0 vs 70.9%), married 
of living with one adult (90.2 vs 81.1%) and were more at work (53.1 vs 46.2%) 
than non responders (see appendix 1 for full details of baseline and 12 months follow-
up). There were no reported differences between responders and non responders 
on the main outcomes. 
Course of chronic low back pain
At baseline, the participants (n=1,760) reported a mean back pain intensity of 55.5 
(SD 23.0) on the 0-100 mm VAS; at the end of therapy (n=1,695) this had decreased 
to a mean of 37 (SD 23.8). At 5 and 12-months follow-up the remaining patients 
reported a mean score of 35.3 (SD 26.1) and 32.3 (SD 26.9), respectively (Table 2). 
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Table 1. Baseline characteristics of the study population (n=1,760)a  
Characteristic Patients (n=1,760)
Number of female patients 1,307(74.3)
Age in years: M (SD) 40.1(10.6)
Demographic factors
Low education 716(40.7)
Marital status/living with one adult 1,515(86.1)
Clinical status
Patients with BMI > 25* 783(44.5)
Duration of complaints in years: M (SD) 7.7(8.8)
Cause reported by patient:
   1 accident/wrong movement 374(21.3)
   2 after physical overload 73(4.1)
   3 during pregnancy or after delivery 586(33.3)
   4 surgery pelvis/back or after HNP 32(1.8)
   5 unknown 672(38.2)
Previous revalidation program 186(10.6)
Comorbidity 275(15.6)
Pain intensity LBP (VAS in mm): M (SD) 
   1 present pain intensity 55.5(23.0)
Pain intensity due to CNLBP in the previous 3 months 
   1 stable pain intensity 865(49.1)
   2 increased pain intensity 723(41.1)
   3 decreased pain intensity 120(6.8)
Degree of fatigue LBP (VAS in mm): M (SD) 
   1 present fatigue 56.5(26.6)
Disability (QBPDS): M (SD) 51.7(15.6)
Psychological factors
Fear avoidance (TSK): M (SD) 36.7(7.3)
SCL90 item 9 M(SD) 149.3(39.7)
SF-36 (health-related quality of life) 
   PCS 31.8(7.1)
   MCS 46.5(10.3)
Work-related factors
Employment status benefit 924(52.5)
Work participation 
   1 100% working 391(22.2)
   2 1-99% working 488(27.7)
   3 not working 689(39.1)
   4 retired 31(1.8)
Physical examination
ADL function – duration > 31 min without pain increase 
   1 walking 410(23.3)
   2 sitting 432(24.5)
   3 standing 106(6.1)
B200 Isostation (strength) (Newton): M (SD) 
   1 extension 81.6(45.8)
 
Values are numbers (percentages) unless stated otherwise.
a   M = mean; SD = standard deviation; BMI = Body Mass Index; CNLBP = chronic non-specific low back pain; 
VAS = Visual analogue scale; QBPDS = Quebec Back Pain Disability Scale; TSK = Tampa Scale Kinesiophobia ; 
SCL-90 (item 9)= Symptom Checklist; SF-36 = Short Form; PCS = Physical Component Summary; MCS = Mental 
Component Summary; ADL= activities of daily living. Missing values ranged from 0.5% (n=9) to 28% (n=493).
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 Compared with baseline, after 2 months therapy a 30% (or more) improvement 
on the VAS was reported by 904 patients (53.8%); at 5 and 12-months follow-up these 
data were 862 (55.2%) and 578 (60.5%) patients, respectively. 
 For absolute recovery from back pain, at baseline 66 patients (3.8%) had a 
score   10 on the VAS but were included in therapy for other outcomes, e.g. back pain 
disability, quality of life, or work participation.6 After 2 months therapy, 233 patients 
(13.7%) scored  10 on the VAS; at 5 and 12-months these data were 310 (19.8%) 
and 275 (28.6%) patients, respectively. 
Table 2. Course of back pain intensity scores in patients with chronic non-specific low 
back pain at 2-, 5- and 12-months follow-up
Baseline 
(n=1,608, 1,405)
5 months 
(n=820)
5 months 
(n=820)
12 months 
(n=589)
Back pain intensity (VAS): mean (SD) 55.5 (SD 23.0) 37.0 (SD 23.8) 35.3 (SD 26.1) 32.3 (SD 26.9)
30% improvement in pain (VAS) 53.8% 55.2% 60.5%
(904/1679) (862/1561) (578/955)
Absolute recovery on pain score  
(  10 points on VAS)
3.8% 13.7% 19.8% 28.6% 
(66/1755) (233/1695) (310/1564) (275/960)
VAS =Visual Analogue Scale; mean (SD= standard deviation), n=number of patients.
Relative recovery: prognostic models at 5 and 12-months follow-up
At 5-months follow-up, multivariate analyses resulted in a final model (AUC=0.66, 
95% CI 0.64-0.69) which included 9 prognostic factors, together explaining 11% 
of the variation in outcome: younger age, female gender, a higher BMI > 25 kg/m2 
at baseline, no previous rehabilitation treatment, more back pain intensity at 
baseline, no psychological/physical dysfunction (psycho-neuroticism) as measured 
with the SCL-90 (item 9), higher scores on the SF-36 PCS and MCS at baseline, 
and higher work participation at baseline (Table 3). The prognostic factor most 
strongly associated with improvement was a BMI of  25-29.9 kg/m2 (OR 1.27, 95% 
CI  0.99-1.62) and a higher work participation at baseline (OR 1.27, 95% CI 0.93-1.73).
 At 12-months follow-up the final multivariate regression model (AUC=0.65, 95% 
CI 0.61-0.67) included 9 prognostic factors, together explaining 10% variation in 
outcome: younger age, female gender, being married/living with one adult, higher 
level of education, no comorbidity, more back pain intensity at baseline, higher 
strength at the extension direction with the B200 Isostation at baseline, no fear of 
movement at baseline, and higher scores on the PCS with the SF-36. Being married 
or living with one adult (OR 1.6, 95% CI 0.99-2.57) was the strongest prognostic 
factor associated with a 30% improvement in recovery (Table 3).
 With regard to internal validation of the model, the explained variance was 
11% and the AUC was 0.66 (95% CI 0.64-0.69) for the 5-month model, compared 
with 10% and 0.66 (95% CI 0.61-0.67), respectively, for the 12-month model.
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Table 3. Multivariable models of prognostic factors for 30% improvement in chronic 
non-specific low back pain, back pain intensity at 5- and 12-month follow-ups
Variable
5-months follow-up 12-months follow-up
 OR 95% CI p-value OR  95% CI p-value
Age in years 0.98 0.97-0.99 < 0.001 0.98 0.96-0.99 0.03
Gender (male/ female) 0.80 0.62-1.03 0.09 0.72 0.49-1.07 0.10
Back pain intensity at 
baseline (VAS)
1.02 1.02-1.03 < 0.001 1.01 1.01-1.02 < 0.001
SF-36 PCS 1.05 1.03-1.08 < 0.001 1.04 1.02-1.06 < 0.001
Sf-36 MCS 1.02 0.99-1.04 0.07
SCL-90 (item 9) 0.99 0.99-0.99 0.03
BMI  25-29.9 kg/m2 1.27 0.99-1.62 0.06
BMI  30 kg/m2 1.04 0.74-1.47 0.81
Previous rehabilitation  
(yes/no)
0.68 0.50-0.94 0.02
Work participation 1.27 0.93-1.73 0.13
Education 1.30 0.93-1.82 0.11
Comorbidity (no/yes) 0.76 0.52-1.11 0.15
Married/being with one 
adult (yes/no)
1.60 0.99-2.57 0.05
B200 Isostation extension 1.00 0.99-1.01 0.13
TSK 0.97 0.95-0.99 0.02
95%-CI= 95% confidence interval, OR = odds ratio, an OR > 1 reflects a higher probability of 30% recovery 
for the outcome back pain intensity and an OR < 1 a lower probability of 30% recovery for the outcome back 
pain intensity, compared to the reference category. OR estimated after multiple imputation (n=5 datasets) 
with p-value of 0.157. VAS = Visual analogue scale; SCL-90 (item 9)= Symptom Checklist; SF-36 = Short 
Form; PCS = Physical Component Summary; MCS = Mental Component Summary. The variable BMI is a 
category value of 3 (18-24.9 kg/m2;  25-29.9kg/m2;  30kg/m2)
Sensitivity analysis for relative recovery 
For the 5-months follow-up, sensitivity analysis of the 30% improvement with 
p-values of 0.05 or 0.157, and using a CCA or 5 or 40 imputed datasets, yielded 
similar results on 6 of the 9 prognostic factors. Repeating the analyses at 12 months 
resulted in 5 of the 9 factors. Because (overall) similar predictors were included, this 
indicates that the most important prognostic factors were selected. In the various 
models, these sensitivity analyses showed an AUC of 0.64-0.68 at 5 and 12 months 
follow-up, with an explained variance of 8-11% that included 4-9 of the prognostic 
factors. 
 With regard to internal validation of the model, the explained variance was 
10-11%. For all models, at 5 months the AUC was 0.66. At 12-months follow-up the 
explained variance was 8-11% and the AUC was 0.64-0.66 AUC (complete data can 
be obtained from the first author).
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Absolute recovery: prognostic models at 5 and 12-months follow-up
The final multivariable model (AUC=0.69, 95% CI 0.66-0.72) for 5-months follow-up 
consisted of 6 prognostic factors, with an explained variance of 11% (Table 4): younger 
age, lower score on back pain at baseline, no psychological/physical dysfunction (psycho-
neuroticism on SCL-90 (item 9), higher scores on the SF-36 PCS/MCS at baseline, and 
more work participation at baseline. Work participation (OR 1.34, 95% CI 0.93-1.93) 
was the strongest prognostic factor in the model associated with absolute recovery.
 The final prognostic model for 12-months follow-up consisted of 8 factors: 
younger age, a higher BMI  30 kg/m2 at baseline, no comorbidity, less back pain 
at baseline, higher scores on the SF-36 PCS and MCS at baseline, higher disability 
score at baseline, and having stable or more back pain intensity due to CNLBP in 
the previous 3 months. The strongest prognostic factors associated with absolute 
recovery were stable or more back pain intensity due to CNLBP in the previous 
3 months (OR 1.42, 95% CI 1.02-1.99) and BMI  30 kg/m2 (OR 1.74, 95% CI 1.10-2.76). 
The explained variance was 18% with an AUC of 0.73 (95% CI 0.71-0.76). 
 With regard to internal validation of the model, at 5-months the explained 
variance was 11% and the AUC was 0.69 (95% CI 0.66-0.72); at 12-months follow-up 
this was 18% and 0.73 (95% CI 0.71-0.76), respectively (i.e., after the start of therapy 
and before/after analysing the internal validation).
Table 4. Multivariable models of prognostic factors for absolute recovery on chronic 
non-specific low back pain, back pain intensity (VAS  10 point) at 5- and 12-month follow-ups
Variable
5-months follow-up 12-months follow-up
 OR 95% CI p-value OR  95% CI p-value
Age in years 0.97 0.96-0.99 < 0.001 0.97 0.95-0.99 0.03
Back pain intensity at 
baseline (VAS)
0.99 0.98-0.99 < 0.001 0.98 0.98-0.99 < 0.001
SF-36 PCS 1.05 1.03-1.07 < 0.001 1.07 1.03-1.11 0.00
SF-36 MCS 1.02 0.99-1.04 0.13 1.02 1.01-1.04 0.02
SCL90 (item 9) 0.99 0.99-1.00 0.09
Work participation 1.34 0.93-1.93 0.11
BMI  25-29.9 kg/m2 1.25 0.84-1.87 0.25
BMI  30 kg/m2 1.74 1.10-2.76 0.02
Co morbidity (yes/no) 0.65 0.42-1.02 0.06
Course of pain intensity due 
to CNLBP in the previous  
3 months (increase of pain)
1.42 1.02-1.99 0.04
Course of pain intensity due 
to CNLBP in the previous  
3 months (decrease of pain)
1.62 0.76-3.47 0.19
Disability at baseline 
(QBPDS)
1.01 1.01-1.02 0.08
95%-CI= 95% confidence interval, OR = odds ratio, an OR > 1 reflects a higher probability of 30% recovery for the  
outcome back pain intensity and an OR < 1 a lower probability of 30% recovery for the outcome back pain intensity, 
compared to the reference category. OR estimated after multiple imputation (n=5 datasets) with p-value of 0.157. 
CNLBP = chronic non-specific low back pain; VAS = Visual analogue scale; SCL-90 (item 9)= Symptom Checklist; 
SF-36 = Short Form; PCS = Physical Component Summary; MCS = Mental Component Summary. The variable BMI 
is a category value of 3 (18-24.9 kg/m2;  25-29.9kg/m2;  30kg/m2). The variable Course of pain intensity due 
to CNLBP in the previous 3 months is a category value of 3 (0=stable, 1= increase of pain, 2=decrease of pain). 
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Sensitivity analysis for absolute recovery 
Sensitivity analysis of the cut-off for the VAS  10 mm with p-values of 0.05 or 0.157 
and/or 5 or 40 imputed datasets or CCA for the 5 and 12-months follow-up resulted 
in similar prognostic factors. In the various models, multivariate analyses showed 
an AUC of 0.68-0.76 for the 5 and 12-months follow-up that included 4-12 
prognostic factors, together explaining 10-15% of the variation. 
 With regard to internal validation of the model, at 5-months the explained 
variance was 10-12% and the AUC was 0.68-0.69 for all models compared with 
11-15% and 0.70-0.71 AUC at 12-months follow-up (complete data can be obtained 
from the first author).
Absolute recovery (VAS  20 mm) on back pain intensity
Repeating the analysis with a cut-off point of  20 for absolute recovery with 
p-values of 0.05 or 0.157 and/or 5 or 40 imputed datasets or CCA for the 5 and 
12-months follow-up resulted in similar prognostic factors. These analyses had an 
AUC of 0.70-0.73 for the 5 and 12-months follow-up that included 6-9 prognostic 
factors with an explained variance of 15-20%.
 For internal validation of the model, at 5 months the explained variance was 
16% and the AUC was 0.70 for all models, compared with 20% and 0.73, respectively, 
for the 12-months follow-up (complete data can be obtained from the first author).
Discussion
The course a CNLBP after 2 months of cognitive behavior therapy shows a decline of 
back pain that continued up to 1-year follow-up. Back pain continued to decrease, 
albeit more slowly, between 5 and 12-months follow-up. The most important finding 
of this prospective cohort study is that there were similarities in prognostic 
factors between the two definitions of recovery (at least 30% improvement and 
VAS  10 mm) and also at the different moments of follow-up. Recovery at 5 
and 12-months follow-up was associated with younger age, back pain intensity at 
baseline and higher baseline scores on the SF-36 PCS/MCS. For both definitions 
of recovery, at 5-months follow-up a higher work participation rate at baseline 
and no psychological/physical dysfunction (psycho-neuroticism) measured with 
the SCL-90 (item 9) were prognostic factors and at 12-months follow-up 
comorbidity was prognostic.
 The reported decrease in back pain intensity over a 1-year period is similar 
to other studies performed in the general population, primary or tertiary care.30-32 
Our study also showed that direct after the 2-month multidisciplinary cognitive 
behaviour therapy at the rehabilitation centre SJC, the patients experienced 
the greatest change in improvement compared to the baseline in all outcomes 
compared to 5 and 12 month follow-up.
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A similar pattern was reported in the first 4-6 weeks in a recent meta-analysis33 and 
other studies30,32,34 describing slowly advancing reductions in average pain and disability 
between 6 and 52 weeks. The duration of complaints in our study population was on 
average 7.7 years. Recent studies35,36 reports that most patients with back pain appear 
to follow a particular pain trajectory over longer time periods. It can be that a particular 
pain trajectory will have certain clinical characteristics. This could influence which 
prognostic factor is important as also the effect of a rehabilitation program.35 
 Our systematic review on prognostic factors in CNLBP patients showed no 
association between age and sex at  6 months follow-up and smoking at  12 months 
follow-up.5 Conflicting evidence was found at  6 months follow-up for fear of 
movement on back pain intensity; at  12 months follow-up conflicting evidence was 
found for the factors age, sex, work status and physical job demands and limited 
evidence for no association between the outcome back pain intensity and the factor 
social work.5 The present results are not in accordance with this latter review, with 
the exception that fear of movement has no association with back pain intensity 
at 5 and 12-months follow-up. The reason for these differences could be due to the 
quality of the studies included in the systematic review, i.e. the risk of bias was high 
in most studies and their statistical performance poorly described.5 
 Recovery is a complex construct and although there is no consensus on 
how it should be defined or measured, there is consensus on which outcomes 
are relevant in the process of recovery.12,25,37,38 A commonly used definition of a 
‘clinically meaningful improvement’ on back pain intensity is 30% improvement on 
a VAS score compared to baseline (15-20 mm).12,39 This definition gives clinicians 
and patients a useful threshold for identifying clinically meaningful improvement 
during a follow-up period or therapy process compared to natural fluctuations. 
However, apart from a 30% improvement, patients are also interested in prognostic 
factors to reach optimal/absolute recovery. The cut-off point on the VAS scale that 
classifies patients as ‘absolutely’ recovered is not yet known. The choice of outcome 
definition does make an important difference. Patients with severe back pain (high 
VAS score) at baseline are probably more likely to achieve a 30% change over time 
than to drop from a high baseline VAS score to a score of  10 mm. A systematic 
review by Kamper et al. described 3 studies that reported the complete absence 
of pain, whereas 3 other studies fixed a cut-off score on the instrument (e.g., VAS 
 10/100 mm; NRS  1/10).40 CNLBP did not have a higher cut-off score for pain 
and disability than acute NSLBP.25 Our study shows that the AUC and explained 
variance was higher for  20 mm than for  10 mm VAS, and 5 out of 6 factors 
were similar. However, selecting a higher cut-off will improve the sensitivity: i.e. a 
greater proportion of patients who consider themselves recovered, will be correctly 
classified. 
 Missing data for baseline assessment items ranged from 0.5-28%. At the 5 
and 12-month evaluations, 10.8% and 45.5% of the patients, respectively, did not 
respond (mainly due to not returning the follow-up questionnaires). 
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We expect that our data are ‘missing at random’, which is not uncommon in prognostic 
studies with a relatively long follow-up period. We chose to impute missing data 
by using known variables of the patients41; the multiple imputation procedure is 
assumed to be more valid than deleting participations with missing data from the 
analyses. Not using the full study sample, but only patients with complete data, can 
reduce the model’s validity.17,29,41 Also, performing sensitivity analyses to compare 
the data with more imputated datasets (n=40 and n=5), level of p-values of 0.05 
and 0.157 and CCA16,19,27,29 showed little or no difference in the identified prognostic 
factors; this reduces the risk of bias. Finally, the chance of overfitting our models by 
including too many variables was avoided by using a ‘rule of thumb’ to calculate the 
maximum number of variables. Finally, fewer variables were included in the models 
than was possible.24 
 In the current study, the prognostic models have typically c-index between 
0.6-0.85 (Royston et al., 2009) and normal confidence interval for the validation 
model.22 The low explained variance (R2) is higher than in other studies (Verkerk 
et al., 2012), but still recommending that other prognostic factors (e.g., physical 
parameters) may be of influence for the course of recovery.6 A larger group of 
patients when using relative recovery will benefit from the treatment given and 
are correctly identified compared to absolute recovery. Choice of cuff-off point 
determines a lot. However, there are patients that may also improve from less 
intensive or another treatment. The generalizability of the results is somewhat 
limited because the patients were recruited from a rehabilitation centre for tertiary 
care and all had received multidisciplinary treatment. A strength of the current 
study is that data was collected prospectively from a cohort of patients in one daily 
clinical care centre, so the risk of confounding will be lower. Comparison these results 
with other settings (e.g. primary care or tertiary care) is the next step to tests the 
generalizability of the results. However, cognitive behaviour therapy with supervised 
exercises, educational and multi-disciplinary treatment, is one of the most common 
intervention for CNLBP in Dutch rehabilitation centres. Two Cochrane reviews42,43 
provided evidence of a greater improvement on the short term than other treatments. 
During the 5-month follow-up at SJC information was collected on adherence, 70% of 
the patients followed the therapy program at 5 months. 
 Better pain management coupled with identification and modification of 
patients’ perception on back pain, being at work and their quality of life are clear 
targets for further research for interventions. More research is needed to clarify 
the course of patients with CNLBP and to establish whether our results are valid in 
other settings. A study in which patients complete a global perceived effect (GPE) 
which is then compared with back pain intensity (VAS) to determine when a patient 
experiences ‘complete’ recovery may provide more insight into the definition of 
‘absolute recovery’. The next step is external validation of the prognostic models to 
enable clinicians to eventually apply these models in daily practice.17
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Appendix 1. Baseline characteristics of the study population with chronic  
non-specific low back paina
Characteristic
Patients 
(n=1,760)
Responders 
(n=965)
Non-responders 
(n=795)
Significance
Number of female patients 1,307(74.3) 743(77.0) 564(70.9) .004*
Age in years: M (SD) 40.1(10.6) 40.6(10.7) 39.4 (10.4) .252
Demographic factors
Low education 716(40.7) 379(39.3) 337(42.4) .085 
Marital status/living with one adult 1,515(86.1) 870(90.2) 645(81.1) .000*
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Characteristic
Patients 
(n=1,760)
Responders 
(n=965)
Non-responders 
(n=795)
Significance
Clinical status
Patients with BMI > 25* 783(44.5) 424(43.9) 359 (45.2) .444
Duration of complaints in years: 
M (SD) 
7.7(8.8) 7.7(8.9) 7.5(8.7) .473
Cause reported by patient: .912
   1 accident/wrong movement 374(21.3) 201(20.8) 173(21.8)
   2 after physical overload 73(4.1) 42(4.4) 31(3.9)
   3  during pregnancy or after 
delivery
586(33.3) 330(34.2) 256(32.8)
   4 surgery pelvis/back or after HNP 32(1.8) 18(1.9) 14(1.8)
   5 unknown 672(38.2) 365(37.8) 307(38.6)
Previous revalidation program 186(10.6) 103(10.7) 83(10.4) .968
Comorbidity 275(15.6) 153(15.9) 122(15.3) .723
Pain intensity LBP (VAS in mm): 
M (SD) 
   1 present pain intensity 55.5(23.0) 54.5(22.8) 56.7(23.3) .551
Pain intensity due to CNLBP in the 
previous 3 months 
.206
   1 stable pain intensity 865(49.1) 495(51.3) 370(46.5)
   2 increased pain intensity 723(41.1) 382(39.6) 341(42.9)
   3 decreased pain intensity 120(6.8) 68(7.0) 52(6.5)
Degree of fatigue LBP (VAS in mm): 
M (SD) 
   1 present fatigue 56.5(26.6) 54.8(26.6) 58.7(26.5) .837
Disability (QBPDS): M (SD) 51.7(15.6) 50.4(15.1) 53.2(16.0) .032*
Psychological factors
Fear avoidance (TSK): M (SD) 36.7(7.3) 36.5(7.1) 36.9(7.6) .105
SCL90 item 9 M(SD) 149.3(39.7) 145.2(36.1) 154.6(43.4) .000*
SF-36 (health-related quality of life) 
   PCS 31.8(7.1) 32.3(7.0) 31.3(7.3) .505
   MCS 46.5(10.3) 47.3(10.1) 45.6(10.4) .462
Work-related factors
Employment status benefit 924(52.5) 481(49.8) 443(55.7) .059
Work participation .019*
   1 100% working 391(22.2) 222(23.0) 169(21.3)
   2 1-99% working 488(27.7) 290(30.1) 198(24.9)
   3 not working 689(39.1) 359(37.2) 342(43)
   4 retired 31(1.8)
Physical examination
ADL function – duration > 31 min 
without pain increase 
   1 walking 410(23.3) 238(24.7) 168(21.2) .440
   2 sitting 432(24.5) 261(27.1) 164(20.6) .042*
   3 standing 103(5.8) 57(5.9) 46(5.8) .291
B200 Isostation (strength) 
(Newton): M (SD) 
   1 extension 81.6(45.8) 81.2(42.1) 82.1(50.1) .000*
a   M= Mean; SD= standard deviation; LBP = low back pain; CNLBP = chronic non-specific low back pain; 
VAS = Visual analogue scale; SCL-90 (item 9)= Symptom Checklist; SF-36 = Short Form; PCS = Physical 
Component Summary; MCS = Mental Component Summary. The variable BMI is a category value of 
3 (18-24.9 kg/m2;  25-29.9kg/m2;  30kg/m2). The variable Course of pain intensity due to CNLBP in 
the previous 3 months is a category value of 3 (0=stable, 1= increase of pain, 2=decrease of pain); 
ADL=Activities in Daily Life. 
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CHAPTER 5
Prognosis and course 
of disability in patients 
with chronic non-specifi c 
low back pain: a 5 and 
12-months follow-up 
cohort study
Verkerk K., Luijsterburg P.A.J., Heymans M.W., Ronchetti I., Pool-Goudzwaard A.L., 
Miedema H.S., Koes B.W.
Phys Ther 2013, 93(12):1603-1614
 
 
Abstract
Background. Few data are available on the course of and predictors for disability in 
patients with chronic non-specifi c low back pain (CNLBP).
Objective. The purpose of this study was to describe the course of disability and 
identify clinically important prognostic factors of low-back-pain-specifi c disability in 
CNLBP patients receiving multidisciplinary therapy. 
Study Design. A prospective cohort study was conducted.
Methods. A total of 1,760 patients with CNLBP who received multidisciplinary 
therapy were evaluated for their course of disability and prognostic factors at 
baseline and at 2, 5- and 12-months follow-ups. Recovery was defi ned as a 30% 
reduction in low-back-pain-specifi c disability at follow-up compared to baseline and 
as absolute recovery if the score on the Quebec Back Pain Disability Scale (QBPDS) 
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was  20 points at follow-up. Potential prognostic factors were identified using 
multi variable logistic regression analysis. 
Results. Mean patient-reported disability scores on the QBPDS ranged from 51.7 
(SD=15.6) at baseline to 31.7 (SD= 15.2), 31.1 (SD 18.2), and 29.1 (SD= 20.0) at 2, 5, and 
12-months, respectively. The prognostic factors identified for recovery at 5 and 
12-months were younger age and high scores on disability and on the 36=Item 
Short-Form Health Survey (SF-36) (Physical and Mental Component Summaries) 
at baseline. In addition, at 5-months follow-up, a shorter duration of complaints 
was a positive predictor, and having no comorbidity and less pain at baseline were 
additional predictors at 12-months follow-up.
Limitations. Missing values at 5- and 12-months follow-ups were 11.1% and 45.2%, 
respectively.
Conclusion. After multidisciplinary treatment, the course of disability in patients 
with CNSPBP continued to decline over a 12-month period. At 5- and 12-months 
follow-ups prognostic factors were identified for a clinically relevant decrease in 
disability scores on the QBPDS.
 
Keywords. chronic low back pain; prognosis; outcome assessment; disability, cohort
 
Introduction
There is no strong evidence to support the claim that 80 to 90% of low back pain 
(LBP) patients become pain free within 1 month; on average, 62% (range=42%-
75%) of the patients still experienced back pain after 12 months.1 Studies following 
patients over a 12-month period have shown that LBP is characterized as having 
periodic attacks and temporary remissions, rather than being ‘’chronic’’.1-3 Shorter 
periods of temporary remissions are frequently seen in patients with chronic 
nonspecific low back (CNLBP) (  12 weeks) in combination with higher levels of 
limitations in activities.4 A recent meta-analysis5 reported that patients with acute, 
subacute (< 12 weeks), and persistent (> 12 weeks to 12 months) LBP experienced 
substantial reductions in pain and improvement in disability in the first 6 weeks, 
but only very small reductions in average pain and disability between 6 and 
52 weeks were demonstrated. The course of limitations in activities among 
patients with CNLBP varies per patient.4,6 Therefore, knowledge on the course 
and prognostic factors of disability experienced by patients with CNLBP might 
be clinically relevant for optimizing rehabilitation. The rehabilitation of normal 
patterns or activities of movements in patients with CNLBP is a focus during 
multidisciplinary treatment.7 
 A systematic review8 including patients experiencing LBP for less than 8 weeks 
identified risk factors for developing persistent, disabling LBP. Prognostic factors 
for the development of persistent LBP at 1-year follow-up were high maladaptive 
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pain coping behaviours, presence of nonorganic signs, high baseline functional 
impairment, low general health status and presence of psychiatric comorbidities. 
Low levels of fear avoidance and low baseline functional impairment were the most 
useful items for predicting recovery at 1 year. Our recent systematic review on 
prognostic factors in patients with CNLBP (  12 weeks) showed that, at short-term 
follow-up (  6 months), there was no association between age and sex on disability 
and that, at long-term follow-up (  12 months), there was no association among 
smoking, pain intensity, and fear of movement. Conflicting evidence was found at 
short-term follow-up for an effect of fear of movement on disability, and at long-term 
follow-up for the factors of age, sex, work status, physical job demands, sick leave 
and feelings of depression. Also, there was limited evidence for no association 
between the outcome disability and the factors leg. pain level and mobility. However, 
the methodological quality of the included studies was mostly poor (high risk 
of bias).9 
 Thus, overall, there is no strong evidence for associations that can help clinicians 
in their clinical decision-making to influence modifiable prognostic factors that 
might have a positive effect on disability. Therefore, the aims of this study were: (1) to 
describe the course of disability in patients with CNLBP (receiving multi disciplinary 
therapy) at 2-, 5- and 12-months follow-ups and (2) to identify prognostic factors 
of LBP-specific disability at 5 and 12 months after completing a multidisciplinary 
therapy program. 
Method
Study design and participations
Patients were recruited (January 2003-December 2008) at the Spine & Joint 
Centre (SJC), a multidisciplinary outpatient rehabilitation clinic in Rotterdam, 
the Netherlands. All patients provided informed consent. Detailed information 
on the study design has been published elsewhere.7 Participants were evaluated 
using mailed questionnaires and physical examinations at baseline and at 2, 5 
and 12-months.
Therapy program
The multidisciplinary treatment at the SJC used a biopsychosocial approach to 
stimulate patients to adopt adequate (movement) behavior aimed at physical 
and functional recovery. Patients with CNLBP not recovering after primary or 
secondary care were referred by their general practitioner (GP) or specialist 
to the SJC for a diagnostic consultation. Diagnostic consultation consisted of 
a 3-hour intake session in which the patient completed several questionnaires 
and undertook history taking and a physical examination.
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The physician could request an additional consultation with a psychologist or 
manual physiotherapist before deciding on treatment management. When patients 
were eligible for treatment, they were invited to participate in the study and informed 
consent was obtained. In the present study, LBP was defined as ‘’non specific’’ 
(i.e., without a specified physical cause, such as nerve root compression, trauma, 
infection or the presence of a tumour). Pain in the lumbosacral region is the most 
common symptom in patients with nonspecific LBP. Pain may also radiate to the 
gluteal region or to the thighs, or to both.10 Patients with CNLBP (complaints 
lasting  3 months) and not improving in primary care (mono-disciplinary) with the 
influence of psychological and social factors besides the physical factors on their 
complaints were invited to participate in the multidisciplinary treatment program. 
Those not eligible or not wanting to participate in this study were referred back 
to their GP.7
 The sample in the current study consisted of a survival cohort with the following 
inclusion criteria: (1) men and women aged 18 years and over, (2) having CNLBP 
(defined as LBP with a duration of  3 months; 3), (3) previous and unsuccessful 
treatment in primary or secondary care (e.g., physical therapy), and (4) signed 
informed consent. 
 Exclusion criteria were: (1) insufficient knowledge of the Dutch language; (2) 
signs indicating radiculopathy, asymmetric Achilles tendon reflex, or passive straight 
leg raise test restricted by pain in the lower leg.; (3) positive magnetic resonance 
imaging findings for disc herniation; (4) recent (< 6 months) fracture or neoplasm 
or recent previous surgery (< 6 months) of the lumbar spine, the pelvic girdle, the 
hip joint, or the femur; (5) specific causes such ankylosing spondylitis and systemic 
disease of the locomotor system; and (6) being pregnant or  6 months post-partum 
at the moment of consultation. 
 The therapy program consisted of 16 sessions of 3 hours each during a 2-month 
period (a total of 48 hours) coached by a multidisciplinary team (physical therapist, 
physician, health scientist, and psychologist). Behavioral principles were applied 
to encourage patients to adopt adequate normal behavioral movement aimed at 
physical recovery. The Quebec Back Pain Disability Scale (QBPDS) was measured to 
indicate the limitations in activity.7
 Five months after the start of the therapy program (2 months at the SJC + 
3 months self-supporting activity), the patients were measured at the 5-month 
follow-up at the SJC. At 12-months follow-up, the measurement was performed by 
means of questionnaires mailed to the patients. 
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Consulting with a physician
Patient history and a physical 
examination:
ASLR, PPPP, LDL, load transfer 
abduction and adduction strength,  
and neurological research
VAS pain and fatigue, QBPDS,  
TSK, work participation, and duration  
of standing, walking, bicycling, sitting 
and lying (in minutes)
In therapy for 2 months at SJC  
and 3 months self-management :
Start therapy: SF-36 , VAS pain  
and fatigue, QBPDS, TSK, GPE  
therapist and client, duration of 
standing, walking, bicycling,  
sitting and lying (in minutes)
Patient self-reported  
questionnaire by post: 
VAS pain and fatigue, QBPDS
Work participation, GPE client 
duration of standing, walking,  
bicycling, sitting and lying  
(in minutes)
Location SJC: 
VAS pain and ‘fatigue’, QBPDS, SF-36  
Work participation, GPE client and 
duration of standing, walking,  
bicycling, sitting and lying  
(in minutes)
Physical examination:
ASLR, PPPP, LDL, load transfer 
abduction and adduction strength
Diagnostic consultation   
(n=2,545)
12-months follow-up after  
start of therapy (n=965) 
Figure 1. Flow chart of the study design
ASLR= Active Straight Leg Raise test, PPPP= Posterior Pelvic Pain Provocation test, LDL= longum dorsal 
sacroiliac ligament, VAS= Visual Analogue Scale, QBPDS= Quebec Back Pain Disability Scale, SF-36=Short 
Form, TSK= Tampa Scale for Kinesiophobia, GPE=Global perceived effect, SJC= Spine & Joint Centre   
Not in therapy (n=785)    
In therapy (n=1,760) 
Two months after therapy  
at SJC 
5-months follow-up after  
start of therapy (n=1,564)
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Outcome criteria
Outcome criteria were based on a minimally important change in LBP as described 
by Ostelo and collegeues11,12 and Helmhout et al.13 for LBP disability. The QBPDS is 
a 20-item self-administered instrument designed to assess the level of functional 
disability in patients with back pain (score range= 0-100). Higher scores indicate 
more disability. The QBPDS has shown to be reliable, valid and responsive measure.14 
The QBPDS was completed by the patients; therefore, the scores were not blinded 
for putative prognostic factors. Recovery from disability was operationalized 
into 2 definitions: (1) 30% improvement in recovery compared to baseline11,12 (the 
QBPDS scores [0-100] were dichotomized into “no improvement in disability” and 
“improvement in disability,” using a reduction of 30% at follow-up compared with 
baseline as a clinically relevant difference,11-13) and (2) ‘’absolute recovery’’, which 
was defined as a QBPDS score of  20 points at follow-up.11,15-17
Prognostic factors
The baseline values of 47 prognostic factors were included in the analyses as 
important or potential prognostic factors. To comply with the rule of at least 
10 events per variable in the analysis (which avoids incorrect estimation of 
variables), we had to restrict the total number of potential prognostic factors.18 The 
choice for eligible factors was made: (1) using a policy Delphi procedure in which the 
factors were independently scored (on a 4-point Likert scale ranging from 1=very 
important to 4=not important) by 8 experts9,19,20, and (2) based on the results of 
a systematic review on prognostic factors for recovery.9,19,20 On the basis of the 
experts’ opinions and the systematic review, 23 potential prognostic factors were 
included (Table 1). 
 The continuous variables were: age, duration of back pain in years, present pain 
intensity (visual analog scale [VAS]: 0-100 mm), degree of present fatigue (VAS: 
0-100 mm), QBPDS score (range=0-100), Tampa Scale for Kinesiophobia (TSK) score 
(range=17-68), 36-Item Short-Form Health Survey (SF-36, Physical Component 
Summary [PCS] and Mental Component Scale [MCS]), Symptom Checklist-90 
(SCL-90; item 9; psychoneurosis) score, B200 Isostation (Isotechnologies, Hills -
borough, North Carolina) (back extension strength in Newtons) and work participation 
(0%-100%). Work participation was measured by dividing current work hours by 
former work employment hours prior to CNLBP. Some of patients were on partial 
sick leave due to back pain. Patients who were retired, not seeking work, unemployed 
as they have family care responsibilities gave no information. 
 The categorical variables were: body mass index (BMI:  24.9, 25-29.9,  30 kg/m2), 
cause of back pain (accident or wrong move made by the patient, after physical load, 
during pregnancy or after delivery, unknown, pelvis or back surgery or Herniated 
Nucleus Pulposus); course of pain in the previous 3 months (stable, increased, 
decreased); and the duration of walking, sitting, and standing (0-15, 16-30, 31-60, 
> 61 minutes) during daily activities.
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 The dichotomized variables were: sex, comorbidity (none versus having one or 
more comorbidities), level of education (less than high school versus high school/
university), married or living with one adult (yes/no), previous rehabilitation treatment 
(none versus one or more previous rehabilitation treatments), and employment 
status benefit (none versus different types of government welfare benefits).
 We excluded the following factors: weight, height, alcohol consumption, 
smoking, drug consumption, patient’s gradual or sudden onset of symptoms, pain 
intensity minimal and maximal (VAS: 0-100 mm), degree of fatigue minimal and 
maximal (VAS: 0-100 mm), and less work due to complaints, unemployment, fully 
working, other reasons. 
 The following physical examination tests were performed: long dorsal sacroiliac 
ligament, mobility by video registration, active straight leg raising (ASLR) test, 
performance of activities of daily living without an increase in pain, posterior pelvic 
pain provocation (PPPP) test, and isometric force of hip abduction and adduction.7 
The long dorsal sacroiliac ligament test (0= no pain; 1= complaint of pain without 
grimace, flinch, or withdrawal [mild]; 2 = pain plus grimace or flinch [moderate]; 3= 
the examiner is not able to complete the test because of withdrawal [unbearable] 
score is positive when bilateral sum score is  2 (score range=0-6; higher score 
indicates severity of the pain provocation test). Mobility by video registration 
assessed range of motion of the pelvis in flexion, the low back in
flexion, and the pelvis + low back in flexion. The ASLR test was scored by the GP 
and the patient (0= not difficult at all, 1= minimally difficult, 2= somewhat difficult, 
3= fairly difficult, 4= very difficult, 5= unable to do) is positive when the bilateral 
sum score is  2 (score range= 0–10; higher score indicates the severity of the load 
transfer disturbance from LBP). Activities of daily living (e.g., walking or bicycling 
in minutes [0 –15, 16–30, 31–60,  61]) without an increase in pain were assessed. 
The PPPP test, unilateral or bilateral (0= no pain, 1= pain unilaterally, 2= pain 
bilaterally) is positive when the bilateral sum score is  2 (0–2). Finally, isometric 
force of hip abduction (score: best to worse > 196–0 N) and adduction (score: best 
to worse > 129–0 N) were measured.7 
Statistical analyses 
Course of disability. Descriptive analyses were used to describe the patients’ scores 
on disability at baseline and at 2-, 5-, and 12-months follow-ups. Also described 
were the 2 definitions of recovery: 30% improvement in QBPDS score compared 
to baseline and the absolute recovery (  20 points on the QBPDS at follow-up 
measurement). These analyses were done on the entire data set, including missing 
values. 
Model building. All of the measures used in this study were conducted during 
normal daily practice of the rehabilitation center. Relevant factors were categorized or 
dichotomized for enhance more easy clinical interpretation of the results.
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Model building was done using the following steps:
Step 1. Eligible prognostic factors were identified which were highly correlated (r > 0.8). 
This was the case for the B200 Isostation (strength in flexion, extension, lateroflexion, 
rotation) and the SCL-90 (items 1-8). Only the B200 extension and the total score 
item 9 of the SCL-90 were included in the analysis.21
Step 2. Continuous factors were checked for linearity using spline regression curves. 
This step revealed a nonlinear relationship between BMI and the QBPDS score 
for disability. Therefore, BMI was changed to a categorical variable, which eases 
clinical interpretation.21
Step 3. Imputation of missing values in the data was carried out by multiple 
imputations. As a primary analysis, a total of 5 imputed datasets were used.21-23 
As a sensitivity analysis, the results were compared when 40 datasets were 
imputed. This number was selected because in the initial analysis, before backward 
selection (as a next step), about 40% of some of the patient data was missing. 
We also compared the results with complete-case analysis (CCA) (i.e., all patients 
with missing data were excluded from the analyses).21-23
Step 4. The most important prognostic variables were selected using a multi -
variable logistic regression analysis (stepwise method, backward: likelihood ratio 
P < 0.157).24-27 The selection of variables was performed over all the imputed 
datasets using Rubin’s rules of multiple imputation.28 To assess whether the level 
of significance influenced the selection of predictors in the final prognostic model 
for all methods described in step 3, the selection of variables was repeated with 
P values of 0.05 and 0.157. A sensitivity analysis also was performed using QBPDS 
cut-off values of  10 and  39 points.1 
Model performance
We checked the performance of the model with regard to the goodness of fit 
(Hosmer-Lemeshow test), the explained variation, and the discriminative ability. 
The explained variation of the model is estimated by Nagelkerke’s R2 statistic. 
Explained variation is the extent to which the outcome can be predicted by the 
model in the current datasets. The discriminative ability is reflected by the area 
under the receiver operating characteristics curve (AUC). The AUC represents the 
ability of the prognostic model to discriminate between patients who will recover 
from disability and those who will not recover from disability and ranges from 
0.5 (chance) to 1.0 (perfect discrimination).29
 Bootstrapping techniques were used to internally validate our models (ie. to 
simulate the performance with respect to the explained variance and the AUC in 
comparable patient datasets).25,26,30,31 All analyses were done using SPSS version 18.0 
(SPSS Inc, Chicago,Illinios) and R software (R Foundation for Statistical Computing, 
Vienna, Austria). 
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Results
This study included 1,760 patients with CNLBP (mean age= 40.1 years, SD 10.6; 74.3% 
women) (Figure 1). Of these patients, 1,696 (96.4%) completed the 2-month multidis-
ciplinary treatment, 1,564 (88.9%) participated in the 5-months follow-up, and 965 
(54.8%) completed the 12-months follow-up. Table 1 presents the baseline characteristics 
of the 1,760 patients and the distribution of the candidate prognostic factors.
Table 1. Baseline characteristics of study participants with chronic non-specific low 
back pain (CNLBP)a  
Characteristic Patients (n=1,760) Missing value n (%)
No. of female patients 1,307(74.3) 0
Age (y), M (SD) 40.1(10.6) 0
Demographic factors
Low education 716(40.7) 71(4.0)
Marital status, living with one adult 1,515(86.1) 46(2.6)
Clinical status
BMI > 25 kg/m2 783(44.5) 88(5.0)
Duration of complaints (y), M (SD) 7.7(8.8) 0
Cause reported by patient: 23(1.3)
   1 Accident/wrong movement 374(21.3)
   2 After physical overload 73(4.1)
   3 During pregnancy or after delivery 586(33.3)
   4 Pelvis/back surgery or after HNP 32(1.8)
   5 Unknown 672(38.2
Previous revalidation program 186(10.6) 101(5.7)
Comorbidity 275(15.6)  88(5.0)
LBP intensity (VAS in mm), M (SD) 
   present pain intensity 55.5(23.0) 5(0.3)
Course of pain intensity due to CNLBP in the  
previous 3 mo 
52(3.0)
   1 Stable pain intensity 865(49.1)
   2 Increased pain intensity 723(41.1)
   3 Decreased pain intensity 120(6.8)
Degree of fatigue LBP (VAS in mm), M (SD) 
   Present fatigue 56.5(26.6) 118(6.7)
Disability (QBPDS), M (SD) 51.7(15.6) 8(0.5)
Psychological factors
Fear avoidance (TSK), M (SD) 36.7(7.3) 50(2.8)
SCL-90 (item 9), M (SD) 149.3(39.7) 227(12.9)
SF-36 (health-related quality of life) 
   PCS 31.8(7.1) 493(28.0)
   MCS 46.5(10.3) 493(28.0)
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Characteristic Patients (n=1,760) Missing value n (%)
Work-related factors
Employment status benefit 924(52.5) 353(20.1)
Work participation 161(9.1)
   1 100% working  391(22.2)
   2 0-99% working 1,059(60.2)
   3 not working b  149(8.5)
Physical examination
ADL function, duration > 31 min without pain increase 
   1 Walking  410(23.3) 10(0.6)
   2 Sitting  432(24.5) 13(0.7)
   3 Standing 106(6.1)  9(0.5)
B200 Isostation (strength) (N), M (SD) 
   1 Extension 81.6(45.8) 107(6.1)
 a   Values are numbers (percentages) unless stated otherwise, of the entire data set of 1,760 patients. BMI 
= body mass index, HNP= herniated nucleus pulposus, LBP = low back pain, VAS = visual analogue scale, 
QBPDS = Quebec Back Pain Disability Scale, TSK = Tampa Scale for Kinesiophobia, SCL-90 = Symptom 
Checklist-90; SF-36 = Medical Outcomes Study36-Item Short Form Health Survey, PCS = Physical 
Component Summary, MCS = Mental Component Summary, ADL= activities of daily living. Missing values 
ranged from 0.5% (n=9) to 28% (n=493).
b   Not working= currently not working because of in search of new work or seeking due to family care 
responsibilities or being retired. 
Course of disability
At 2-months follow-up (n=1,696) the disability scores on the QBPDS decreased to a 
mean of 31.7(SD= 15.2) versus. a mean of 51.7 (SD= 15.6) at baseline. At 5- and 12-month 
follow-ups, these scores decreased to a mean of 31.1 (SD= 18.2) and 29.1 (SD= 20.0), 
respectively (Table 2).
 The predefined outcomes regarding recovery on the QBPDS disability score at 
follow-up showed the following results: (1) compared with baseline, 1,058 patients 
(62.6%) reported a 30% improvement in disability after 2 months therapy, 955 
patients (61.3%) reported improvement at the 5-months follow-up, and 611 patients 
(63.4%) reported improvement at the 12-months follow-up; and 2) for absolute 
recovery, 46 patients (2.6%) had a score  20 on the QBPDS at baseline; however, 
this finding is explained by the fact that additional patients were included for 
therapy based on other outcomes, such as pain intensity, quality of life or work 
participation.7 After 2 months therapy, 409 patients (24.1%) scored  20 on the 
QBPDS; at 5- and 12 month follow-ups these numbers were 484 (30.9%) and 
370 patients (38.3%), respectively. 
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Table 2. Course of disability scores in patients with chronic non-specific low back pain at 
2, 5 and 12-months follow-upa 
Measure
Baseline 
(n=1,752)
2 months 
(n=1,696)
5 months 
(n=1,564)
12 months 
(n=965)
Disability (QBPDS): mean (SD) 51.7 (SD 15.6) 31.7 (SD 15.2) 31.1 (SD 18.2) 29.1 (SD 20.0)
30% improvement in disability 
(QBPDS), % 
62.6% 61.3% 63.4%
Absolute recovery on disability score 
(  20 points on QBPDS), %
2.6% 24.1% 30.9% 38.3%
Back Pain (VAS) mean (SD) 55.5 (23.0) 37.0 (23.8) 35.3 (26.1) 32.3 (26.9)
Quality of life (SF-36)
   PCS, mean (SD) 31.9 (7.1) 40.7 (8.2)  42.1 (10.1)
   MCS, mean (SD) 46.6 (10.3) 49.2 (9.4) 50.4 (9.8)
Work participation,b mean (SD) 38.3 (43.1)  73.4 (44.9) 81.7(52.9)
a   QBPDS = Quebec Back Pain Disability Scale (range= 0-100, higher score means more disability), VAS = 
visual analogue scale (0-100, 0=no pain), SF-36 = Medical Outcomes Study 36-Item Short- Form Health 
Survey (range=0-100, higher score means better quality of life), PCS = Physical Component Summary, 
MCS = Mental Component Summary. Missing values ranged from 0.5% to 35.2%. SD= standaarddeviation
b  work participation (0%-100%) included those patients with paid work (n= 1,608)
30% improvement between baseline and 5- and 12-month follow-ups 
Table 3 shows the results of the multivariable logistic regression analyses of the 
potential prognostic factors regarding recovery defined as a 30% improvement 
in disability measured on the QBPDS at 5- and 12-month follow-ups.
 At 5-months follow-up, the prognostic factors were: being married or living 
with one adult, shorter duration of back complaints at baseline, younger age, higher 
disability score at baseline, no previous rehabilitation, decreased course of pain 
in the 3 months prior to baseline, more work participation at baseline, and higher 
scores on the SF-36 PCS and MCS. The AUC of this model was 0.68 and the explained 
variance was 12.8%. 
 At 12-months follow-up the prognostic factors were: being married or living 
with one adult, having no comorbidity, younger age, a higher education level, higher 
disability score at baseline, no previous rehabilitation, reporting low pain intensity 
at baseline, and a higher score on the SF-36 PCS. The AUC of this model was 0.66, 
and the explained variance was 10.7%.
 With regard to internal validation of the model, the explained variance at 
5-month follow-up was 12.8% and the AUC was 0.68 (before and after analyzing 
the internal validation); at 12-month follow-up these data were 10.7% and 0.66, 
respectively.
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Table 3. Multivariable models of prognostic factors for 30% improvement in chronic 
non-specific low back pain (CNLBP) disability at 5- and 12-month follow-up’sa
Variable
5-months follow-up 12-months follow-up
 OR 95% CI P OR  95% CI P
Married/living with one  
adult (yes/no)
1.32 0.93-1.87 .12 1.54 0.88-2.68 .12
Age 0.97 0.96-0.98 < .001 0.98 0.97-0.99  .01
Disability at baseline 
(QBPDS)
1.04 1.03-1.04 < .001 1.03 1.01-1.04  .001
Previous revalidation 
program (yes/no)
0.52 0.37-0.74 < .001 0.72 0.48-1.08 .11
Work participation 1.42 1.02-1.96 .04
SF-36 PCS 1.08 1.06-1.11 < .001 1.06 1.04-1.09 < .001
SF-36 MCS 1.03 1.02-1.04 < .001 1.02 1.00-1.03 .05
Course of pain intensity due 
to CNLBP in the previous  
3 mo (1= increase of pain)
1.05 0.84-1.32 .65
Course of pain intensity due 
to CNLBP in the previous  
3 mo (2=decrease of pain)
1.66 1.05-2.62 .03
Duration of complaints 0.98 0.97-0.99 .01
Comorbidity 0.61 0.42-0.90 .02
Education level 1.45 1.01-2.07 .04
Pain intensity at baseline 
(VAS)
0.99 0.99-1.00 .09
a   95% CI= 95% confidence interval, OR = odd ratio(an OR > 1 reflects a higher probability of 30% recovery 
for the outcome back pain disability and an OR < 1 reflects a lower probability of 30% recovery for 
the outcome back pain disability, compared with the reference category; OR estimated after multiple 
imputation [n=5 datasets] with P value of.157, VAS = visual analogue scale, QBPDS = Quebec Back Pain 
Disability Scale, SF-36 = 36-Item Short-Form Health Survey, PCS = Physical Component Summary, MCS = 
Mental Component Summary. The variable ‘’course of pain intensity due to CNLBP in the previous 3 mo’’ 
is a category value of 3 (0=stable, 1= increase of pain, 2=decrease of pain). 
Sensitivity analysis. Repeating the analysis with P values of 0.05 or 0.157, and using 
a CCA or 5 or 40 imputed datasets, resulted in more or less similar prognostic factors 
for a 30% improvement in recovery at 5- and 12-month follow-ups (Table 3). At 
5-months follow-up, only the factor being married or living with one adult was 
excluded in all final models. At 12-months follow-up, the SF-36 MCS and previous 
rehabilitation were included only once. The various models included 5 to 10 factors 
with an AUC range of 0.64 to 0.68 (exact data can be provided by the first author). 
 
Absolute recovery (QBPDS score  20 Points) at 5- and 12-month follow-ups 
Table 4 shows the results of the multivariable logistic regression analyses of the 
potential prognostic factors for absolute recovery (QBPDS score  20) at 5- and 
12-month follow-ups. The final prognostic model at 5-month follow-up included 
shorter duration of complaints at baseline, younger age, lower disability score at 
baseline, no psychoneurosis (SCL-90 item 9) and higher scores on the SF-36 PCS 
and MCS. The AUC of this model was 0.58 and the explained variance was 2.7%. 
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 At 12-month follow-up, absolute recovery was associated with a greater baseline 
strength in the trunk (B200 Isostation), no comorbidity,  60 minute walking duration 
at baseline, shorter duration of complaints at baseline, younger age, lower disability 
score at baseline, lower pain intensity at baseline, and higher scores on the SF-36 
PCS and MCS. The AUC of this model was 0.66 and the explained variance was 10.7%.
 With regard to internal validation of the model, the explained variance at 
5-month follow-up was 2.7% and the AUC was 0.58; for the 12-month follow-up 
these data were 18.6% and 0.72, respectively.
Table 4. Multivariable models of prognostic factors for absolute recovery on chronic non- 
specific low back pain disability (CNLBP) (QBPDS  20 Points) at 5- and 12-month follow-up’sa
Variable
5-months follow-up 12-months follow-up
 OR 95% CI P OR  95% CI P
Duration of complaints 0.98 0.97-1.00 .05 0.98 0.97-1.00 .05
Age 0.98 0.96-0.99 < .001 0.98 0.97-0.99 < .01
Disability at baseline 
(QBPDS)
0.97 0.96-0.98 < .001 0.99 0.98-1.00 .09
SF-36 PCS 1.07 1.04-1.10 < .001 1.05 0.99-1.11 .05
SF-36 MCS 1.03 1.01-1.05 .01 1.03 1.00-1.06 .05
SCL-90 (item 9) 0.99 0.99-1.00 .08
B200 Isostation extension 1.00 1.00-1.01 .09
Comorbidity 0.62 0.37-1.03 .07
Duration of walking 1  
(0-15 min)
1.13 0.85-1.49 .40
Duration of walking 2  
(16-30 min)
1.46 0.86-2.49 .15
Duration of walking 3  
(31-60 min)
1.63 1.00-2.66 .05
Pain intensity at baseline 
(VAS)
0.99 0.98-1.00 .08
a   95% CI= 95% confidence interval, OR = odd ratio(an OR > 1 reflects a higher probability of < 20 point 
Quebec Back Pain Disability Scale [QBPDS] for the outcome back pain intensity and an OR < 1 reflects a 
lower probability of < 20 point QBPDS for the outcome back pain intensity, compared with the reference 
category; OR estimated after multiple imputation [n=5 datasets] with P value of .157), VAS = visual 
analogue scale, SCL-90 (item 9)= Symptom Checklist-90, SF-36 = 36-Item Short-Form Health Survey. PCS 
= Physical Component Summary, MCS = Mental Component Summary. The variable ‘duration of walking’ 
is a category value of 4 (1=0-15 min, 2=16-30 min, 3= 31-60, 4= > 61 min). 
Sensitivity analysis. Repeating the analysis with P values of 0.05 or 0.157, and using 
a CCA or 5 or 40 imputed datasets, resulted in more or less similar results for the 
prognostic factors as reported in the 5-month follow-up model (Table 4). At the 
12 month, comorbidity, lower pain intensity (VAS), and the SF-36 MCS were included 
in all final models (except for 1 or 2 of the models). The other factors mentioned 
above for a QBPDS score  20 were reported or excluded only once or twice. The 
various models had 4 to 11 factors with an AUC range of 0.70 to 0.76.
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 Performing the sensitivity analysis with QBPDS cut-off scores of  10 and  39 
points, yielded similar results. Only at the cut-off score  39 points did some new 
prognostic factors emerge (i.e., higher education and previous rehabilitation at the 
5-month follow-up, no psychoneurosis (SCL-90 item 9) at 12-months follow-up, and 
more work participation at baseline). At 12-month follow-up the SF-36 MCS was 
excluded at the QBPDS score  39 points. The various models had 5 to 9 factors, 
with an AUC range of 0.68 to 0.82 (exact data can be provided by the first author). 
Discussion 
Main study findings
After 2 months of multidisciplinary therapy, patients with CNLBP showed a decrease 
in mean reported disability. At 5- and 12-month follow-ups, this trend continues but 
with a slight decrease in 30% improvement and also in absolute recovery (QBPDS 
score  20). 
 The present study explored potential prognostic factors at 5- and 12-month 
follow-ups for the outcome 30% improvement in recovery from baseline and 
absolute recovery (QBPDS score  20 score). All patients received multidisciplinary 
therapy based on behavioral principles.7 
 For 30% improvement in recovery compared with baseline, the prognostic 
factors at both 5- and 12-month follow-ups (P < .157) were married or living with one 
adult, younger age, higher disability at baseline, no previous rehabilitation, and a 
higher baseline score on the SF-36 PCS and MCS. 
 Younger age, less disability at baseline, shorter duration of back complaints 
at baseline, and a higher baseline score on the SF-36 PCS and MCS were predictors 
of absolute recovery (QBPDS score  20 points) at both 5- and 12-month follow-
ups. Despite having either severe or less severe disability at baseline, the difference 
between the 30% improvement (odds ratio > 1) and absolute recovery (odds ratio 
< 1) was relatively small (ie, an odds ratio (95% confidence interval) of around 
1.0. We can expect that patients with severe disability (high scoring on the 
QBPDS) at baseline will change 30% over time easier than going from a high score 
to  20 points. For example, a patient with a baseline score of 80 points on the 
QBPDS will easier decrease 30% (around 24 points) in his disability scale at follow 
up, then go from 80 points to less than 20 points. Thus, the choice of outcome 
definition makes the difference. 
 The sensitivity analysis shows similar prognostic factors for the defined 
recovery at both 5- and 12-month follow-ups; this finding indicates that the 
outcome recovery defined with QBPDS disability scores and the identified 
prognostic factors are similar, irrespective of the duration of follow-up within 1 year. 
At the 5-month follow-up, a shorter duration of back complaints at baseline was 
a positive prognostic factor for both 30% improvement and absolute recovery. 
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At the 12-month follow-up, having no comorbidity and less pain at baseline were 
positive prognostic factors for both outcomes. In general, younger patients and 
those with higher scores on the SF-36 PCS and MCS, had a higher odds ratio to 
recover from CNLBP. 
Strengths and Limitations
Prognostic model research includes 3 main phases: model development (including 
internal validation), external validation, and investigations of impact in clinical 
practice.32 To improve the quality of a prognostic study, the following considerations 
are important: (1) dealing with missing data, (2) modelling continuous prognostic 
factors, (3) the complexity of the model, and (4) checking the model assumptions.32 
Our study aimed to develop several models and determined the internal validation 
of these models. To our knowledge, this is one of the first studies that examined 
prognostic factors for good recovery of patients with CNLBP treated multidisci-
plinary team. 
 In the present study, one of the limitations is that several factors had missing 
values (range= 0.5%-28%). We decided to impute the missing data using information 
on the other variables in the dataset.33 At the 5- and 12-month follow-ups, 11.1% and 
45.2% of the patients, respectively, failed to return the follow-up questionnaires for 
a variety of reasons (e.g., vacation, envelope not stamped, recovered from disability, 
did not find it necessary, starting another intervention). The multiple imputation 
procedure is assumed to be more valid than simply omitting these participants 
from the analysis. Also, not including the full study sample but only those patients 
with complete data reduces the sample size and power and thus, the model’s 
validity.24,30,33 In addition, performing sensitivity analyses that compare the data with 
more imputed datasets (n=40 and n=5), with P value levels of .05 and .157, and the 
CCA improves the validation of the model.21,23,29,30 The sensitivity analysis revealed 
little or no difference in the identified prognostic factors. This findings indicates that 
the selection of the most important predictors was not strongly influenced by the 
selection criterion or by the amount of missing data. In all analyses, the CCA showed 
slightly higher standard errors (SEs) and coefficients compared to the imputed 
datasets. This finding indicates that, as expected, both the power and precision 
were increased by imputation.34 
 We dichotomized the outcome disability as recommended in some studies 
of LBP11,35,36 for ease of interpretation by clinicians and patients. Dichotomising 
continuous variables such as the QBPDS has some implications for the results: (1) 
information loss on patients outcome, (2) patients close to but on opposite sides of 
for example the cut-off point of 30% improvement are characterised as being very 
different rather than very similar, and (3) using 2 groups (e.g., improved versus. 
not improved) conceals any nonlinearity in the relation between the variable and 
outcome.37
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 Furthermore the values odds ratio (95% confidence interval), variance and AUC 
demonstrated in this study remained quite similar. An AUC of 0.5 to 0.7 is considered 
moderate discrimination; the explained variance ranged between 2.7% and 12.8% 
which indicates that other potential prognostic factors (e.g., physical parameters) 
should be considered to predict recovery of a patient. However, other studies in the 
field showed similar low ranges of explained variance.9  
 This current survival cohort represent patients with CNLBP persisting over 
a long time (mean= 7.7 years). Thus, the clinical course could differ between the 
patients recruited in an inception cohort, those with more complex in condition, 
and those having more complex factors that influence recovery.38 However, this 
study represented patients who did not recover in the Dutch primary care system 
and were eligible for a rehabilitation treatment. Therefore, comparison of the baseline 
characteristics may differ from other cohorts on CNLBP because most of them are 
inception cohorts and recruited in primary care setting.5 The generalizability of 
the results is limited because the patients were recruited in a rehabilitation centre 
for tertiary care and received multidisciplinary therapy. However, this is a group 
of patients who some patients as well as clinicians would believe cannot recover, 
whereas the present study shows potential for the future. 
Comparison with the literature 
In the present study, more patients were improved during 12-months follow-up 
based on a cut-off of 30% improvement compared with baseline than on a score 
of  20 points on the QBPDS. However, patients with a lower baseline score have 
less potential for improvement, and patients with more severe baseline disability 
need to perceive a greater improvement in order to feel that it is relevant.39 This 
findings promote discussion as to which cut-off point to use in daily practice: the 
clinical change (30%) that can be measured to show that someone is improving or 
to consider the wish of the patient who wants an absolute recovery. One possibility 
is to discuss these options in relation to the wishes and objections of the patient and 
clinician over time and perhaps combine these outcomes.
 Our results do not support the findings of our previous systematic review,9 except 
that fear of movement is not associated with disability at 5- and 12-month follow-
ups. Perhaps, as reported by others authors,4,40,41 the impact of fear of movement 
only plays a role in the transition from subacute to CNLBP. Nevertheless, because 
several multidisciplinary programs for patients with CNLBP mainly focus on fear 
of movement, the question arises whether this is an optimal choice for patients in 
this phase. Furthermore, we found several prognostic factors that have a positive 
association with disability such as younger age, and less pain intensity and more 
work participation at baseline; our systematic review found no studies with these 
associations with disability.9 In another study (149 patients with acute or CNLBP 
for 1 month, treated with manual therapy and spine strengthening exercises until 
discharge) the outcome disability was measured with Oswestry Disability Index at 
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a mean follow-up of 35.7 days (SD= 29.9); the reported prognostic factors similar 
to those in the present study were shorter duration of symptoms, lower Oswestry 
Disability Index score at baseline, and younger age.42 In essence, prognostic factors 
based on a single outcome measure may not fully represent all aspects of recovery 
from a multidimensional condition such as CNLBP.42 Our previous review also 
indicates that disability is not an ‘’isolated’’ condition but is associated with, for 
example, the degree of pain.9
Outcome Measurement 
This study benefited from the large sample size, its prospective design, and patients’ 
self-report. In the study of Davidson and Keating,43 the Oswestry Disability Question-
naire, the SF-36 Physical Functioning scale, and the QBPDS had sufficient reliability 
and scale width to be applied in an ambulatory clinical population with low back 
problems. The responsiveness of the questionnaires was similar, and the authors 
concluded that one questionnaire cannot be preferred over another based on the 
magnitude of the absolute values of responsiveness indexes.43
 The present study shows that, when determining the cut-off point for a clinically 
relevant recovery from disability, there is little difference between the two defini-
tions used (i.e., 30% improvement and absolute recovery defined as a QBPDS score 
 20) with regard to the identified prognostic factors. However, Table 2 shows that 
fewer patients were recovered at 12-month follow-up based on the absolute recovery 
compared with 30% improvement option (i.e., 38.3% versus 63.4%, respectively). 
Undoubtedly the cut-off points will differ based on the severity of symptoms within 
the study population, the condition of interest, and other factors.42 A study in which 
the global perceived effect scale of the patient (e.g., ‘’completely recovered’’) is 
compared with the score on the QBPDS may provide more insight into the most 
relevant cut-off point. 
Clinical Value
This study shows that in patients with CNLBP, positive predictors for recovery at 
5- and 12-month follow-ups are: younger age, higher scores on the SF-36 PCS and 
MCS and scoring higher on disability at baseline. For the 5-month follow-up, these 
positive predictors are shorter duration of complaints, and at 12-month follow-up, 
they are having no comorbidity and less pain at baseline. For daily practice, this study 
provides preliminary evidence for clinicians to estimate the prognosis for disability 
over a 1-year period based on easy-to-obtain baseline data. We have developed and 
internally validated prognostic model for recovery at 5- and 12-month follow-ups 
for patients with CNLBP in tertiary care. However, because the explained variance 
ranged from 2.7% to 12.8%, the results must be interpreted with caution. 
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Future Research
Future studies should identify the potential prognostic factors in different settings 
and over a longer period of time. These factors may provide more insight into the 
validity of the presented models. A subsequent step is external validation of the 
prognostic models with the aim to use them in daily practice.25 Overall, the results 
of this study indicate that biopsychosocial factors may be important in the course 
of and changes in disability level at 5- and 12-month follow-ups and that some 
preliminary prognostic factors can be identified. 
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Prognosis and course 
of work participation 
in patients with chronic 
non-specifi c low back 
pain: a 12-months 
follow-up cohort study
Verkerk K., Luijsterburg P.A.J., Pool-Goudzwaard A.L., Heymans M.W., Ronchetti I., 
Miedema H.S., Koes B.W.
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Abstract 
Question. What is the course of work participation in patients with chronic non-
specifi c low back pain (CNLBP) who followed a multidisciplinary treatment? Which 
prognostic factors are related to the course of work participation at 5 and 12-months 
follow-up? 
Design. A prospective cohort study. 
Participants. A total of 1,608 patients (mean age 39.5 years) were included after 
diagnostic consultation in a multidisciplinary rehabilitation centre.
Intervention. A 2-month multidisciplinary rehabilitation program. 
Outcome measures. Included were 23 potential prognostic factors of demographic, 
physical, clinical, psychological and work-related context. The outcome of interest 
was work participation. 
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Results. Patients reported an increase in work participation from (on average) 
38% at baseline to 82% after 12 months. Baseline factors affecting outcome at 
5-months follow-up were low back pain intensity, low work participation, duration of 
standing and the cause. The baseline factors younger age, higher education, lower 
work participation and higher mental scale component (SF-36) were associated 
with a 30% improvement in work participation at 12-months follow-up. Prognostic 
factors for absolute work participation (  90% work-participation) at 5 months 
were being married, female, a high score on the disability (QBPDS) and physical 
component scale (SF-36), previous rehabilitation, not receiving sickness benefits, 
and higher work participation at baseline. Higher work participation at baseline and 
female gender were also prognostic factors at 12-months follow-up.
Conclusion. At 12-months follow-up, these patients had increased their work 
participation. Several baseline characteristics associated with improvement in work 
participation at 5- and 12-months follow-up were identified. 
 
Introduction 
Currently, much research on low back pain (LBP) focuses on progression from the acute 
to a chronic stage and prognosis within the chronic stages.1,2 The natural course of 
LBP affects the ability to function in both work and personal life3,4 and less than 
two-thirds of patients who develop chronic non-specific low back pain (CNLBP) 
recover within 12 months.3 
 An Australian study that defined complete recovery as patients that are 
‘recovered from pain, disability and work status, showed that the prognosis is 
less favourable for those who have taken previous sick leave for LBP, have more 
disability or severe pain intensity at onset of CNLBP (> 3 months), have a lower 
education level, and perceive themselves as having a high risk of persistent pain.5 
 Our systematic review6 on prognostic factors of CNLBP at 12-month follow-up 
showed no association with the factor strength, and conflicting evidence for the 
association between return to work and age, sex, mobility and activities of daily 
living. At baseline, there was limited evidence for a positive influence of lower 
pain intensity and lower physical job demands on the outcome return to work. 
 More extensive information on the course and modifiable prognostic factors 
for improvement in work participation could be helpful for professionals to better 
inform their patients and to influence their return to work. Therefore, we formulated 
the following research questions:
1)  What is the course of work participation of patients with CNLBP managed in 
a multidisciplinary rehabilitation centre after 5- and 12-months?
2)   Which potential prognostic factors are associated with work participation in 
CNLBP patients at 5 and 12 months following a multidisciplinary treatment?
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Method
Design 
A prospective cohort study in CNLBP patients selected from a multidisciplinary 
outpatient rehabilitation clinic the Spine & Joint Centre (SJC) in Rotterdam, the 
Netherlands. All patients received several (postal) questionnaires and underwent a 
physical examination. Data were collected at baseline and at 2-, 5- and 12-months- 
follow-up. 
The Medical Ethics Committee of the SJC approved the study protocol and all 
patients provided informed consent. Details on the study design are described 
elsewhere.7
Participants
All CNLBP patients were recruited between January 2003 and December 2008 
at the SJC. Inclusion criteria were complaints lasting  3 months, aged  18 years, 
and previous unsuccessful treatment (e.g., physiotherapy) in primary or secondary 
care. For the analysis, in the present study, having a work contract at baseline 
was added as an extra inclusion criterion. Exclusion criteria were insufficient 
knowledge of the Dutch language, signs indicating radiculopathy, asymmetric 
Achilles tendon reflex and/or straight leg raise test restricted by pain in the lower 
leg, positive MRI findings for disc herniation, neoplasm, recent (< 6 months) 
fracture or surgery (< 6 months) of the lumbar spine, the pelvic girdle, the hip joint, 
or the femur, systemic disease of the locomotor system, and being pregnant or 
 6 months post-partum at consultation.
Intervention
The multidisciplinary treatment at the SJC centre used a bio-psychosocial approach 
consisting of 16 sessions of 3 h each during a 2-month period (total of 48 h). 
Patients were coached by a multidisciplinary team (e.g., a physical therapist, 
physician, health scientist, psychologist).7 
Prognostic factors and outcome
The selection of relevant prognostic factors was performed in two steps; 1) the 
literature on prognosis for CNLBP and work participation was reviewed, and 2) a 
clinical group of experts on CNLBP composed a list of 47 prognostic factors. Using 
the Policy Delphi method, this list was scored for importance (scored on a 4-point 
Likert scale ranging from 1=very important to 4=not important) by 8 experts 
working in different clinical settings.8,9 A total of 23 prognostic factors were finally 
included, complying with the rule of at least 10 events per variable in the analysis10 
(see Box 1). 
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Box 1. The 23 potential prognostic factors 
Continuous variables
1 Age
2 Duration of back pain in years
3 Present pain intensity (VAS: 0-100 mm)
4 Degree of present fatigue (VAS: 0-100 mm)
5 Quebec Back Pain Disability scale (QBPDS: 0-100)
6 Tampa scale for kinesiophobia (TSK, 17-68)
7  Short-form health survey 36 (SF-36); 
Physical Component Scale (PCS) (range 0 ‘’low quality of life’’-100 points)
8 Short-form health survey 36 (SF-36; 
 Mental Component Scale (MCS) (range 0 ‘’low quality of life’’-100 points)
9 Symptom Checklist 90 (SCL90;item 9; psychoneuroticism)
10 Work participation (0-100%)
11 B200 Isostation (strength back extension in Newton)
Categorical variables
12 Body Mass Index (BMI  24.9/ 25-29.9/  30 kg/m2)
13  Cause of back pain (accident movement; after physical load; during pregnancy 
or after delivery; unknown; surgery pelvis/back or HNP)
14 Course of pain in the previous 3 months (stable; increased; decreased)
15 Duration of walking (0-15/ 16-30/ 31-60/ > 61 minutes)
16 Duration of sitting (0-15/ 16-30/ 31-60/ > 61 minutes)
17 Duration of standing (0-15/ 16-30/ 31-60/ > 61 minutes)
Dichotomized variables
18 Gender
19 Comorbidity (no versus having one or more co-morbidities)
20 Marital status (being alone versus being married/living with one adult) 
21 Level of education (< high school versus  high school/university)
22  Previous rehabilitation treatment (no versus one or more previous  
rehabilitation treatments)
23  Sickness benefit (no versus all kinds of benefits from the government or employer)
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The outcome was work participation, which was defined by dividing ‘current work 
hours’ by ‘former work employment hours’ prior to CNLBP.7 Recovery of work 
participation was operationalised according to two definitions: 1) 30% improvement 
in work participation from baseline11-13 and 2) absolute work participation, defined 
as  90% work participation at follow-up.12,14,15
Data analysis
Descriptive analysis was performed to describe the course of work participation and 
patient characteristics. 
First, eligible prognostic factors were identified which were highly correlated (r > 0.8). 
This was the case for the B200 Isostation (strength in flexion, extension, lateroflexion, 
rotation) and the Symptom Checklist 90 (SCL90, items 1-8). Only the B200 extension 
and the total score (i.e., item 9) of the SCL90 were included in the analysis.16 The 
con - tinuous factors were checked for linearity using spline regression curves which 
revealed a non-linear relationship between body mass index (BMI) and work 
participation. 
 For all five outcomes belonging to the same study design, the same 23 
 prognostic factors were included.7 BMI was changed into a categorical variable. 
With regard to missing values, we applied multiple imputation of 5 datasets. Because 
in some patients 28% of data were missing, the results were compared with 40 
datasets and complete case analyses (CCA).16,17 
 To develop our prognostic model, multivariable backward logistic regression 
analysis was performed and initially included 23 potential factors. The variables with 
the highest p-value were removed one by one, until all remaining variables had a 
p-value of < 0.157.18-21 The selection of variables was done over all imputed datasets 
using Rubin’s rules.22 To assess whether the level of significance influenced the final 
prognostic model, the selection of variables was repeated with a p-value of 0.05. A 
sensitivity analyses was performed with different work participation cut-off values 
of 80% working and 100% working, and p-values of 0.05 and 0.157.12 
 The performance of the model was checked with regard to the goodness of fit 
(Hosmer-Lemeshow test), the explained variation, and the discriminative ability of 
the model. The explained variation of the model was estimated by Nagelkerke’s 
R squared. Explained variation is the extent to which the outcome can be predicted 
by (the predictors in) the model in current dataset(s). The discriminative ability is 
reflected by the area under the receiver operating characteristic curve (AUC) [range 
0.5 (chance) to 1.0 (perfect discrimination)].23
 Bootstrapping techniques were used to internally validate the models, i.e. to 
simulate the performance with respect to the explained variance and the AUC in 
comparable patient datasets.19,20,24,25 
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Results
Study population
The original cohort consisted of 1,760 patients, of which 1,608 had a work contract 
at baseline and were included (Figure 1). Table 1 presents the baseline characteristics. 
Mean age of the patients was 39.5 (SD 9.8) years and 73.1% of the patients were 
female. Of all patients, 1,059 patients worked 0-99% of their ‘former work employment 
hours’ implying that they had either productivity loss, or partial or complete sick 
leave. At baseline, mean duration of back pain complaints was 7.3 (SD 8.2) years. 
 Of all participants, 1,557 (97%) completed the 2 months multidisciplinary treatment, 
1,433 (89%) returned the 5-month follow-up and 886 (55%) returned the 12-month 
follow-up questionnaire. The main reasons for missing variables were incomplete or not 
returned questionnaires. 
Course
Table 2 presents the course of work participation at baseline, and at 5 and 12-months 
follow-up. At baseline, mean work participation was 38.3% (SD 43.1), at 5 months 
this had increased to 73.4% (SD 44.9) and at 12-months follow-up to 81.8% (SD 
52.9). Regarding the 30% work improvement, 30.3% reported work participation at 
5 months, increasing to 60.5% at 12-months follow-up. Absolute work participation 
(  90%) was present in 25.4% at baseline, 43.2% at 5 months and in 52.0% at 
12-months follow-up. 
Prognostic factors at 30% improvement work
Table 3 shows the multivariable backward stepwise logistic regression analysis between 
baseline variables and work participation at 5- and 12-months follow-up. At 5 months 
the following prognostic factors were present: low back pain intensity, low work partici-
pation, duration of standing (31-60 min) and the cause (accident or wrong movement) 
at baseline, with an explained variance of 59% and an AUC of 0.89. 
 At 12-months follow-up the multivariate regression model (AUC=0.90) consists 
of 4 prognostic factors explaining 60% of the variation: younger age, higher 
education, low work participation at baseline, and a higher Mental Component 
Summary (MCS) on the SF-36 at baseline. With regard to internal validation of the 
model, the explained variance was 59% and 60%, respectively, with an AUC of 0.89 
and 0.90 at 5 and 12-months follow-up, respectively. 
 The sensitivity analysis at 5 months showed that low back pain intensity and 
lower work participation were the most frequently mentioned factors. At 12-months 
follow-up, higher education level and lower work participation were most often 
reported. The factor lower work participation was present in all models at 5 and 12 
months. The CCA also revealed other factors in both the 5 and 12-months follow-up. 
At 5-months follow-up the explained variance was 47% and the AUC was 0.83- 
0.92 compared with 10-60% and 0.60-0.91, respectively, at 12-months follow-up. 
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Consulting with a physician
Patient history and a physical 
examination:
ASLR, PPPP, LDL, load transfer 
abduction and adduction strength,  
and neurological research
VAS pain and ‘fatigue’, QBPDS,  
TSK, Work participation, and  
duration of standing, walking,  
bicycling, sitting and lying  
(in minutes)
In therapy for 2 months at SJC  
and 3 months self-management:
Start therapy: SF-36, VAS pain and 
‘fatigue’, QBPDS, TSK, GPE therapist 
and client, Duration of standing, 
walking, bicycling, sitting and lying  
(in minutes)
Patient self-reported  
questionnaire by mail: 
VAS pain and ‘fatigue’, QBPDS
Work participation, GPE client 
Duration of standing, walking,  
bicycling, sitting and lying  
(in minutes)
Location SJC: 
VAS pain and ‘fatigue’, QBPDS, SF-36  
Work participation, GPE client and 
duration of standing, walking,  
bicycling, sitting and lying  
(in minutes)
Physical examination:
ASLR, PPPP, LDL, load transfer 
abduction and adduction strength
Diagnostic consultation     
(n=2,545)
12-months follow-up after  
start of therapy  (n=886) 
Figure 1. Study design
SJC=Spine & Joint Centre; ASLR= Active Straight Leg Raise test; PPPP= Posterior Pelvic Pain Provocation 
test; LDL= longum dorsal sacro-iliac ligament; VAS= Visual Analogue Scale; QBPDS= Quebec Back Pain 
Disability Scale; SF-36=Short Form; TSK= Tampa Scale Kinesiophobia; GPE=Global perceived effect. 
Not in therapy (n=785) 
Retired, unemployed or not 
working because of family  
care responsibilities (n=152) 
Included (n=1,608) 
5-months follow-up after  
start of therapy (n=1,557)
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Table 1. Baseline characteristics of 1,608 patients with chronic non-specific low back pain (CNLBP)a 
Characteristic Patients (n=1,608) Missing values(%)
Number of female patients 1,176(73.1) 0
Age in years: M (SD) 39.5(9.8) 0
Demographic factors
Low education level* 630(39.2) 3.7
Marital status/living with one adult* 1,386(88.2) 2.7
Clinical status
Patients with BMI > 25* 495(30.8) 4.7
Duration of complaints in years: M (SD) 7.3(8.2) 0
Cause reported by patient: 0.81
   1 accident/wrong movement 349(21.7)
   2 after physical overload 62(3.9)
   3 during pregnancy or after delivery 552(34.3)
   4 surgery pelvis/back or after HNP 27(1.7)
   5 unknown 605(37.6)
Previous revalidation program* 169(10.5) 5.5
Comorbidity 234(14.6) 4.7
Pain intensity LBP (VAS in mm): M (SD) 
   1 present pain intensity 55.4(22.9) 0.12
Pain intensity due to CNLBP in the previous 3 months 2.5
   1 stable pain intensity 804(51.3)
   2 increased pain intensity 648(41.4)
   3 decreased pain intensity 115(7.3)
Degree of fatigue LBP(VAS in mm):M(SD)* 
   1 present fatigue 56.67(26.6) 6.2
Disability (QBPDS): M (SD) 51.69(15.4) 0.19
Psychological factors
Fear avoidance (TSK): M (SD) 36.6 (7.3) 2.6
SCL90 item 9 M(SD) 149.3(40.0) 12.4
SF-36 (health-related quality of life) 
   PCS  31.8(7.1) 27.4
   MCS 46.5(10.3) 27.4
Work-related factors
Sickness benefit 891(67.1) 17.4
Work participation 9.8
   1 100% working 391(24.3)
   2 0-99% working 1,059(65.9)
Physical examination
ADL function – duration > 31 min without pain increase 
   1 walking 367(22.8) 0.31
   2 sitting 395(24.6) 0.56
   3 standing 96(6) 0.37
B200 Isostation (strength) (Newton): M(SD) 
   1 extension 82.6(46.3) 5.8
a*  these factors were reported when therapy started, or gathered from the personal status; values are numbers 
(percentages) unless stated otherwise; M = mean; SD = standard deviation; BMI = Body Mass Index; CNLBP =  
chronic non-specific low back pain; VAS = Visual analogue scale; QBPDS = Quebec Back Pain Disability Scale;  
TSK = Tampa Scale Kinesiophobia ; SCL-90 (item 9) = Symptom Checklist; SF-36 = Short Form; PCS = Physical 
Component Summary; MCS = Mental Component Summary; ADL= activities of daily living. Missing values ranged  
from 0.12% (n=2) to 27.4% (n=441). For work participation (n=1608 had a work contract) in 9.8% of cases there  
were missing values for ‘current work hours’ at baseline, therefore work participation could not be calculated. 
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Table 2. Course of disability scores in patients with chronic non-specific low back pain 
(CNLBP) at 5- and 12-months follow-up
Variable
Baseline 
(n=1,608, 1,405)
5 months (n=820) 12 months (n=589)
Work participation (mean, SD) 38.3 (SD 43.1) 73.4 (SD 44.9) 81.7 (SD 52.9)
30% improvement on work participation 30.3% 60.5%
(170/560) (125/376)
Absolute work participation (  90%) 25.4% 43.2% 52.0%
CNLBP= chronic non-specific low back pain; mean (SD= standard deviation), n=number of patients.  
Missing values ranged from 12.6% to 36.2%.
Table 3. Multivariable models of prognostic factors for 30% improvement in chronic 
non-specific low back pain, work participation at 5- and 12-month follow-ups
Variable
5-months follow-up 12-months follow-up
 OR 95% CI p-value OR  95% CI p-value
Back pain at baseline (VAS) 0.99 0.98-1.00 0.026
Duration of standing
   16-30 min 0.86 0.38-1.95 0.680
   31-60 min 0.39 0.15-1.06 0.065*
   61 min and longer 1.14 0.39-3.37 0.809
Cause
   After physical overload 1.69 0.51-5.62 0.37
    During pregnancy or after 
delivery
1.27 0.53-3.05 0.56
   Unknown 1.37 0.82-2.27 0.22
    Surgery pelvis/back or 
after HNP
2.27 0.14-36.42 0.51
Work participation (0-100%)
0.017 0.00-1.05 0.052 0.0095 (0.0024-
0.0380)
< 0.001
Age 0.97 (0.95-1.00) 0.068
Education 2.11 (0.90-4.92) 0.075
SF-36 MCS 1.03 (0.99-1.07) 0.152
95% CI= 95% confidence interval, OR = odds ratio, an OR > 1 reflects a higher probability of 30% recovery 
for the outcome work participation and an OR < 1 a lower probability of 30% recovery for the outcome work 
participation, compared to the reference category. OR estimated after multiple imputation (n=5 datasets) 
with p-value of 0.157. 
HNP= Hernia Nucleus Pulposus; SF-36 = Short Form; MCS = Mental Component Summary. 
Prognostic factors for absolute work participation (  90% at work)
Table 4 shows the results of the patients working  90% of their contract hours 
at 5- months and 12-months follow-up. At 5-months the factors remaining in the 
final model yield an explained variance of 30% with an AUC of 0.78. These factors 
were: being married or living with one adult, being male, high score on disability 
at baseline, previous rehabilitation, no sickness benefit, high work participation at 
baseline, and a high Physical Component Scale (PCS) score on the SF-36 at baseline. 
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At 12-months follow-up the explained variance was 17%, with an AUC of 0.70. Higher 
work participation at baseline and being male were identified as prognostic factors.
 At 5 and 12-months follow-up, internal validation of the model revealed an 
explained variance of 30% and 17%, respectively, with an AUC of 0.78 and 0.70, 
respectively. 
 At 5-months follow-up, sensitivity analyses demonstrated similarity in almost all 
of the prognostic factors between the different models. Only the CCA included some 
different factors. Work participation and being male were reported most frequently. 
For the 12-months analysis, higher work participation was present in every model, 
as were several other factors similar to the presented final models. At 5-months 
follow-up the explained variance was 28-30% with AUCs of 077-0.78 compared with 
11-17% and AUCs of 0.66-0.70 at 12-months follow-up. 
Table 4. Multivariable models of prognostic factors for absolute recovery on chronic 
non-specific low back pain (CNLBP), work participation (90%) at 5- and 12-month follow-ups
Variable
5-months follow-up 12-months follow-up
 OR 95% CI p-value OR  95% CI p-value
Married/living with one adult 
(no/yes)
1.72 (1.12-2.65) 0.01
Disability at baseline 
(QBPDS)
1.00 (0.997-1.02) 0.15
Previous revalidation 
program (no/yes)
1.85 (1.14-2.98) 0.01
Sickness benefit (no/yes) 0.52 (0.24-1.10) 0.08
Work participation (0-100%) 4.86 (2.35-10.04) < 0.001 5.22 (3.47-7.85) < 0.001
SF-36 PCS 1.05 (1.02-1.07) < 0.001
Gender (female/male) 1.99 (1.24-3.20) 0.09 1.79 (1.25-2.55) 0.003
95% CI= 95% confidence interval, OR = odds ratio, an OR > 1 reflects a higher probability of 90% recovery 
for the outcome work participation and an OR < 1 a lower probability of 90% work participation compared 
with the reference category. OR estimated after multiple imputation (n=5 datasets) with p-value of 0.157. 
QBPDS= Quebec Back Pain Disability Scale; SF-36= Short Form 36 questionnaire, PCS = Physical 
Component Summary. 
Discussion
New and important findings of this current study are that the course of work par ti -
ci pa tion showed a clear increase during the 12-months follow-up and various 
prognostic factors were identified of which some can be influenced by a clinician. 
To our knowledge, only long-term follow-up (  6 months) of prognostic factors have 
previously been reported.6 Short-term follow-up (  6 months) of work recovery is 
presented for the first time for this population with CNLBP. 
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 In the 5-months analysis the 30% work improvement is associated with (at 
baseline) low back pain intensity, low work participation, duration of standing (31-60 
min) and the cause of pain (accident or wrong movement), where as at 12-months 
analysis improvement is associated with (at baseline) younger age, higher education, 
higher MCS and lower work participation. In the 5-months analysis prognostic 
factors for absolute work participation were (at baseline) being married, male 
gender, high QBPDS score or PCS score, previous rehabilitation, no sickness 
benefits, and higher work participation. In the 12-months analysis (at baseline) 
higher work participation and being male were identified. No clear reason emerged 
for the difference between the definitions and models at 5 and 12-months follow- 
up, and the sensitivity analysis showed similar result. 
 A systematic review by Guzman et al. provides evidence that intensive multi -
disciplinary bio-psycho-social rehabilitation with a functional restoration approach 
improves pain and function in patients with CNLBP. Some trials reported improvements 
in work readiness, whereas others showed no significant reduction in sickness 
leave.26 Our study population received a therapy aimed at physical/functional 
recovery, which may partly explain the positive course of work participation. 
 In our systematic review, baseline lower pain intensity and physical job demands 
were found to be positive prognostic factors at 12 months.6 In the present study, 
baseline lower back pain intensity was associated with a < 30% improvement at 
5-months follow-up; details on physical job demands were not included in the 
present study. 
 This study has some limitations. First, it is unknown whether the patients had the 
same contract work hours at baseline and one year later. Also, it is unknown if patients 
returned to work to their former job, or to a job with adjustments, or to another job; 
details on contractual working hours were asked only at follow-up. A second limitation 
is that we were unable to limit missing data (0-27.4%) at baseline and during the 
following year (45% loss of patients at 12 months), because data were collected 
during the daily process in rehabilitation care. However, we assume our missing data 
to be ‘at random’, which is not uncommon in long-term follow-up. Imputation of 
data is a valid method16, and the sensitivity analyses showed similar results with 
a range of (low to high) explained variances (17-60%) and AUCs (0.66-0.90).
 The present study is part of larger investigation on a number of outcome 
measures, besides that of work participation.7 For all outcomes, the same 23 
prognostic factors were used in the multivariate regression models. Therefore, 
certain other variables such as socio-economic variables (e.g. bread winner), 
occupational variables (e.g., social security agency), job characteristics (e.g., 
job satisfaction) and other factors such as work attitude and help with personal 
problems, were not selected in this study.27 It is also possible that other potential 
factors have not been addressed in the present study. 
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 Clinical, work and psychosocial-related variables contribute to the development 
of improvement from CNLBP. The most promising variables over the 12 months appear 
to be staying at work and low psychosocial factors at baseline. These variables are 
relevant for clinicians in order to advise their patients with respect to treatment 
strategy and optimal chance to improve over time.
 We used contemporary statistical methods to internally validate the prognostic 
models. These methods reduce the tendency for variable selection procedures 
to produce overly optimistic estimates of model performance.19 Further research 
is recommended in other settings to enable clinicians to eventually apply these 
models.18
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course for successful 
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specifi c low back pain: 
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study 
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Abstract
This study investigates the clinical course of and prognostic factors for quality of 
life and global perceived effect (GPE) in patients treated for chronic non-specifi c 
low back pain at 5 and 12-months follow-up. Data from a prospective cohort (n=1,760) 
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of a rehabilitation center were used, where patients followed a 2-months cognitive 
behavior treatment. Quality of life was measured with the Short Form 36-item 
Health Survey (SF-36). The outcome ‘improvement in quality of life’ was defined 
as a 10% increase in score on the SF-36 at follow-up compared with baseline. 
On the GPE scale, patients who indicated to be ‘much improved’ were coded as 
‘clinically improved’. Multivariable logistic regression analysis included 23 baseline 
charac teristics. At 5-months follow-up, scores on the SF-36 Mental Component Scale 
(SF36; MCS) and the Physical Component Scale (SF-36; PCS) had increased from 
46.6 (SD 10.3) to 50.4 (SD 9.8) and from 31.9 (SD 7.1) to 46.6 (SD 10.3), respectively. 
At 5-months follow-up, 53.0% of the patients reported clinical improvement (GPE), 
which increased to 60.3% at 12-months follow-up. The 10% improvement in quality 
of life (SF-36 MCS) at 5-months follow-up was associated with patient characteristics 
and psychological factors. At 5-months follow-up, the 10% improvement in quality 
of life (SF-36 PCS) and GPE was associated with patient characteristics, physical 
examination, work-related factors and psychological factors; for GPE, an association 
was also found with clinical status. At 12-months follow-up GPE was associated with 
patient characteristics, clinical status, physical examination and work-related factors. 
The next phase in this prognostic research is external validation of these results.
Keywords. chronic non-specific low back pain; course; prognosis; psychological 
factors 
Introduction
Chronic non-specific low back pain (CNLBP) is one of the most prevalent health 
problems.1 Although it is known that physical, psychosocial and personal factors play 
a role, the way they interact with each other remains unclear. Several prognostic 
models for non-specific low back pain have been described; however, the prognostic 
factors varied depending on the choice of, for example, the prognostic variables, 
outcome definition, or the stage of pain (e.g., acute, sub-acute or chronic).2-4 A 
recent systematic review focusing on musculoskeletal complaints considered 
relevant for physical therapists in primary care, reported that the available 
prediction models are not yet ready to be applied in clinical practice because of 
their preliminary stage of development.5 Also, the available models for back pain 
patients need external validation and impact evaluation before applying them in 
daily practice.5 Compared to patients with (sub) acute NSLBP, patients with CNLBP 
are the least investigated regarding their course and prognosis, especially in relation 
to the outcomes ‘quality of life’ and ‘global perceived effect’ (GPE).4 Therefore, 
clinicians and researchers increasingly recognize the importance of such patient-
reported outcome measures in the evaluation of the effectiveness of treatment, 
prognosis or course of CNLBP.6 
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Achieving and maintaining the best possible quality of life is a primary goal of care 
and several questionnaires are available to measure this item, including the Short 
Form 36-items Health Survey (SF-36).7 
 With regard to evaluating GPE, the patient can be asked to rate how much their 
condition (i.e., important aspects of recovery) has improved or deteriorated since 
some predefined time point.8 
 The present study was designed to investigate the course of and identify prognostic 
factors (with internal validation) for quality of life and GPE in patients treated for CNLBP. 
 
Methods
Population
Patients were recruited between January 2003 and December 2008 in a prospective 
cohort study from a multidisciplinary outpatient rehabilitation clinic the Spine & Joint 
Centre (SJC; Rotterdam, the Netherlands). The Medical Ethics Committee of SJC 
approved the study protocol and all patients provided informed consent. Details on the 
study design are described elsewhere.9 Inclusion criteria were: 1) men and women aged 
 18 years; 2) having CNLBP defined as a duration of LBP for  3 months; 3) previous 
and unsuccessful treatment in primary and/or secondary care (e.g. physiotherapy). 
Patient didn’t improve in pain, function, work participation and quality of life. 
 Exclusion criteria were insufficient knowledge of the Dutch language; signs 
indicating radiculopathy, asymmetric Achilles tendon reflex and/or (passive) straight 
leg raise test restricted by pain in the lower leg; positive MRI findings for disc 
herniation; recent (< 6 months) fracture, neoplasm or recent previous surgery (< 6 
months) of the lumbar spine, the pelvic girdle, the hip joint, or the femur; specific 
causes such as ankylosing spondylitis and systemic disease of the locomotor system; 
and being pregnant or  6 months post-partum at the moment of consultation. 
 A total of 2,545 patients [mean age 40.4 (10.9) years; 73.3% women] visited 
the SJC for an intake consultation, but 785 patients [mean age 41.3 (11.5) years; 
70.3% women] decided not to start therapy (e.g., only wanted consultation, 
diagnose, advise, referred to another specialist, decided later not to come). Data 
were collected at baseline (n=1,760) and at 2 (n=1,696), 5 (n=1,564) and 12 (n= 965) 
months-follow-up10 during regular daily care at the SJC. 
Measurements
Outcome measures and defining recovery
To determine the course of quality of life in patients with CNLBP the SF-36 was 
used and, at 5 months, represented by the two SF-36 domains the Mental 
Component Scale (SF-36; MCS) and the Physical Component Scale (SF-36; PCS), 
both ranging from 0-100 (high quality of life).11-14
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Clinical improvement was measured at 2-, 5- and 12-months follow-up with the 
GPE score, which consists of a 5-point scale on global change (1=much improved, 
2=slightly improved, 3=no change, 4=slightly worsened, 5=much worsened).15 
The two instruments have shown to be reliable and valid.8,11,12,14,16
 Recovery was defined as a 10% improvement on the MCS or PCS compared 
to baseline. The scale was dichotomized into ‘no improvement in MCS or PCS’ and 
‘improvement in MCS or PCS’ based on an increase of 10% at follow-up compared 
to the baseline value; we considered this to be a clinically relevant difference. A 
clinically relevant improvement for these scales has not yet been defined, but beside 
empirical evidence an expert clinical interpretation and judgment is of value. An 
expert advised us that the most appropriate value for this kind of questionnaire is 
10%. Because the changes are smaller than the more common outcomes such as 
pain and disability. The SF-36 was only followed up to 5 months because this was 
done electronically at the SJC. The predefined time point for the GPE score8 was 
measured following 2 months of therapy at the SJC. In addition, patients judged their 
own improvement compared with this previous measurement, at 5 and 12-months 
follow-up. Patients who indicated ‘much improved’ were coded ‘clinically improved’ 
and patients who indicated ‘slightly improved’, ‘no change’, ‘slightly worsened’ or 
‘much worsened’ were coded as ‘clinically not improved’.15
Potential prognostic factors
The selection of relevant prognostic factors was performed in two steps: 1) the 
literature on prognosis for CNLBP and quality of life and GPE were reviewed17, and 
2) a clinical group of 8 experts on CNLBP composed a list of 23 of the 47 potential 
prognostic factors. All factors were retrieved from step 1 (with exception of the 
factor previous rehabilitation) in combination of the available variables at the SJC. 
Using the Policy Delphi method (scored on a 4-point Likert scale ranging from 1=very 
important to 4=not important)18,19, there were 3 rounds and each time the responses 
were aggregated, tabulated, summarized, and returned to the experts. In the third 
round the experts were asked to decide whether to keep or remove the factor from 
the list, through consensus meeting. The final list consisted of factors that were 
included by at least 80% consensus. Using these 23 variables, in the analysis we 
complied with the rule of at least 10 events per variable (which avoids incorrect 
estimation of variables), we had to restrict the total number of potential prognostic 
factors.20 (Box 1) The excluded prognostic factors can be obtained from the first 
author. 
Prognosis and course of quality of life and patients’ perceived effect in patients with chronic-specific low back pain     121 
Box 1. The 23 potential prognostic factors
Continuous variables
1 Age
2 Duration of back pain in years
3 Present pain intensity (VAS: 0-100 mm)
4 Degree of present fatigue (VAS: 0-100 mm)
5 Quebec Back Pain Disability scale (QBPDS: 0-100)
6 Tampa scale for kinesiophobia (TSK, 17-68)
7  Short-form health survey 36 (SF-36); 
Physical Component Scale (PCS) (range 0 ‘’low quality of life’’-100 points)
8 Short-form health survey 36 (SF-36; 
 Mental Component Scale (MCS) (range 0 ‘’low quality of life’’-100 points)
9 Symptom Checklist 90 (SCL90;item 9; psychoneuroticism)
10 Work participation (0-100%)
11 B200 Isostation (strength back extension in Newton)
Categorical variables
12 Body Mass Index (BMI  24.9/ 25-29.9/  30 kg/m2)
13  Cause of back pain (accident movement; after physical load; during pregnancy 
or after delivery; unknown; surgery pelvis/back or HNP)
14 Course of pain in the previous 3 months (stable; increased; decreased)
15 Duration of walking (0-15/ 16-30/ 31-60/ > 61 minutes)
16 Duration of sitting (0-15/ 16-30/ 31-60/ > 61 minutes)
17 Duration of standing (0-15/ 16-30/ 31-60/ > 61 minutes)
Dichotomized variables
18 Gender (female/male)
19 Comorbidity (no versus having one or more co-morbidities)
20 Marital status (being alone versus being married/living with one adult) 
21 Level of education (< high school versus  high school/university)
22  Previous rehabilitation treatment (no versus one or more previous  
rehabilitation treatments)
23  Sickness benefit (no versus all kinds of benefits from the government or employer)
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Treatment at the Spine & Joint Centre 
The multidisciplinary treatment at the SJC centre used a bio-psychosocial approach 
consisting of 16 sessions of 3 hours each during a 2-month period (total of 48 hours). 
Patients were coached by a multidisciplinary team (e.g., a physical therapist, 
physician, health scientist, psychologist).9
Data Analysis
Course of quality of life and GPE
Descriptive analysis was performed to describe the course of quality of life (SF-36; 
PCS and MCS) and GPE in CNLBP patients according to their characteristics.
 The percentage of patients defined as recovered based on a 10% improvement 
of the MCS and PCS at 2- and 5-months follow-up compared to baseline, was 
calculated. This was also done for GPE, ’clinically improved’ versus ‘not clinically 
improved’, at 2-, 5- and 12-months follow-up.
Model development
First, eligible prognostic factors were identified which were highly correlated 
(r > 0.8). This was the case for the B200 Isostation (strength in flexion, extension, 
lateroflexion, rotation) and the SCL-90 (items 1- 8). Only the B200 extension and 
the total score item 9 of the SCL-90 were included in the analysis.21 The continuous 
factors were checked for linearity using spline regression curves which revealed 
a non-linear relationship between body mass index (BMI) and the PCS, MCS or 
GPE. Therefore, BMI was changed into a categorical variable, and also used for the 
present study and the presented outcomes. 
 To develop our prognostic model, multivariable logistic regression analysis 
was performed.22-25 Regarding missing values, we applied multiple imputation of 5 
datasets.26 Regression equations are used to estimate the missing values. Results 
of 5 imputed datasets were compared when 40 imputed datasets are used to see if 
the results would change; this number of 40 was used because in the initial model 
selection 45.2% of the patients at 12 months (n=795) was missing (loss-to- follow 
up). Because the results were similar, 5 imputed datasets were used as the primary 
analysis methods. We also compared the results with complete case analysis (CCA), 
i.e. all patients with missing data were excluded from the analyses.27,28 
 To develop our prognostic model, multivariable backward logistic regression was 
performed and initially included 23 potential factors. The variables with the highest 
p-value were removed one by one, until remaining variables had p < 0.157.23-25,29 
The selection of variables was made over all imputed datasets using Rubin’s rules.30 
To assess whether the level of significance influenced the final prognostic model 
for all models, selection of the variables was repeated with p-values of 0.05. 
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With forward and stepwise selection important variables may be missed in the initial 
selection phase.31
 Sensitivity analysis was performed repeating all procedures using GPE as out come 
and with a different quality of life cut-off of a 30% improvement on the MCS and 
PCS with p-values of 0.05 and 0.157.15 
Performance of the prognostic model 
The performance of the model was checked with regard to the goodness of fit 
(Hosmer-Lemeshow test), the explained variation, and the discriminative ability of 
the model. The explained variation of the model was estimated by Nagelkerke’s R 
squared. Explained variation is the extent to which the outcome can be predicted 
by (the predictors in) the model in current dataset(s). The discriminative ability is 
reflected by the area under the receiver operating characteristic curve (AUC) [range 
0.5 (chance) to 1.0 (perfect discrimination)].32
 Bootstrapping techniques were used to internally validate the models, i.e. to 
simulate the performance with respect to the explained variance and the AUC in 
comparable patient datasets.23,24,33,34 
 All analyses were done using SPSS version 18.0 (SPSS Inc., USA) and R software 
(R Foundation for Statistical Computing, Vienna, Austria). 
Results
Population
A total of 1,760 patients [mean age 40.1 (10.6) years; 74.3% women] with CNLBP 
participated in the study. Of these 1,760 patients,1,696 (96.4%) completed the 
2-month multidisciplinary treatment, 1,564 (88.9%) participated in the 5-month 
follow-up, and 965 (54.8%) completed the 12-month follow-up after start of therapy. 
Table 1 presents the baseline characteristics of the 1,760 patients and the distribution 
of the possible prognostic factors.9
 The baseline characteristics of responders versus nonresponders at 5- and 
12-months were similar (data obtained by first author).
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Table 1. Baseline characteristics of 1,760 study participants with chronic non-specific low back paina
Characteristic Patients (n=1,608) Missing values(%)
Number of female patients 1,307(74.3) 0
Age in years: M (SD) 40.1(10.6) 0
Demographic factors
Low education level 716(40.7) 71(4.0)
Marital status/living with one adult 1,515(86.1) 46(2.6)
Clinical status
Patients with body mass index > 25 783(44.5) 88(5.0)
Duration of complaints in years: M (SD) 7.7(8.8) 0
Cause reported by patient: 23(1.3)
   1 accident/wrong movement 374(21.3)
   2 after physical overload 73(4.1)
   3 during pregnancy or after delivery 586(33.3)
   4 surgery pelvis/back or after HNP 32(1.8)
   5 unknown 672(38.2)
Previous revalidation program 186(10.6) 101(5.7)
Comorbidity 275(15.6) 88(5.0)
Pain intensity LBP (VAS in mm): M (SD) 
   1 present pain intensity 55.5(23.0) 5(0.3)
Course of pain intensity due to CNLBP in the previous 
3 months 
52(3.0)
   1 stable pain intensity 865(49.1)
   2 increased pain intensity 723(41.1)
   3 decreased pain intensity 120(6.8)
Degree of fatigue LBP (VAS in mm): M (SD) 
   1 present fatigue 56.5(26.6) 118(6.7)
Disability (QBPDS): M (SD) 51.7(15.6) 8(0.5)
Psychological factors
Fear avoidance (TSK): M (SD) 36.7(7.3) 50(2.8)
SCL90 item 9 M(SD) 149.3(39.7) 227(12.9)
SF-36 (health-related quality of life) 
   PCS 31.8(7.1) 493(28.0)
   MCS 46.5(10.3) 493(28.0)
Work-related factors
Sickness benefit 924(52.5) 353(20.1)
Work participation 161(9.1)
   1 100% working 391(22.2)
   2 0-99% working 1,059(60.2)
   3 not working* 149(8.5)
Physical examination
ADL function – duration > 31 min without pain increase 
   1 walking 410(23.3) 10(0.6)
   2 sitting 432(24.5) 13(0.7)
   3 standing 106(6.1) 9(0.5)
B200 Isostation (strength) (Newton): M (SD) 
   1 extension 81.6(45.8) 107(6.1)
a   Values are numbers (percentages) unless stated otherwise in the entire data set of 1760 patients. M = mean; SD 
= standard deviation; CNLBP = chronic non-specific low back pain; VAS = Visual analogue scale; QBPDS = Quebec 
Back Pain Disability Scale; TSK = Tampa Scale Kinesiophobia ; SCL-90 (item 9)= Symptom Checklist; SF-36 = Short 
Form; PCS = Physical Component Summary; MCS = Mental Component Summary; ADL= activities of daily living. 
Missing values ranged from 0.5% (n=9) to 28% (n=493). *’’not working’’ were patients not working at this moment 
due to seeking new work, or not seeking work because they have family care responsibilities or are retired. 
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Course and prognostic models of quality of life 
Course at 2- and 5-months 
At 2- and 5-months follow-up the mean MCS improved slightly from 46.6 (SD 10.3) 
at baseline to 49.2 (SD 9.4) at 2 months and to 50.4 (SD 9.8) at 5 months. The mean 
PCS also improved from 31.9 (SD 7.1) at baseline to 40.7 (SD 8.2) at 2 months and to 
42.1 (SD 10.1) at 5 months. At 5 months, a 10% improvement was reported by 20.6% 
of the patients with regard to the MCS score and by 76.3% with regard to the PCS 
score (Table 2).
Table 2. Course of quality of life (SF-36) and global perceived effect (GPE) in patients 
with chronic non-specific low back pain at 2-, 5- and 12-month follow-ups
Quality of life (SF-36)
Baseline 
(n=1,267)
2 months 
(n=1,252)
5 months 
(n=1,013)
12 months
   PCS; mean (SD) 31.9 (SD 7.1) 40.7 (SD 8.2)  42.1 (SD 10.1)
   MCS ; mean (SD) 46.6 (SD 10.3) 49.2 (SD 9.4) 50.4 (SD 9.8)
10% improvement in 
   PCS 76.6% 76.3%
   MCS 39.6% 20.6%
Global Perceived Effect Baseline  2 months
5 months 
(n=1,564)
12 months 
(n=965)
   1 much improved 45.1% 53.0% 60.3%
   2 slightly improved 44.1% 32.1% 19.1%
   3 no change 7.4% 9.3% 10.8%
   4 slightly worsened 3.1% 3.9% 5.7%
   5 much worsened 0.3% 1.8% 4.1%
Clinical improvement 45.1% 53.0% 60.3%
PCS= Physical Component Scale of the Short Form-36; MCS= Mental Component Scale of the Short-Form 
36; mean (SD = standard deviation), n = number of patients.
Prognostic factors for improved quality of life at 5-months follow-up
Table 3 shows the associations between potential prognostic factors and PCS and 
MCS at 5-months follow-up.
 The outcome of 10% improvement on the SF-36 PCS was most strongly 
associated with the following baseline scores: a BMI score  30 kg/m2 (OR 1.56, 95% 
CI 0.96-2.53), receiving sickness benefit (OR 1.90, 95% CI 1.08-3.34), a higher level 
of work participation (OR 2.03, 95% CI 0.93-4.41), and 16-30 min duration of walking 
(OR 1.78, 95% CI 1.08-2.97). The AUC of this model was 0.69 and the explained 
variance was 11%. 
 The factors most strongly associated with a 10% improvement on the MCS 
score were being female (OR 0.70, 95% CI 0.43-1.113) and having a lower MCS score 
at baseline (OR 0.82, 95% CI 0.79-0.84). The AUC of this model was 0.88 and the 
explained variance was 44%. 
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 With regard to internal validation of the models, for PCS the explained variance 
at 5-months follow-up was 12% with an AUC of 0.69; for MCS these figures were 
44% and 0.88, respectively. 
Table 3. Multivariable models of prognostic factors for 10% improvement in quality of 
life in patients with chronic non-specific low back pain at 5 months
Outcome and domains 5-months follow-up
Outcome Physical Component Scale  OR 95% CI p-value
Patient characteristics
Age in years 0.98 0.97-0.99 < 0.001
BMI  25-29.9 kg/m2 1.14 0.87-1.50 0.334*
BMI  30 kg/m2 1.56 0.96-2.53 0.07
Psychological factors
SF-36 PCS 0.94 0.92-0.96 < 0.001
SF-36 MCS 1.03 1.01-1.05 0.01
SCL-90 (item 9) 1.00 0.99-1.01 0.14
Work-related factors
Sickness benefit(no/yes) 1.90 1.08-3.34 0.03
Work participation 2.03 0.93-4.41 0.07
Physical examination 
Duration walking 1 (0-15 min) 1.19 0.75-1.89 0.419*
Duration walking 2 (16-30 min) 1.78 1.08-2.97 0.03
Duration walking 3 (31-45 min) 1.68 0.77-3.69 0.17*
Outcome Mental Component Scale  OR 95% CI p-value
Patient characteristics
Gender (female/male) 0.70 0.43-1.13 0.13
Psychological factors
SF-36 PCS 1.03 1.00-1.07 0.05
SF-36 MCS 0.82 0.79-0.84 < 0.001
SCL-90 (item 9) 0.99 0.99-1.00 < 0.001
95% CI= 95% confidence interval, OR = odds ratio, an OR > 1 reflects a higher probability of 10% recovery for  
the outcome PCS and MCS and an OR < 1 a lower probability of 10% recovery for the outcome back pain intensity, 
compared to the reference category. OR estimated after multiple imputation (n=5 datasets) with p-value of 0.157.
SCL-90 (item 9)= Symptom Checklist; SF-36 = Short Form; PCS = Physical Component Summary; MCS = 
Mental Component Summary. The variable body mass index (BMI) is a category value of 3 (18-24.9 kg/m2;   
 25-29.9 kg/m2;  30 kg/m2); the variable duration walking is a category value of 4 (0-15;16-30;31-45;60>).
Course and prognostic models of GPE 
Course at 5- and 12-months follow-up
At 5- and 12-months follow-up, clinical improvement was reported by 53% and 60.3% 
of the patients, respectively. In addition, at 5- and 12-months follow-up, ‘no change to 
much worsened’ was reported by 15% and 20.6% of the patients, respectively (Table 2). 
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Prognostic factors for GPE at 5- and 12-months follow-up
Table 4 shows associations between potential prognostic from the predefined time 
point (i.e., after 2 months of therapy at SJC) and GPE of the patients at 5- and 
12- months follow-up.
 Being married (OR 1.39, 95% CI 1.00-1.91), decrease of pain intensity in the last 
3 months (OR 2.07, 95% CI 1.23-3.48), receiving sickness benefit (OR 1.61, 95% CI 
0.96-2.69) and a higher work participation (OR 1.92, 95% CI 1.03-3.59) were the 
strongest factors associated with clinical improvement on the GPE scale at 5-months 
follow-up. At 12-months the following factors showed the strongest associations: 
being female (OR 0.63, 95% CI 0.47-0.84), being married (OR 1.51, 95% CI 1.03-2.21), 
higher work participation at baseline (OR 1.65, 95% CI 1.18-2.29) and duration of 
walking 16-31 min at baseline (OR 1.58, 95% CI 0.88-2.82). The explained variance 
and AUC for 5 and 12 months were 11% and 0.66, and 9% and 0.65, respectively. The 
internal validation showed similar results in the GPE for explained variance and AUC. 
Table 4. Multivariable models of prognostic factors for absolute recovery in chronic 
non-specific low back pain, global perceived effect (GPE) at 5- and 12-month follow-ups
Outcome and domains 5-months follow-up 12-months follow-up
Outcome GPE  OR 95% CI p-value OR  95% CI p-value
Patient characteristics
Age in years 0.97 0.96-0.99 < 0.001 0.98 0.97-0.99 0.002
Gender (female/male) 0.63 0.47-0.84 0.002
Married/being with one 
adult (no/yes)
1.39 1.00-1.91 0.05 1.51 1.03-2.21 0.03
Clinical status
Duration of complaints 0.99 0.97-1.00 0.05 0.98 0.97-0.99 0.02
Course of pain intensity due 
to CNLBP in the previous  
3 months (increase of pain)
1.05 0.84-1.30 0.681*
Course of pain intensity due 
to CNLBP in the previous  
3 months (decrease of pain)
2.07 1.23-3.48 0.007
Back pain intensity (VAS) 1.00 0.99-1.00 0.09 0.99 0.98-0.99 < 0.001
Disability (QBPDS) 1.01 1.00-1.02 0.01
Psychological factors
TSK 0.97 0.96-0.99 0.005
SF-36 PCS 1.05 1.03-1.07 < 0.001
Sf-36 MCS 1.02 1.00-1.03 < 0.001
Work-related factors
Sickness benefits (no/yes) 1.61 0.96-2.69 0.07
Work participation 1.92 1.03-3.59 0.04 1.65 1.18-2.29 0.005
Physical Examination
B200 Isostation extension 1.00 0.99-1.00 0.08
Duration walking 1 (0-15 min) 1.00 0.74-1.36 0.99*
Duration walking 2 (16-30 min) 1.58 0.88-2.82 0.11
Duration walking 3 (31-45 min) 1.32 0.89-1.96 0.16
95%-CI= 95% confidence interval, OR = odds ratio, OR estimated after multiple imputation (n=5 datasets) 
with p-value of 0.157. VAS= Visual Analog Scale; QBPDS = Quebec Pain Disability Scale; SF-36 = Short Form; 
PCS = Physical Component Summary; MCS = Mental Component Summary. The variable course of pain 
intensity due to CNLBP in the previous 3 months is a category variable, 1) increase, 2) decrease and 3) 
stable of pain intensity; the variable duration walking is a category value of 4 (0-15;16-30;31-45;60>)
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Sensitivity analysis regarding quality of life and GPE
Repeating the analysis with p-values of 0.05 or 0.157, and using CCA or 5 or 40 
imputated datasets, resulted in similar prognostic factors for a 10% improvement in 
the PCS, MCS and GPE-score at 5-months follow-up. At 12-months, younger follow-up 
age, less pain intensity at baseline, higher work participation or shorter duration 
of complaints were often related to GPE in the different models. The explained 
variance, AUC and internal validation were similar to earlier findings. 
Discussion
In the present study, a main finding is the sustained 10% improvement on the PCS 
(76.3% of the population) up to 5-months and on GPE (60.3%) up to 12-months. 
For MCS this 10% improvement is slightly less (20.6%) at 5-months, but a mean of 
50 (SD of 10) represents normal health and function.14 Some patients reported no 
improvement on GPE at 5- and 12-months follow-up (15% and 20.6%, respectively). 
 The present study shows that improvement in quality of life (on SF-36 MCS) 
at 5- months follow-up was associated with patients’ characteristics and psycho-
logical factors. At 5 months, improvement on quality of life (on SF-36 PCS) and GPE 
was associated with patients’ characteristics, physical examination, work-related 
factors and psychological factors. For GPE, clinical status was also associated with 
improvement. 
 At 12-months follow-up GPE was associated with patients’ characteristics, clinical 
status, physical examination and work-related factors. The sensitivity analyses 
showed overall similarity for the prognostic factors. The prognostic models provide 
additional information to present a more realistic expectation regarding outcome. 
However, development of a prognostic model does not involve investigating the 
causal associations between individual prognostic factors and outcome.
 Comparison of the present results with earlier studies is limited, because our 
systematic review identified only 3 low-quality studies addressing this topic.4 For 
the outcome SF-36 PCS, Keeley et al. had a 6-months follow-up with a mean SF-36 
PCS score of 34.9 (SD 10.9) compared with a baseline score of 33.3 (SD 10; n=93).35 
The present study showed a greater improvement on the PCS score, i.e. from 31.9 
(SD 7.1) at baseline to 42.1 (SD 10.1) at 5 months. The difference in results might be 
due to differences in study characteristics; e.g. patients in the study of Keeley et 
al. did not follow a therapy program but could contact their healthcare provider 
when needed35; the authors concluded that an intervention targeting these psycho-
social variables in patients, may lead to improved quality of life and reduction of 
healthcare costs.35 A study by van der Hulst et al.36 from the same systematic review 
on SF-36 PCS and MCS, showed more similarity with the present study at 6-months 
follow-up. 
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Their patients with CNLBP experienced (on average) better health-related quality of 
life than at baseline, regardless of the type of treatment [Roessingh Back Rehabilita-
 tion Program (RBRP) vs. usual care]. At follow-up the RBRP (7-week program) 
resulted in a PCS score of 37 (SD 9) and an MCS score of 51 (SD 9) compared with 
baseline scores of 31 (SD 7) and 49 (SD 10), respectively.36
 In relationship to the course of GPE, our systematic review4 found only one 
study, which reported that 29% of the non-surgical group assessed themselves as 
improved at 2-year follow-up.37 In contrast, 60.3% of our patients reported clinical 
improvement on the GPE scale at 12-months follow-up. 
 In the final prognostic model on PCS reported by Keeley et al.35, the Hospital 
Anxiety and Depression Scale (HADS) total score and back-pain related social stress, 
continued to make a significant contribution to the model (R2 = 0.72; incidence rate 
ratio around 1.00). In the present study, the psychological factors [SCL-90 (item 
9) and MCS; OR around 1.00] were included, as were other factors with a strong 
association. In both studies, the psycho-social results had a low association; further 
research on these items is necessary. 
 In the present study no association was found for the factor ‘fear avoidance 
beliefs’ and the outcome PCS. In two of the studies in our systematic review4 
conflicting evidence was found for their 8-week36 and 6-month35,36 follow-up, 
whereas the 6-month follow-up data of Keeley et al.35 are similar to those in the 
present study. The discrepancy between these results may be due to differences 
in characteristics between the two studies, including a smaller patient population 
(n < 200), differences concerning treatment/no treatment, in the length of follow-up 
(8 weeks), and in the included prognostic factors. In the 2-months therapy at the 
SJC and in the 7-week RBRP program of van der Hulst et al.36, fear of avoidance 
beliefs was a part of the program but yielded differing results, possibly due to other 
aspects of the therapy program. In van der Hulst’s study, presence at work predicted 
improvement for the PCS at 6-months follow-up36, which is in line with our results 
at 5-months follow-up. This might be explained by the fact that people at work are 
generally healthier and more physically active, which may be related to greater 
physical wellbeing. However, because this comparison is with only one study, more 
research is needed on this topic. Also, in van der Hulst’s study, whereas higher 
depression scores (SCL-90-dep) predicted deterioration on the MCS on the short and 
long-term follow-up regardless of treatment36, this was in contrast to our results. 
 For the outcome GPE only one study was found4, reporting that increased 
pre-treatment depressive symptoms measured with the Zagazig Depression Scale 
predicted improvement of the GPE score in a non-surgical group of CNLBP patients37, 
We found no association with the SCL-90 (item 9) in the final model at 5- and 12- 
months follow-up. 
 The present study benefited from a large sample size (n=1,760), prospective design, 
and patients’ self-report. Although there are many ways to build a prognostic model 
(including internal validation), we followed the optimal way as reported in the literature.38 
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We used the rule of 10 events per variable to minimize the risk of bias due to 
over fitting. 
 The outcome quality of life and GPE were two of the 5 outcomes (back pain 
intensity, disability due back pain, work participation, quality of life and patients’ 
perceived recovery) measured in this prospective cohort study. The choice for 
these current outcomes is because this is important to the patient and also only 
a few other studies are known. 
 Of all patients, 90.2% had stable or increased low back pain intensity in the 
3 months prior to intake.10 The duration of complaints in our study population was 
on average 7.7 years. During the 12 months there we those patients that recovered 
from back pain, those who experience it off and on and those who have it most of 
the time.39-41 Recent studies39,40 reports that most patients with back pain appear 
to follow a particular pain trajectory over longer time periods, and do not have 
frequently recurring of widely fluctuating patterns. It can be that a particular 
pain trajectory will have certain clinical characteristics. This could influence which 
prognostic factor is important as also the effect in rehabilitation.39 
 The present study also has some limitations. First, despite the large sample size, 
at baseline there were missing values (0.5-28%). Also, at 12-months follow-up only 
54.5% of the patients could be compared with the baseline measurements. Our 
study gathered the data at the rehabilitation centre SJC during daily practice and 
at 12 months this was done postal. The SF-36 (28% missing values at the baseline) is 
collected electronically and separately from the other data at the start of therapy by 
a therapist. The general practitioner (GP) asked at baseline which kind of sickness 
benefit (20%) a patient had. Sometimes this was forgotten. Other reasons could 
be that Dutch was not the first language of the patient maybe not all the questions 
were understood, or an incomplete questionnaire was retrieved. Loss to follow-up 
(i.e., failure to return the follow-up questionnaires) occurred for various reasons, 
including vacation, envelope not stamped, recovered from CNLBP, did not find it 
necessary, starting another intervention, etc. No reminder was send to patient. 
We assume that the missing values occurred at random, which is not uncommon 
with a long-term follow-up. Also, we used imputation of data (multiple imputation 
techniques); however, this is reported to be a valid method to deal with missing 
values28 and the sensitivity analyses yielded similar results. 
 We cannot demonstrate the influence of the given cognitive behaviour therapy 
with supervised exercises, educational and multi-disciplinary treatment. Only, that 
this is one of the most common intervention for CNLBP in Dutch rehabilitation 
centres and two Cochrane reviews42,43 provided evidence of a greater improvement 
on the short term than other treatments.
 For the present study, although we chose for a cut-off point of 10% improvement 
on the SF-36 PCS and MCS, there was little difference in identifying prognostic 
factors when a 30% improvement was used.
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A 30% improvement is a more commonly used criteria in CNLBP especially for the 
outcome pain and disability15,44; however, the problem remains that patients close to, 
but on opposite sides of the cut-off point, are characterized as being very different 
rather than very similar. Also, although the currently available GPE scale has the 
option ‘completely recovered’45, this was not yet in use in the SJC when the data 
were retrieved. This latter outcome measure is often dichotomized because it is 
easier for interpretation by clinicians and patients, albeit with the risk of losing 
some information.46 Because patients have difficulty taking their baseline status 
into account when scoring the GPE scale8, this item was compared with the end of 
therapy at the SJC. 
 Further research should focus on (external) validation of the presented 
prognostic models with appropriate study methodology, rather than developing 
new ones. With further testing the practical value of the models can be properly 
established.23 The impact for the clinician is that the current thought suggest a 
more complex interaction between factors rather than singular prognostic factors 
that influence the patient through time. There is clearly a need to investigate 
how prognostic factors work together in their usefulness and feasibility in clinical 
practice. 
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CHAPTER 8
General Discussion
  
The overall aim of this thesis was to: 1) review the literature to identify prognostic 
factors for the following 5 outcomes: low back pain intensity, disability, return to 
work, quality of life, and patients’ perceived recovery with chronic non-specifi c low 
back pain on the short-term (  6 months) and long-term (> 6 months) follow-up; 2) 
assess the characteristics and clinical course for patients with chronic non-specifi c 
low back pain treated in a tertiary rehabilitation centre with a 12-month follow-up 
period, and 3) identify the prognostic factors for recovery (including internal 
validation of the prognostic models) of patients treated in a tertiary rehabilitation 
centre for the outcomes: low back pain intensity, low-back-pain-specifi c disability, 
work participation, quality of life and patients’ perceived recovery with chronic 
non-specifi c low back pain. 
A substantial part of this thesis is based on a prospective cohort study performed 
among patients from a multidisciplinary outpatient rehabilitation centre the ‘Spine 
& Joint Centre’ (SJC) in Rotterdam, the Netherlands. All participating patients 
(n=1,760) were recruited between January 2003 and December 2008 and were 
evaluated by means of questionnaires and physical examinations at baseline, 
during the 2-month therapy program and at 5-months after the start of the SJC 
therapy program (2 months twice a week at the SJC + 3 months self-supporting 
activity). The 12-month follow-up measurement was performed by means of a postal 
questionnaires sent to the patients. The baseline characteristics of the included 
patients (Chapter 3) were similar to those of patients in other studies on chronic 
non-specifi c low back pain.1, 2 
In our study, recovery was assessed using various outcome measures and operati-
onalised according to two defi nitions: 1) a 30% improvement compared with 
baseline scores for the outcomes back pain intensity, disability, work participation 
and quality of life (SF-36; 10% improvement)3-5 and 2) an ’absolute recovery’ 
as defi ned using a Visual Analogue Scale (VAS) score of pain intensity  10 mm, 
disability as assessed by the Quebec Back Pain Disability Scale (QBPDS) score of 
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 20 points, work participation (0-100% working) of  90% at follow-up, and global 
perceived effect (GPE) using a 5-point scale dichotomised into ‘clinically improved’ 
vs. ‘clinically not improved’.4,6-9 The therapy protocol at the rehabilitation centre used 
a bio-psychosocial approach to stimulate patients to adopt adequate (movement) 
behaviour aimed at physical and functional recovery (see Chapter 3).2 Prognostic 
models, including internal validation of the 5 outcomes of interest, were developed 
for both the 5 and the 12-month follow-up.10-12 
Clinical course 
This section presents the results of the clinical course of chronic non-specific low 
back pain for both the percentage of improvement and the absolute recovery. In 
addition, for each of the 5 outcomes, comparisons with other studies are discussed. 
 The clinical course based on the 5 outcomes described in Chapters 4-7 showed 
a slight improvement for all outcomes during the 1-year period after treatment 
(Table 1). On average, about 60% of the patients reported a 30% improvement in 
back pain intensity, disability and work participation at their 12-month follow-up. 
Patients also reported a  60% improvement in quality of life (SF-36), and an 
improvement on the Physical Component Scale (PCS) at 5-months for the outcome 
‘10% improvement of recovery’. On the Mental Component Scale (MCS) of the SF-36, 
21% of the patients reported a 10% improvement at 5-months. However, when 
recovery was defined with a cut-off percentage [pain intensity  10 mm, disability 
 20 points, work participation (0-100% working) of  90% at follow-up, and GPE on 
a 5-point scale dichotomized into ‘clinically improved’ vs. clinically not improved’4, 
6-9] the results were lower, i.e. 29%, 38%, 52% and 60% for back pain intensity, 
disability, work participation, and clinical improvement on the GPE, respectively. 
 With regard to comparison with other studies, many used a different methodology, 
or were population-based investigating the general population, or a primary care 
or another type of group. Moreover, they often used a different cut-off point to 
classify patients as being ‘recovered’ and used different points of measurement 
over time to evaluate patient recovery.13-19 Although all these differences hamper 
a direct comparison, some general comparisons can be made. 
 The results of our study on the clinical course of back pain intensity (Chapter 4) 
and on disability (Chapter 5) showed some similarities compared with earlier 
studies.13-21 In the study of Costa et al. (2009), of the 259 patients who had not 
recovered (not pain-free, still had disability from back pain, and had not returned 
to work in their previous capacity for 30 consecutive days), on entry to that study 
47% had recovered after 1 year.22 Results of two systematic reviews showed that 
 50% of the patients had recovered from low back pain within 1 year.21,23 Studies 
with  1-year follow-up (such as a Dutch population study that measured three times 
over a 10-year period) found that 30% of the population were free of back pain at 
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all follow-up points (low back pain was considered long standing if persisting for > 3 
months).24 One Swiss study with a 5-year follow-up reported similar results, i.e. 35% 
(low back pain problems at least once a month in the last 12 months) pain free at 
follow-up.25 Another study by Enthoven et al. (2004) showed that 52% of chronic 
and recurrent low back pain patients reported pain (VAS > 10 mm) and back-related 
disability (Oswestry, > 10%) at the 1 and 5-year follow-up.16 
 In the present study, an interesting finding was that there was more improvement 
in disability than in pain intensity. This finding is consistent with results from earlier 
trials26, 27 and a systematic review28 in which patients received a program on cognitive 
behaviour principles. Grotle et al. (2010) found only a moderate change in disability 
after 1 year (25% reduction) in patients with chronic low back pain.29 However, a 
recent meta-analysis found a greater change in pain than in disability over 1 year30; 
however, the studies included in the latter review did not include exercise programs 
with cognitive behavioural principles, which may explain the differences in findings.
 Our study also showed that, directly after the 2-month multidisciplinary 
cognitive behaviour therapy at the SJC rehabilitation centre, patients experienced 
the greatest change in improvement post-baseline in all outcomes compared with 
the 5 and 12-month follow-up. At the 5-month follow-up in which the patients 
followed a 3-month self-management program2 the differences compared with a 
2-month program were relatively small. A similar pattern was reported during the 
first 4-6 weeks in a recent meta-analysis30 and in other studies13,16,19 describing a 
slowly advancing reduction in average pain and disability between 6 and 52 weeks. 
 Our study population received therapy aimed at physical/functional recovery, 
which may partly explain the positive increase in work participation (Chapter 6). 
A systematic review by Guzman et al. (2002) provides evidence that intensive 
multidisciplinary bio-psycho-social rehabilitation with a functional restoration 
approach, improves pain and function in patients with chronic non-specific low 
back pain and increases the ability to work.28 Social disadvantage (e.g., income, 
health care access, immigration status, language barriers), social factors at work 
(e.g. supervisor & co-workers support, job stress and burn-out), spousal support 
and family conflict may increase the time period before some patients are able 
to return to work.31 Thus, many factors can interfere with the course of improving 
patients’ work participation. For sub-acute low back pain there is moderate evidence 
showing that multidisciplinary rehabilitation (which includes a workplace visit or 
a more comprehensive occupation healthcare intervention) results in patients 
returning to work faster.32 A work place visit might be a positive addition to the 
program of the SJC rehabilitation centre. 
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For the course of quality of life (SF-36 PCS, MCS) and GPE (Chapter 7) fewer studies are 
available with which to compare our results.8,16,33-35 Our study showed more improvement 
on the PCS of the SF-36 at the 5-month follow-up compared with other studies.33,34 
This lack of consistency may be the result of differences in study methods33,34; for 
instance, in other studies patients did not follow a therapy program, but could contact 
their clinicians if required. The MCS of the SF-36 showed more similarity with an earlier 
study that also followed patients after a multidisciplinary therapy for 6 months.35 
 In relationship to the course of GPE, in our systematic review1 only one study 
reported that, in a non-surgical group of chronic low back pain patients, 29% 
assessed themselves as improved at the 2-year follow-up. Other studies also 
showed improvement from the patient’s perspective over a 12-month period; 
however, because they used other scales and different cut-off points comparison 
is difficult.36,37 In our study we found that 60% of the patients reported a clinically 
relevant improvement at the 12-month follow-up. 
 In summary, the clinical course of patients with chronic non-specific low back 
pain who did not recover during primary and secondary care seems to improve 
after a rehabilitation program, with success rates up to 60% at 12-months follow- 
up depending on the definition of recovery and the type of outcome measure used. 
Prognostic models 
Knowledge on prognostic factors is important to help identify patients who are 
more likely to recover from chronic non-specific low back pain following multidis-
ciplinary cognitive behaviour treatment. In essence, prognostic factors based on 
a single outcome measure may not fully represent all aspects of recovery from a 
multidimensional condition, such as chronic non-specific low back pain.38 
 Our earlier systematic review emphasises that evidence on the prognostic 
factors for recovery in patients with chronic non-specific low back pain is not only 
scarce but also inconclusive.1 In our prospective cohort study, prognostic factors 
for the 5 outcomes were found (Chapters 4-7). These findings proved to be similar 
to those of earlier studies by others, but also provided new insight into the prognosis 
in patients with chronic non-specific low back pain treated in multidisciplinary 
tertiary care. This is a first initiative to collect and analyse data for 5 outcome 
measurements in tertiary care, for patients in whom primary and secondary care 
failed to lead to recovery of the patient’s complaints. In various previous studies, 
certain prognostic factors had not been studied and the outcome of work partici-
pation had not been evaluated on the short-term follow-up. 
 Chapters 4-7 presented the multiple prognostic models; in each article, the 
factors, limitations and influence of these models are described. Below, for each 
domain, we describe the prognostic factors that most frequently occurred in the 
results (e.g., patients’ characteristics) and in the outcome (e.g., work participation). 
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Table 1. Results of the clinical course of chronic non-specific low back pain over a  
12- month follow-up period (data are mean and SD or % as indicated)a
Clinical course
Baseline 
(n=1,752)
2 months 
(n=1,696)
5 months 
(n=1,564)
12 months 
(n=965)
Back pain intensity (VAS)
Back pain intensity: mean (SD) 55.5 (SD 23.0) 37.0 (SD 23.8) 35.3 (SD 26.1) 32.3 (SD 26.9)
30% improvement in back pain 
intensity 
53.8% 55.2% 60.5%
Absolute recovery on pain score  
(  10 points) 
3.8% 13.7% 19.8% 28.6%
Disability (QBPDS)
Back Pain Disability: mean (SD) 51.7 (15.6) 31.7 (15.2) 31.1 (18.2) 29.1 (20.0)
30% improvement on back pain 
disability
62.6% 61.3% 63.4%
Absolute recovery on disability 
score (  20 points)
2.6% 24.1% 30.9% 38.3%
Work participation *
Work participation: mean (SD) 38.3 (SD 43.1) 73.4 (SD 44.9) 81.7 (SD 52.9)
30% improvement on work  
participation
30.3% 60.5%
Absolute recovery on work  
participation (90%)
25.4% 43.2% 52.0%
Quality of Life (Short Form-36) 
Physical Component Scale (PCS): 
mean (SD)
31.9 (SD 7.1) 40.7 (SD 8.2) 42.1 (SD 10.1)
Mental Component Scale (MCS): 
mean (SD)
46.6 (SD 10.3) 49.2 (SD 9.4) 50.4 (SD 9.8)
10% improvement on the PCS 76.6% 76.3%
10% improvement on the MCS 39.6% 20.6%
Global perceived effect (GPE 5-point scale)
Clinical improvement GPE 45.1% 53.0% 60.3%
   1 much improved 45.1% 53.0% 60.3%
   2 slightly improved 44.1% 32.1% 19.1%
   3 no change  7.4%  9.3% 10.8%
   4 slightly worsened  3.1%  3.9%  5.7%
   5 much worsened  0.3%  1.8%  4.1%
a   n= number of patients in analysis ;SD= standard deviation; VAS = Visual analogue scale, 0-100, 0=no pain; 
QBPDS = Quebec Back Pain Disability Scale, range 0-100, higher score indicates more disability; work 
participation (0-100%) current work hours/ contracted hours; * included those patients with paid work 
(n= 1608); SF-36 = Short Form; PCS = Physical Component Summary; MCS = Mental Component Summary 
range 0-100, higher score indicates better quality of life; Missing values ranged from 0.5% to 35.2%.
Patients’ characteristics 
A lower age [OR 0.98 (CI 95% 0.96-0.99)] was shown to provide a better chance of 
recovery during the 12-month follow-up for the outcome back pain intensity (Chapter 4), 
low-back-pain-specific disability (Chapter 5), patients’ perceived recovery (Chapter 7), 
as well as for the outcome PCS on the SF-36 (Chapter 7) at 5 months, and work 
participation (Chapter 6) at 12-month follow-up. 
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Our systematic review consistently revealed no association between age, and back 
pain intensity and low-back-pain-specific disability; also, work participation showed 
conflicting evidence with regard to age on the long term (> 6 months).1 In summary, 
in all our multivariable models the course seems to be less favourable for older 
than for younger patients. The difference between these two groups probably 
lies in the patient’s overall health, different life stages, and the chance of having 
co-morbidities39 and/or less compliance with the treatment, because changes in 
cognition and behaviour may become more challenging as patients become older. 
Neurophysiological musculoskeletal changes or genetic factors39, a normal part 
of the aging process, may imply that a patient needs more time or another type 
of treatment to recover from chronic non-specific low back pain. A recent study 
showed that back pain had a greater impact with increasing older age.40
 Being female [OR 0.72 (CI 95% 0.49-1.07)] was positive for the 5-month course 
when using the percentage of improvement for the outcome back pain intensity 
and the MCS on the SF-36. The same results were found for the outcome of back 
pain intensity and the GPE score of the patients at 12 months. Absolute recovery 
on work participation was associated with being male [OR 1.79 (CI 95% 1.25-2.55)]; 
this might be because, in Dutch society, men traditionally earn the most wages for 
the family and it is less acceptable to work fewer hours. Other results from our 
systematic review provide consistent evidence for no association on the short 
term (  6 months) and conflicting evidence on the long term (> 6 months) follow-up 
for back pain intensity, low-back-pain-specific disability and the outcome work 
participation.1 Most low back pain studies report that older age and female gender 
are risk factors for poorer outcomes with acute and/or chronic low back pain, 
whereas some studies report no such effects.1,31 
 Being married or living with another adult [OR 1.60 (CI 95% 0.99-2.57)] can 
provide social support for patients during their rehabilitation process, especially 
when they are involved in the program, as was the case with our cohort study. For 
the 30% improvement, this had a positive influence at 5 months for disability and 
for absolute recovery, GPE, and work participation. During the 12-month follow-up 
the outcome of back pain intensity was also added to the model, whereas for work 
participation there was no association. We have no explanation as to why there 
is no association between being married and work participation. There is some 
evidence for detrimental consequences of low back pain on marital satisfaction, 
partner emotions and relationship quality41; on the other hand, beneficial effects are 
reported of spousal support and social interaction with other patients on low back 
pain coping and function for the outcome ‘pain and disability’.42,43 
Clinical status at baseline
Within the domain clinical status, the prognostic factors most frequently present 
in the different models for the outcome measures (except for the outcome quality 
of life) were the baseline scores of self-reported back pain intensity and low-back-
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pain-specific disability. Due to the low value of association (OR around 1), it seems 
that the choice of outcome definition of the minimal clinically important changes 
(MCICs) caused the difference. In our systematic review, self-reported pain at 
baseline had no association with back pain intensity and disability at 12 months, and 
there was limited evidence for a positive effect if a patient had less self-reported 
pain at baseline for the outcome of work participation.1 In our models, less back pain 
intensity at baseline (6 models) shows a trend of an increased positive influence to 
recover, than more back pain intensity at baseline (2 models). Pain reduction is not 
a primary outcome measurement in most of the cognitive behaviour treatments, 
but seemed to play a role in the prognosis for recovery in these patients. Patients 
may have different types of pain, e.g. some have pain consistently, whereas others 
experience pain sporadically throughout their life.39 Whether these differences are 
due to different levels of vulnerability (e.g., genetic and environmental factors) or 
to a cumulative impact of the pain experience remains to be seen.39 Two studies 
performed in a primary care setting found that patients’ belief about their back 
pain is an important and robust prognostic factor on both the short and long term, 
together with pain intensity, depression and compensation claim status.44,45 The 
question remains whether we as clinicians should take this into account during 
the rehabilitation program, by more frequently informing patients about the 
mechanism(s) of recovery for chronic non-specific low back pain. 
Furthermore, more consistent associations have been found between less back 
pain and more physical activity in the elderly than in the younger population.46 
Psychological factors 
Overall, our study showed that over the course of 12-months the factor 
‘kinesiophobia’ was not associated with the outcomes of interest. Our systematic 
review found conflicting evidence for the outcome of back pain intensity and 
low-back-pain-specific disability at short-term follow-up.1 For the long-term 
follow-up, the PCS and MCS on the SF-36 also demonstrated conflicting evidence. 
Only the outcome low-back-pain-specific disability showed consistent evidence 
of no association with kinesiophobia on the long-term follow-up. However, some 
of the studies in our systematic review were of low methodological quality and 
the value of the prognostic factor was not always convincing. A recent study 
among acute and chronic low back pain patients in primary care reported the 
same results as found in our cohort study, i.e. no association with the outcome 
back pain and disability.44 Also catastrophising, passive coping, anxiety and 
depression were included in their model, but showed no association on the 
short term (6 months) and long term (5 years).44 The lack of prognostic value 
of the factor ‘fear avoidance’ is interesting, because this is considered to be 
an important aspect of cognitive behaviour therapy. This probably explains why 
a small subgroup of acute low back pain patients develops a chronic pain 
problem.47 
144     Chapter 8
However, this factor may be less important (or overrated) for patients with chronic 
non-specific low back pain. Another explanation may be that, nowadays, most 
patients already receive several therapy sessions, with the fear-avoidance model 
as a basis for intervention, applying operant conditioning and graded activity in 
primary/secondary care before starting a tertiary care rehabilitation process. 
Therefore, perhaps only a small majority of patients with chronic non-specific 
low back will experience fear, catastrophising and/or anxiety during a relapse 
of intensified pain intensity or functional disability and are not able to cope, 
whereas others can.47 We also have to take into account the inconsistent and 
weak metho dological values in the other studies, implying that the clinical value 
may be overrated. This raises the question of how the fear-avoidance model might 
best be tackled within the treatment, or whether there is some acceptance of 
chronic pain by patients in their daily life. 
 A higher baseline score for quality of life [OR for PCS 1.07 (CI 95% 1.03-1.11) 
and OR for MCS 1.02 (CI 95% 1.01-1.04)] increases the chance of recovery for 
patients over a 12-month period, except for the outcome work participation and the 
GPE; however, the ORs were small. Although there is no explanation for this in 
the literature, the answer might depend on the definition of work participation 
used. We did not measure other qualitative values, such as willingness to work, 
enjoyment in one’s work, or the desire to return to work. For the GPE a recent study 
concluded that the rating of the GPE scale is strongly influenced by the patient’s 
current health status.48 Overall, the mechanisms behind the relationships between 
back pain and general physical/mental health are poorly understood, but appear 
to be present throughout life.39 
Work-related factors 
For back pain intensity and low-back-pain-specific disability, the factor ‘work 
participation’ at baseline [OR 1.27 (CI 95% 0.93-1.73)] showed the tendency: “the 
more one is working at baseline, the better it is for one’s recovery” at 5 months 
follow-up. However, at 12 months there was no such association. Our systematic 
review found conflicting evidence for this association with back pain intensity or 
disability on the long term (> 6 months).1 All the studies included in our review were 
of low methodological quality. If we add these results to our findings on the clinical 
course and our prognostic models on absolute recovery for work participation, GPE 
and a 10% improvement on the PCS for quality of life, this shows that being at 
work is important for recovery at 5 and 12-month follow-up. This might be because 
people who are working are generally healthier, experience social support and are 
more physically active, all of which may be related to greater physical wellbeing 
and an increased chance to recover.49 The factors of pain and disability are often 
related to returning to work1,50 but, on our findings, are inconclusive. The challenge 
remains for the practitioner to advise their patients to continue working and also to 
even extend their working hours over time, despite the experienced pain and disability. 
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General comments on course and prognosis
When examining the results of the clinical course and prognosis of the work 
presented here in relation to other studies, some general comments can be made.
 In our study, absolute recovery showed less improvement over the clinical 
course than the percentage of improvement during the 12-month follow-up. An 
explanation for this could be that the optimal cut-off point is not well described 
in earlier studies, making it difficult to choose an appropriate cut-off point 
compared with the percentage of improvement. This idea is supported by other 
studies.3,4,6,8,9,11,33,34,51 Patients with a lower baseline score on the characteristics of 
low back pain also have less potential for improvement than patients with more 
severe baseline values. When using our definition for absolute recovery, the latter 
group need to perceive a greater improvement in order to feel that it is indeed 
relevant.52 Another challenge for both definitions is the interpretation of the 
definition. For example, patients close to but on opposite sides of the cut-off for, 
e.g., a 30% improvement compared with the baseline score, are characterized as 
being very different rather than being very similar. Another example is the problem 
with MCIC values: i.e. a patient with a baseline score of 80 points on the QBPDS will 
more easily achieve a decrease of 30% (around 24 points) on their disability scale 
at 5-months follow-up, than the progression from 80 points to less than 20 points 
(cut-off point of absolute recovery). These findings imply that the choice of a low 
cut-off value for absolute recovery will entail that fewer patients will recover. Also, 
a 30% improvement is deceptive, because even a decrease from 80 to 56 points 
on the QBPDS still represents limitations in daily life for the patient. Unfortunately, 
variations in the choice of cut-off points hamper comparison of the clinical course 
over time; moreover, it is then unclear how important this particular change is for 
the individual patient. Knowing that the course of low back pain varies between 
individuals, with differences in both duration and intensity, mean it is difficult to 
determine the ‘real value’ of recovery. It might be more better to define recovery 
in consultation with the patient’s perspective and with the clinicians, and by means 
of further prospective research whilst also defining and selecting the most suitable 
outcome(s). 
 We selected our prognostic factors and outcomes based on current evidence, 
theory, and clinical expertise. The Multinational Musculoskeletal Inception Cohort 
Study Statement (MMICS) described some factors which we also found relevant, 
e.g. lifestyle (e.g., alcohol consumption, smoking), work-related factors (e.g. job 
satisfaction, social support) and number of sick days.53 However, to comply with 
the rule of at least 10 events per variable in the analysis (which avoids incorrect 
estimation of variables), we had to restrict the total number of potential prognostic 
factors.54 However, in the methodologically robust studies presented in this 
thesis, the baseline factors only account for a (small) proportion of the variance 
in outcome, ranging from 2.7% to 59%. In future research, it is recommended to 
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include additional factors39,44,55,56 (e.g., social factors, lifestyle factors, work-related 
factors, patient beliefs). Nevertheless, our study demonstrates stability for over 12 
months in the key prognostic factors during both the short and long-term follow-up. 
 Another important aspect is the description of outcome. For example, terminology 
such as ‘back pain intensity’ can be used to refer to the sensation of pain in the back; 
however, this term is also used to describe a disabling health condition in which the 
patient can experience functional impairment, difficulties in performing tasks, and/
or restricted ability to participate in activities such as work.57 It may be preferable 
to combine the outcome ‘back pain’ and ‘disability’ into one outcome measurement 
as, e.g., in the Pain Disability Index (PDI)58, or to identify distinct groups of back pain 
patients to improve our understanding of the course of back pain; this may then 
provide a basis for certain prognostic factors or of (sub)classifications for interven-
tions.14,44,59,60 One example is based on a multi-domain prognostic model, in which 
each patient’s risk for developing persistent back pain is determined and used to 
match the patient to an appropriate treatment. This STarT Back (Subgroups for 
Targeted Treatment) approach was developed to allow choice in the investigation 
and treatment in primary care decision-making.61-63
 The MMICS’ statement recommends ’days of work’ for the outcome work.53 
However, we were unable to retrieve this information from our data and therefore 
used work participation (dividing ‘current work hours’ by ‘former work employment 
hours’ prior to chronic non-specific low back pain) as outcome. This definition 
has not been used before, because the clinometric values are unknown, thereby 
making comparison of the results difficult. VAS pain intensity, QBPDS, and GPE 
are frequently used outcome instruments.3,4,51,64 In our studies we used the GPE 
5-point scale without the option ‘completely recovered’. Kamper et al. conclude 
that the rating of the GPE scale is strongly influenced by the patient’s current 
health status and this may increase with longer transition times into months 
(recall bias and/or measurement bias).48 Errors in the interpretation of the 
measurement (confounding) can also be made by therapists and/or researchers. 
This type of information raises the question as to whether transition ratings truly 
reflect change or, rather, only the current state of health.48 When assessing the 
GPE, it remains unclear what this measure actually represents for patients with 
chronic non-specific low back pain. One study reported that the GPE captures a 
patient’s perception of change in various domains that are important for their 
individual pain experience, i.e. items which may not be captured by other outcome 
instruments65 however, this latter study was performed among neck pain patients 
only. 
 The identification of factors predictive of a higher impact of chronic non-specific 
low back pain on quality of life would help to define management Stategies. We 
used the quality of life questionnaire (SF-36) which has several (sub)scales besides 
the PCS and MCS. The validity of the scores for several (sub)scales of the SF-36 
need to be taken into consideration as they contain many items which are not 
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practical for clinical use. At baseline, patients who had recently suffered an exacer-
bation, or had recovered during follow-up, may have had difficulty in rating their 
status during the period of evaluation and may have been influenced by their 
perceptions at the time of assessment.55,66 This might be a reason for the 28% 
missing data. A simpler and shorter questionnaire might alleviate this problem; 
for example, instead of using the complicated SF-36, use a VAS assessing ‘global 
quality of life’ (which has demonstrated good validity and reliability).67 On the 
other hand, this might result in some loss of information. The MMICS teams also 
recommended to include outcome measures on psychological factors, and diaries 
to measure utilisation of care and medication consumption, or satisfaction with 
care.53 In future prospective cohort studies, the research group needs to (re-)
consider baseline factors, outcome factors and which measures to use, since 
knowledge is lacking on all the complicated areas in which chronic non-specific 
low back pain is manifested. 
 In summary, this work has shown that some baseline characteristics are 
associated with recovery. This provides better insight into chronic non-specific low 
back pain, which can help researchers and clinicians to be better informed about their 
patients, the possible clinical course and the patient’s potential to recover. The next 
research steps will involve external validation of our models and a feasibility study, 
before implementation of our prognostic models is possible in clinical practice.68,69
Study limitations 
All studies have some limitations that should be addressed; this is also the case 
for the work presented here. 
 The question arises as to whether it is wise to conduct a prospective cohort 
study with a maximum of 12 months follow-up after a 5-month therapy program 
(2 months SJC and 3 months self-management), knowing that chronic non-specific 
low back pain has an unknown course and that the duration to recovery may 
take longer than expected. In our study population the duration of complaints 
was (on average) 7.7 years. Recent studies report that most patients with back 
pain appear to follow a particular pain trajectory over a longer time period, and 
do not have frequently recurring widely fluctuating patterns.59,60 It is possible that 
a particular pain trajectory will have certain clinical characteristics and that this 
might influence which prognostic factor is important and also the eventual result of 
a rehabilitation program.59 
 The present study collected data at the SJC rehabilitation centre during daily 
practice. For the baseline data (0-28% missing values) this was relatively successful. 
The standard electronic patient files provided most of the information on the 
variables at baseline and up to the 5-month follow-up; additional data were 
acquired via paper questionnaires.
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At the 5 (location SJC) and 12-month (postal questionnaires) follow-up, 11.1% and 
45.2% of the patients (n=1,760), respectively, failed to submit the follow-up data. 
There are various reasons for this loss of data. For example, the SF-36 information 
(28% missing values at the baseline) was collected both electronically and, 
separately from the other data, at the start of therapy by a therapist; on some 
occasions this step was forgotten. Other reasons could be that the Dutch 
terminology used in the questionnaire was too difficult for the patient, or an 
incomplete questionnaire was returned. The physician performed the baseline 
measurements and a therapist carried out the 5-month follow-up measurement. 
Although both the physician and therapist followed a protocol, some differences 
may have occurred. At the 5-month follow-up, loss of data was due to several 
reasons, e.g. abandoning the protocol during the course of conversation with 
the patient, time management, patient forgot an appointment, and/or there was 
no check to see whether all data were collected, etc. At the 12-month follow-up, 
the postal questionnaires were also subject to loss of data., e.g. the patient was 
on vacation, the envelope was not stamped, the patient had completely recovered 
from chronic non-specific low back pain or had started another intervention, 
the SJC’s policy of not sending a reminder to the patient, and no electronic 
collection of the data. Each time that data were collected, this involved information 
on over 100 variables; this can lead to overload for the patient and may result in lack 
of participation and/or incomplete questionnaires. 
 Also, because most of our data are based on self-reported questionnaires, 
we cannot exclude possible overestimation/underestimation of the patients’ 
complaints. Although the validation and reliability are acceptable (Chapter 3), 
from the patient’s perspective other interests may be involved when answering 
the questionnaire (e.g. role in the family, social benefits, beliefs and perception 
about illness). 
 Missing data and the impact of non-response at baseline and follow-up were 
analysed by comparing patients’ baseline response on individual prognostic factors 
with those at 5- and 12-months follow-up. There were no reported differences 
between responders and non-responders on the main outcomes. However, 
some non-responders may have difficulty in implementing new behaviour and 
changed cognitions from one setting to another, or in remaining compliant to the 
therapy. Also, these patients may have already undergone at least some kind of 
unsuccessful treatment and are, therefore, more cautious regarding the interven-
tions offered and the effect upon themselves. To obtain more insight into this 
topic, or in the subgroup who do not recover, an option is to use the credibility/
expectancy questionnaire (CEO) before the start of intervention and again at 
the follow-up.70 For patients who do not recover during the long-term follow-up, 
a ‘refresher prevention session’ might be necessary. Also, further research on 
the effectiveness of the intervention of the SJC protocol may be advisable. 
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Some general changes can be recommended for health policies regarding how to 
continue to inform, socially interfere as clinician31 and motivate the patient to follow 
the therapy strategy, in order to tackle the problem of persisting/recurrent low back 
pain after an intensive rehabilitation period.
 Comparison of our patients with other study populations has both limitations 
and challenges. First, our patients were recruited from a rehabilitation centre of 
tertiary care with a multidisciplinary cognitive behaviour therapy, in contrast 
with many studies which were conducted in primary care and among the general 
population.23,71 There is a possibility of selection bias, e.g. our cohort is not an 
inception cohort and this may influence the clinical course through the selection 
of patients. Our patients may have more complex conditions and/or complaints 
and may be dealing with additional factors that may influence recovery.22 In many 
studies low back pain is not clearly defined72; we conformed to the (inter)national 
definitions and selection criteria73 to ensure as far as possible that our patients are 
a good reflection of the chronic non-specific low back pain population. Our study did 
suffer from loss to follow-up, which implies a smaller number of patients for the full 
analysis. Also, the quality of the data depends on the completeness of registration 
by the patient, care.g.ivers, administrative staff and/or researchers. The possibility 
of selection bias and residual confounding cannot be ruled out. It would be better if 
all data could be collected electronically and with timely reminders. 
Prognostic research and methodological issues
Developing useful prognostic models to predict recovery in daily clinical practice 
is not simple. Chronic non-specific low back pain fluctuates over time and some 
methodological issues need to be addressed. There are three main types of 
prognostic study: 1) the prognostic course studies, 2) prognostic (explanatory) factor 
studies, and 3) outcome prediction (risk group) studies.74 Our patients were seeking 
help in tertiary care75 were recruited, and then we described their clinical course. 
 We performed the most common type of prognostic research, i.e. investigation, 
exploration and identification of potential prognostic factors.69,74 Hayden et al. report 
that this gives the least conclusive information regarding the independence of the 
variable as a valid prognostic factor.74 Through our systematic review (Chapter 3) 
we concluded that for chronic non-specific low back pain only a few studies have 
examined our 5 outcome measurements and that the majority of these are of low 
methodological value, making it necessary to conduct this type of study.69 
 There are different ways to derive prognostic models and also different statistical 
approaches, all of which can lead to differences in prognostic models.74,76 
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First, when dealing with missing data we decided to use the multiple imputation 
procedure, as this is assumed to be more valid than simply omitting these patients 
from the analysis.10 Another consequence is that it reduces the sample size/power and 
thus the model’s validity.12,77,78 By performing sensitivity analyses and completed 
cases analyses (CCA), we validated our models in the population.79-81 In our studies 
(Chapters 4-7) this revealed little to no difference in the identified prognostic factors, 
indicating that these models were relatively stable. Furthermore, in all analyses, 
the CCA showed slightly higher standard errors (SEs) and coefficients compared 
with the imputed datasets. This indicates that, as expected, both the power and 
the precision were increased by use of imputation.81 
 The C-index or area under the curve (AUC) and the explained variance showed 
a range of 0.65-0.90 and 2.7-59%, respectively (Chapter 4-7). The AUC may give 
a general estimation of the discriminative ability of a prediction model, but is not 
directly meaningful for clinical purposes.74 In low back pain it is not uncommon for 
prognostic factors to show a significant association with the outcome at group level, 
but little prognostic value at the individual level; also, there is no evidence for a 
single factor that substantially affects low back pain prognosis on its own for all 
individuals. 
 In our study we chose to split some continuous variables into two or more 
cate.g.ories during the development of the multivariable logistic regression models. 
The advantage of this categorisation or dichotomising is that it simplifies the 
interpretation of the model and the application to clinical practice.12 We did this for 
all outcome measurements, i.e. dichotomising the variable into ‘no improvement’ 
vs. ‘improvement’ with either the percentage of improvement and/or the so-called 
‘optimal’ cut-off points, absolute recovery.4,5,64 This can introduce additional bias in 
the analysis (e.g., overestimation of the discriminative ability) which carries the risk 
of a poorer performance model. 
Implications for daily practice
For daily practice this thesis provides preliminary evidence for clinicians and 
patients in tertiary care about the clinical course of back pain and which prognostic 
factors have most influence in the recovery from chronic non-specific low back 
pain. The evidence remains preliminary because external validation is required 
and the impact on daily practice still needs to be examined.68,69 Nonetheless, we 
provide evidence that some patients with chronic non-specific low back pain 
show improvement in the clinical course during the 12-month follow-up and 
that the following domains help to predict possible recovery during follow-up: 
patients’ characteristics (younger age, female, being married or living with one 
adult), clinical status (present back pain intensity, disability, higher physical quality 
of life at baseline), psychological factors (higher score on the mental part of 
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quality of life at the baseline), and work-related factors (higher work participation 
at baseline). The domain ‘physical examination’ was only sporadically applied.
 A substantial proportion of the patients in this study experienced repeated 
episodes or recurrences of low back pain, whereas another proportion reported 
continuous symptoms over many years.13,16,19,21 During the 12-month follow-up, some 
patients recovered from back pain, others sporadically experienced back pain, and 
others continued to suffer from back pain most of the time.39,59,60 Non-specific low 
back pain is not a self-limiting disease in all patients; a large proportion of patients 
experience persistent low-intensity pain and disability, but are able to return to 
work82 this has been confirmed in our studies. Awareness of the impact of low back 
pain may help physicians and therapists to better inform the patient about their 
course of chronic non-specific back pain. 
 Regular use of patient-reported outcome measures (PROMs)83, which is 
more common in tertiary care, should be further implemented in Dutch primary 
and secondary care. This will provide clinicians with more insight into the clinical 
course and identification of potential subgroups and makes comparison of results 
with tertiary care possible. For some questionnaires more evidence is required, 
or a shorter and simpler questionnaire should be developed for daily practice. 
In addition, for general health care the questionnaire should capture the impact 
of items related to the patient-clinician relationship and the patient’s contribution 
to their own recovery.84 
 Current treatments regularly use or incorporate techniques drawn from 
cognitive behavioural therapy. Cognitive behavioural therapy focuses on the beliefs, 
feelings, and behaviours of pain patients, most often concentrating on the pain 
experience (e.g. fear avoidance, catastrophising). However, our results show that fear 
avoidance was not an important variable in our sample of chronic non-specific low 
back pain patients.2,85
 Our results suggest that additional attention should be paid to patients’ 
psychological factors, their clinical course of back pain intensity, disability, and 
their work participation. All these components can also be implemented in primary 
and secondary (outpatient clinic) care; however, close collaboration with other 
disciplines/professionals that have the same vision/goals, and are available during 
the same period, will be difficult to achieve. We are unable to demonstrate the effect 
of the cognitive behaviour therapy combined with supervised exercises, education 
and a multi-disciplinary treatment; however, Cochrane reviews have shown a greater 
improvement on the short term than other forms of treatments.28,86
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Implications for further research
Clinical course 
The research conducted in this thesis concerned the description of the 5 outcome 
measurements at the 2-, 5- and 12-month follow-up. Further research on the clinical 
course should include study of the prognosis using more frequent and longer follow-up 
periods (up to 5-10 years or the life-course).39,59,60 This will help researchers and 
clinicians to better understand the patterns of recovery and change over time74 and 
to identify different subgroups. Further research is also required to establish which 
patients should enter the SJC, can receive other interventions within the therapy 
program, or are in need of more guidance and/or longer follow-up programs. Also, 
for the MCIC on absolute recovery (cut-off point) more insight is required into the 
probable course, and information on the expectations and views/experiences of the 
clinician and patient is also desirable. 
Prognostic research
For all 5-outcome measurements, several prognostic models were developed and 
internally validated. Collaboration with other rehabilitation centres would help to 
combine focus on the external validation of these results on the 5 outcomes and 
their feasibility for daily practice.68,69,77 This investigation needs to take place before 
implementation into daily practice and into guidelines.87 Once the prognostic factors 
for recovery have been identified and validated, more studies are needed to examine 
whether these prognostic factors influence the recovery rate in patients with chronic 
non-specific low back pain. Effective models provide more accurate predictions 
that inform patients and caregivers, support clinical research and allow informed 
decisions to improve patient outcomes – especially by means of a bio-psycho-social 
model. Thus, rather than (always) developing new models from scratch, we should 
consider whether existing models can be improved by recalibration or by adding 
prognostic factors, such as findings from physical examinations.69 
 Before improving the models, additional research should determine whether 
the MCIC can be better expressed as a percentage of improvement, or in scale points 
of absolute recovery (cut-off point), including the patient’s and clinician’s view on 
this topic. 
 Further development and enhanced cooperation with other research groups 
regarding the existing international standard core set53 and statistical techniques 
might also enable better comparison of the results and more appropriate 
inter pretation of the dynamic (clinical) nature of chronic non-specific low back pain 
between different studies and/or countries. To have a multi-domain prognostic 
model, where each patient’s risk for persistent chronic non-specific low back pain is 
determined and used to match the patient to the most optimal treatment, would be 
an important asset. 
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SUMMARY
Chapter 1 is an introduction of the topic and aims of this thesis. The overall aim 
of this thesis was to acquire knowledge about the clinical course and identify 
clinically important prognostic factors (including internal validation) of patients 
with chronic non-specific low back pain receiving cognitive behaviour therapy in a 
tertiary multidisciplinary setting. The outcomes of interest were: back pain intensity, 
disability, work participation, quality of life and global perceived effect. 
In Chapter 2 we describe a systemic review based on the literature available in 
PubMed, CINAHL and EMBASE (through March 2010) in order to retrieve prognostic 
factors for low back pain intensity, disability, return to work, quality of life, and global 
perceived effect in patients with chronic non-specific low back pain on short-term (  6 
months) and long-term (> 6 months) follow-up. After applying the inclusion/exclusion 
criteria 14 studies were included, most of them reporting on the outcomes of low back 
pain intensity and disability. The included studies used different definitions for the 
outcomes and prognostic factors. Most of the studies (71%) were considered to have 
a high risk of research bias. When considering the outcomes of low back pain intensity 
and disability, the results showed no associations with age and sex on short-term 
follow-up, and with smoking on long-term follow-up. Conflicting evidence was found 
for ’fear of movement’ and the outcomes of low back pain intensity and disability on 
short-term follow-up. On long-term follow-up, baseline low back pain intensity and ‘fear 
of movement’ had no association with the outcome disability. On long-term follow-up, 
conflicting evidence was found for an association between the factors age, sex, and 
physical job demands, and the outcomes of low back pain intensity and disability. 
On long-term follow-up, conflicting evidence was found for an association between 
the factors age, sex, activities of daily living and mobility, and the outcome return to 
work. At baseline, there was limited evidence for a positive influence of lower pain 
intensity and physical job demands on return to work. No high-quality studies were 
found for the outcomes quality of life and global perceived effect. 
Chapter 3 describes the design and methods of the prospective cohort study. 
We assessed the baseline characteristics of patients with chronic non-specific 
low back pain and described the methods used to investigate the clinical course 
and to identify potential prognostic factors (including internal validation) in a 
12-month follow-up study. All participating patients with chronic non-specific low 
back pain (n=1,760) were recruited between January 2003 and December 2008 at 
the Spine & Joint Centre rehabilitation centre (mean age 40.1 years, SD 10.6; 73% 
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female) and were evaluated by means of (postal) questionnaires and physical 
examinations at baseline, at 2-months follow-up (after the 2-months therapy 
program), and again at 5 and 12-months follow-up. At the rehabilitation centre, the 
multidisciplinary behaviour therapy protocol used a bio-psychosocial approach to 
stimulate patients to adopt adequate (movement) behaviour aimed at physical and 
functional recovery. The program consists of 16 sessions of 3 hours each over an 
8-week period (in total 48 hours), followed by a 3-month self-management program 
(e.g. exercises twice a week). The primary outcomes were back pain intensity, 
disability, work participation, quality of life, and patient’s global perceived effect.
 Each model had the same 23 potential prognostic factors. The factors for the 
domain ‘patient’ characteristics’ were: age, gender, educational level (less than high 
school vs. high school/university), body mass index (BMI  24.9, 25-29.9,  30 kg/m2) 
and marital status/living with one adult (no/yes). For clinical status the following 
factors were included: duration of back pain in years, cause of back pain (accident 
movement; after physical load; during pregnancy or after delivery; unknown; surgery 
pelvis/back or HNP), previous rehabilitation treatment (none vs. one or more previous 
rehabilitation treatments), comorbidity (none vs. having one or more co-morbidities), 
present pain intensity (Visual Analogue Scale (VAS) 0-100 mm; with higher scores 
indicating more pain), course of pain in the previous 3 months (stable; increased; 
decreased), degree of present fatigue (VAS 0-100 mm; with higher scores indicating more 
fatigue) and the Quebec Back Pain Disability Scale (QBPDS; 0-100; with higher scores 
indicating more disability). Psychological factors were: the Dutch version of the Tampa 
Scale for Kinesiophobia (TSK-DV, 17-68; with a higher score indicating more pain-related 
fear), SF-36 MCS and PCS at baseline (0-100; with higher scores indicating better quality 
of life), and the Symptom Checklist 90 (SCL-90; item 9; psychoneurosis). Domain 
work-related factors consisted of two prognostic factors, work participation (0-100%; 
by dividing ‘current work hours’ by ‘former work employment hours’ prior to chronic 
non-specific low back pain) and sickness benefit (none vs. receiving different types of 
government welfare benefits). Finally, the domain physical examination consisted of the 
B200 Isostation (strength of back extension in Newton) and the duration of walking, 
sitting, standing (0-15, 16-30, 31-60, > 61 min) during daily activities.
 In our study, every outcome for recovery was operationalised according to two 
definitions: 1) 30% improvement during follow-up compared to the baseline score 
for the outcome back pain intensity, disability and work participation and a 10% 
improvement in the score on the SF-36 PCS and MCS, and 2) ’absolute recovery’ was 
defined as a VAS score of  10 mm, a QBPDS score of  20 points, work participation 
working (0-100%)  90% at follow-up, and global perceived effect on a 5-point scale 
(GPE) dichotomized into ‘clinically improved’ vs. ‘clinically not improved’.
 Multivariable logistic regression analysis included the 23 baseline characteristics 
with imputed datasets of 5 models and a p-value of 0.157. A sensitivity analysis 
was performed; the selection of variables was repeated in imputed datasets of 5 
and 40 models with p-values of 0.05 and/or 0.157, respectively. We also compared 
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the results with complete-case analysis, i.e. all patients with missing data were 
excluded from the analyses. Furthermore, every outcome was also changed regarding 
the percentage improvement and/or absolute recovery score (cut-off point) during 
the sensitivity analysis. 
The results of our prospective cohort study are described in Chapters 4 to 7. 
In Chapter 4 we assessed the clinical course and potential prognostic factors 
(including internal validation of the models) for recovery defined with the outcome 
back pain intensity at 2, 5 and 12-months follow-up. Patient-reported back pain 
decreased from 55.5 (SD 23.0) at baseline to 37.0 (SD 23.8), 35.3 (SD 26.1) and 
32.3 (SD 26.9) at 2, 5 and 12-months follow-up, respectively. At 12 months, 61% 
of the patients experienced a 30% improvement and 29% of the patients an 
absolute recovery (VAS  10 mm) with regard to back pain intensity. 
 At 5-months follow-up, a 30% improvement resulted in a final model (AUC=0.66) 
which included 9 prognostic factors, together explaining 11% of the variation 
in outcome: younger age, female gender, a baseline BMI > 25 kg/m2, no previous 
rehabilitation treatment, higher baseline level of back pain intensity, no psycho 
logical/physical dysfunction, higher baseline scores on the SF-36 (PCS and MCS), and 
higher work participation at baseline. At 12-months follow-up the following factors 
were related to a 30% improvement: younger age, female gender, being married/
living with one adult, higher level of education, no comorbidity, higher back pain 
intensity, higher strength at the extension direction, no fear of movement, and higher 
scores on the PCS (SF-36), with a 10% explained variance and an AUC of 0.65.
 At 5 and 12-months follow-up, for absolute recovery the explained variance 
was 11% and 18%, respectively, with an AUC of 0.69 and 0.73, respectively. At 5 and 
12 months the factors younger age, less back pain intensity at baseline and higher 
scores on the SF-36 were prognostic factors for back pain intensity. Also added to 
the 5-month follow-up were the factors: no psychological/physical dysfunction, and 
more work participation at baseline. At baseline, a BMI  30 kg/m2, no comorbidity, 
higher disability score and having stable or more back pain intensity due to chronic 
non-specific low back pain in the previous 3 months were added to the 12-month 
follow-up. For every prognostic model, the internal validation showed identical 
results in experienced variance and AUC as in the developed prognostic models. 
The sensitivity analyses (e.g.  20 mm VAS) also showed similar results. 
Chapter 5 reports on the clinical course of and prognostic factors (including 
internal validation) for recovery defined with the outcome low-back-pain-
specific disability in patients with chronic non-specific low back pain at 2, 5 and 
12-months follow-up. The results show that the mean disability scores on the 
QBPDS decreased from 51.7 (SD 15.6) at baseline to 31.7 (SD 15.2), 31.1 (SD 18.2), 
and 29.1 (SD 20.0) at 2, 5 and 12 months, respectively. At 12-months follow-up, 
63% of the patients reported a 30% improvement in disability.
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Absolute recovery (QBPDS  20) increased to 24%, 31% and 38% at 2, 5 and 12 
months, respectively. 
 The following prognostic factors were identified for a 30% improvement on 
disability at 5 and 12 months: younger age, being married or living with one adult, 
higher baseline score on disability, higher scores on the SF-36, and no previous 
rehabilitation program. In addition, at 5 months, having more work at baseline, a 
decreased course of pain in the previous 3 months before the start of therapy, and 
a short duration of back complaints, were additional predictors (explained variance 
12.8% and an AUC of 0.68). At 12 months the additional factors in the model were: 
having no comorbidity, higher educational level, and less back pain at baseline 
(explained variance 10.7% and an AUC of 0.66). 
 For the outcome absolute recovery (  20 QBPDS) younger age, shorter duration of 
back pain complaints, lower baseline score on disability, and higher score on the SF-36 
were similar for 5 and 12-months follow-up. The 5-month follow-up showed 
an explained variance of 2.7% and an AUC of 0.66 with the addition of the factor 
no psychological/physical dysfunction. For the 12-month follow-up, having no 
comorbidity at baseline, less back pain intensity,  60 min walking duration, and 
strength in the trunk, were added to the model, with an explained variance of 10.7% 
and an AUC of 0.66.
 With regard to internal validation of the models and the sensitivity analysis, the 
values were similar. The sensitivity analysis was performed using the QBPDS cut-off 
values of  10 and  39 points and showed similar results. 
Chapter 6 describes the clinical course and recovery as defined with the outcome 
work participation (0-100%) in patients with chronic non-specific low back pain. 
For these analyses we included 1,608 patients, i.e. those reporting to have a paid 
work contract at baseline. The outcome was work participation: this was defined by 
dividing ‘current work hours’ by ‘prior contract work hours’. Patients reported an 
increase in work participation from 38% (SD 43.1) at baseline to 73% (SD 44.9) and 
82% (SD 52.9) at 5 and 12 months, respectively. Regarding the 30% improvement in 
work participation, this was 30.3% at 5-months and 60.5% at 12-months follow-up. 
At baseline, 25.4% of the patients worked  90% when weighted against the 
absolute value of recovery; this increased from baseline to 43.2% and 52% at 5 and 
12 months, respectively. At 5 months, for the outcome 30% improvement in work 
participation, the following prognostic factors were found: less back pain intensity at 
baseline, low percentage of work participation, duration of standing (31-60 min) and 
the cause (accident or wrong movement), with an explained variance of 59% and an 
AUC of 0.89. At 12-months follow-up the multivariate regression model (AUC=0.90) 
consisted of 4 prognostic factors explaining 60% of the variation: younger age, 
higher education, low percentage of work participation at baseline, and a higher MCS 
(SF-36) at baseline. Prognostic factors for ‘absolute recovery’ (  90% work partici-
pation) at 5 months were being married or living with one adult, female gender, 
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higher disability score, higher score on the PCS SF-36, previous rehabilitation, 
not receiving sickness benefits, and higher work participation at baseline. Higher 
work participation at baseline and female gender were also prognostic factors for 
‘absolute recovery’ at 12-months follow-up. At 5-months follow-up the explained 
variance was 30% and the AUC 0.78 whereas it was 17% and 0.70, respectively, 
at 12-months follow-up. The internal validation of the models and the sensitivity 
(cut-off values of 80% working and 100% working) showed similar results. 
 
In Chapter 7 we investigated the clinical course of and identified prognostic factors 
for the outcomes quality of life and global perceived effect in patients with chronic 
non-specific low back pain at 5 and 12-months follow-up.  
 Patients reported an increase of the MCS and PCS (SF-36) from on average 46.6 
(SD 10.3) at baseline to 49.2 (SD 9.4) at 5-months follow-up for the MCS compared to 
31.9 (SD 7.1) at baseline to 40.7 (SD 8.2) for the PCS. A 10% improvement on the MCS 
and PCS was reported by 39.6% and 76.6% of the patients, respectively, at 2 months, 
and by 20.6% and 76.3% of the patients, respectively, at 5-months follow-up. At 2 
months 45.1% reported a clinical improvement using the GPE scale; this improvement 
increased to 53.0% and 60.3% at the 5 and 12-months follow-up, respectively.
 Baseline variables showing an association with a 10% improvement on the 
PCS (SF-36) at 5-months follow-up were: younger age, BMI of  30 kg/m2, lower 
score on the PCS (SF-36), higher score on the MCS (SF-36), psychological/physical 
dysfunction, receiving sickness benefit, having more work at baseline, and duration 
of walking of 16-30 min. The following baseline variables were associated with 
a 10% improvement of the MCS (SF-36) at 5-months follow-up: female gender, 
higher score on the PCS (SF-36), lower score on the MCS (SF-36) and no 
psychological/physical dysfunction (SCL-90, item 9). The AUCs were 0.69 and 0.88, 
respectively, and the explained variance was 11% for the PCS and 44% for the 
MCS SF-36. Younger age, being married or living with one adult, shorter duration 
of back pain complaints at baseline, lower back pain intensity, and working more 
often at baseline were associated with a clinical improvement on the GPE at 5 and 
12-months follow-up. At 5 months the explained variance was 11% and the AUC 
was 0.66. At 5 months additional factors were included such as decrease of back 
pain intensity in the previous 3 months before baseline, higher disability, no fear 
of movement, higher score on the MCS and the PCS SF-36, receiving sickness 
benefit, and strength. At 12-months follow-up the factors being female and duration 
of walking (16-30 min) were added to the model with an explained variance of 
9% and an AUC 0.65 for the total prognostic model. The internal validation and 
sensitivity analysis (30% improvement on the MCS and PCS) showed similar results. 
Chapter 8 addresses the main findings and limitations of the studies described in 
this thesis, discusses implications for daily practice, and makes some recom men-
dations for further research.
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SAMENVATTING
  
Hoofdstuk 1 vormt een inleiding op het onderwerp en de doelstellingen van dit 
proefschrift. De algemene doelstelling van dit proefschrift was het verkrijgen van 
kennis van het klinische beloop en de identificatie van potentiële prognostische 
factoren (inclusief interne validatie) voor herstel bij patiënten met chronische 
aspecifieke lage rugpijn, die een cognitieve gedragstherapie in een tertiaire 
multi disciplinaire setting hebben gevolgd. Hierbij stonden de volgende patiënt-
gebonden uitkomstmaten centraal: rugpijnintensiteit, beperkingen in activiteiten 
door de rugpijn, werkparticipatie, kwaliteit van leven en ervaren herstel.
In hoofdstuk 2 is er systematisch in de literatuur gezocht, die beschikbaar was 
in PubMed, CINAHL en EMBASE (tot maart 2010), ter verkrijging van informatie 
over prognostische factoren bij patiënten met chronische aspecifieke lage rugpijn. 
Identificatie van prognostische factoren heeft plaatsgevonden voor de uitkomst-
maten rugpijnintensiteit, beperkingen in activiteiten, werkparticipatie, kwaliteit 
van leven en ervaren herstel in de follow-up op korte termijn (  6 maanden) of 
op langere termijn (> 6 maanden). Na toepassing van de insluit- en uitsluitcriteria 
zijn er 14 studies geïncludeerd. De meeste studies betroffen onderzoek naar de 
uitkomstmaten rugpijnintensiteit en beperkingen in activiteiten. 
Het onderling vergelijken van de studies was moeilijk, omdat de uitkomstmaten 
op verschillende manieren gedefinieerd en gemeten waren, met daarnaast een 
diversiteit aan prognostische factoren. Ook waren de meeste studies van mindere 
methodologische kwaliteit. 
 In de korte termijn follow-up zijn geen associaties gerapporteerd van de uitkomst-
maten rugpijnintensiteit en beperkingen in activiteiten met de factoren leeftijd en 
geslacht, en in de langere termijn follow-up niet met de factor roken. In de korte 
termijn follow-up is tegenstrijdig bewijs gevonden voor een relatie tussen de 
uitkomstmaten rugpijnintensiteit en beperkingen in activiteiten en de factor angst 
om te bewegen. Op langere termijn vertoonden de intensiteit van de rugpijn op 
baseline en de factor angst om te bewegen geen associatie met de uitkomstmaat 
beperkingen in activiteiten. Voor de langere termijn is tegenstrijdig bewijs gevonden 
voor een relatie tussen de uitkomstmaten rugpijnintensiteit en beperkingen in 
activiteiten en de factoren leeftijd, geslacht en fysieke componenten. Voor de 
langere termijn is ook tegenstrijdig bewijs gevonden voor een relatie tussen de 
uitkomstmaat werkparticipatie en de factoren leeftijd, geslacht, dagelijkse activi-
teiten in het leven en mobiliteit. 
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Er is weinig bewijs gevonden voor een positieve invloed van een lage rugpijnintensi teit 
en fysieke componenten binnen het werk op de uitkomstmaat werkparticipatie. 
Er zijn geen studies gevonden met hoge methodologische kwaliteit voor de 
uitkomstmaat kwaliteit van leven en door de patiënten ervaren herstel. 
De methode van het uitgevoerde prospectieve cohort onderzoek is beschreven in 
hoofdstuk 3. Ook zijn de baselinegegevens van de patiënten met chronische aspeci-
fieke lage rugpijn gepresenteerd en de methoden voor het bepalen van het klinisch 
beloop en de identificatie van potentiële prognostische factoren (inclusief interne 
validatie) gedurende een follow-up van 12 maanden. Alle deelnemende patiënten 
zijn geworven tussen januari 2003 en december 2008 bij het Spine and Joint Centre 
(gemiddelde leeftijd 40,1 jaar, SD 10,6; 73% vrouw). Patiënten hebben vragenlijsten 
ingevuld en zijn lichamelijk onderzocht aan het begin van het onderzoek en 2, 5 en 
12 maanden na de start van de therapie. De therapie binnen het revalidatiecentrum 
heeft een bio-psychosociale benadering, waarbij patiënten worden gestimu-
leerd om op adequate wijze te bewegen, gericht op fysiek en functioneel herstel. 
Het programma bestaat uit 16 bijeenkomsten van elk drie uur over een periode 
van acht weken (in totaal 48 uur). Patiënten volgen daarna drie maanden lang 
een ‘’self-management’’-programma buiten het revalidatiecentrum. De primaire 
uitkomstmaten waren rugpijnintensiteit, beperkingen in activiteiten, werkpartici-
patie, kwaliteit van leven en ervaren herstel. 
 Er zijn 23 potentiële prognostische factoren onderzocht voor elke uitkomstmaat. 
De factoren voor het domein patiëntenkenmerken waren: leeftijd, geslacht, 
opleidingsniveau (minder dan de middelbare school versus middelbare school/
universiteit), body mass index (BMI:  24,9, 25–29,9,  30 kg/m2) en getrouwd/
samenwonend met een volwassene (ja/nee). De factoren voor het domein klinische 
kenmerken, allemaal gemeten op baseline, waren: duur van de rugpijn in jaren, 
oorzaak van de rugpijn (ongeval/na lichamelijke belasting/tijdens de zwangerschap 
of na de bevalling/onbekend/chirurgie aan het bekken, rug of HNP), eerdere revali-
datiebehandeling (geen/een of meerdere revalidatiebehandelingen), comor biditeit 
(geen/een of meerdere comorbiditeiten), rugpijnintensiteit op baseline (Visuele 
Analoge Schaal, VAS; 0–100 mm; een hogere score staat voor meer rugpijn), beloop 
van de pijn in de voorafgaande drie maanden (stabiel/toenemend/afnemend), 
vermoeidheid (VAS; 0–100 mm; een hogere score staat voor meer vermoeidheid) en 
beperkingen (Quebec Back Pain Disability Scale, QBPDS; 0–100; een hogere score 
staat voor meer beperkingen). De psychologische factoren gemeten op baseline 
waren: bewegingsangst (Tampa Schaal voor Kinesiofobie, TSK-DV, 17–68; een hogere 
score staat voor meer pijngerelateerde angst om te bewegen), SF-36 mentale (MCS) 
en fysieke (PCS) componenten bij baseline (0–100; een hogere score staat voor 
een betere kwaliteit van leven) en geestelijke en lichamelijke klachten (Symptom 
Checklist 90, SCL-90, item 9; psychoneurose). 
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De werkgerelateerde factoren bestonden uit: werkparticipatie (0–100%, door 
het delen van ‘huidige werkuren’ door ‘voormalige werkuren voorafgaand aan 
de chronische aspecifieke lage rugpijn’) en arbeidsongeschiktheid (wel/niet). 
Ten slotte bestonden de factoren uit het domein lichamelijk onderzoek uit: 
spierkracht van de rug (B200 Isostation, in Newton) en duur van het lopen, zitten 
en staan (0–15, 16–30, 31–60, > 61 minuten) tijdens dagelijkse activiteiten.
 In deze studie is herstel voor elke uitkomstmaat geoperationaliseerd in twee 
definities: 
1)  Herstel is gedefinieerd als 30% verbetering op het meetmoment in de 
follow-up in vergelijking met de baselinescore, voor de uitkomstmaten 
rugpijnintensiteit, beperkingen in activiteiten en werkparticipatie en als 
10% verbetering voor de uitkomsten SF-36 PCS en MCS; 
2)  Absoluut herstel is gedefinieerd als een VAS-score van  10 mm, een QBPDS-
score van  20 punten en een werkparticipatie van  90% en door de patiënt 
ervaren herstel is gedichotomiseerd in ‘klinisch verbeterd’ versus ‘klinisch niet 
verbeterd’.
Er is een multivariabele logistische regressieanalyse (5 datasets en een p-waarde 
van 0,157) uitgevoerd met de 23 baseline factoren voor elk van de vijf uitkomst-
maten. Een sensitiviteitsanalyse is uitgevoerd, waarbij de selectie van factoren 
met 5 en 40 geïmputeerde datasets en met een p-waarde van 0,05 en/of 0,157 is 
gemaakt. We hebben een completed-case-analyse (CCA) uitgevoerd, dat wil zeggen 
dat alle patiënten van wie gegevens ontbraken, van de analyses waren uitgesloten. 
Ook zijn voor elke uitkomstmaat het percentage van de verbetering en/of de score 
van het absolute herstel (afkappunt) aangepast, om de invloed hiervan nader te 
onderzoeken.
De resultaten van het prospectieve cohort onderzoek zijn beschreven in de 
hoofdstukken 4 tot en met 7. 
In hoofdstuk 4 is het klinische beloop beschreven en de identificatie van prognos-
tische factoren (met de interne validatie van de modellen) die gerelateerd zijn 
aan de uitkomstmaat rugpijnintensiteit in de follow-up na 2, 5 en 12 maanden. De 
rugpijnintensiteit daalde van 55,5 mm (standaarddeviatie, SD, was 23,0) op baseline 
tot respectievelijk 37,0 mm (SD 23,8), 35,3 mm (SD 26,1) en 32,3 mm (SD 26,9) op 2, 
5 en 12 maanden follow-up. Op 12 maanden follow-up gaf 61% van de patiënten 30% 
verbetering aan en 29% van de patiënten gaf absoluut herstel (VAS  10 mm) aan 
met betrekking tot de uitkomstmaat rugpijnintensiteit. 
 Het model met de uitkomstmaat 30% verbetering op 5 maanden follow-up 
resulteerde in 9 prognostische factoren (AUC 0,66), met een verklarende variantie 
van 11%. De factoren waren: jongere leeftijd, vrouwelijk geslacht, BMI van > 25 kg/m2, 
geen eerdere revalidatie behandeling, hogere intensiteit van rugpijn, geen psychische 
fysieke dysfunctie, hogere scores op de SF-36 (PCS en MCS) en hogere werkparticipatie. 
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In de follow-up na 12 maanden zijn de volgende factoren betreffende 30% verbetering 
gevonden: jongere leeftijd, vrouwelijk geslacht, getrouwd/samenwonend met een 
volwassene, hoger opleidingsniveau, geen comorbiditeit, hoge intensiteit van 
rugpijn, meer spierkracht richting extensie, geen angst voor beweging en hogere 
score op de PCS (SF-36) met een verklarende variantie van 10% en AUC van 0,65.
 Voor absoluut herstel was de verklarende variantie op 5 en 12 maanden follow-up 
respectievelijk 11% en 18%, met een AUC van 0,69 en 0,73. Op 5 en 12 maanden 
follow-up waren jongere leeftijd, lagere intensiteit van de rugpijn en hogere score 
op de SF-36 de gemeenschappelijke prognostische factoren met betrekking tot de 
uitkomstmaat rugpijnintensiteit. Ook overgebleven in het eindmodel in de follow-up 
na 5 maanden waren de factoren: geen psychische of fysieke dysfunctie en hogere 
werkparticipatie. Toegevoegd aan de follow-up na 12 maanden zijn de factoren: 
een BMI van  30 kg/m2, geen comorbiditeit, meer beperkingen door rugpijn en een 
stabiele of toenemende rugpijn als gevolg van chronische aspecifieke lage rugpijn 
in de voorgaande drie maanden. De interne validatie toonde in alle prognostische 
modellen dezelfde resultaten voor de verklarende variantie en de AUC als in de 
aangereikte prognostische modellen. Ook de sensitiviteitsanalyse (bijv.  20 mm 
VAS) toonde vergelijkbare resultaten.
In hoofdstuk 5 zijn beschreven het klinisch beloop en de prognostische factoren 
(inclusief interne validatie) voor de uitkomstmaat beperkingen in activiteiten door 
rugpijn bij patiënten met chronische aspecifieke lage rugpijn in de follow-up na 
2, 5 en 12 maanden. De resultaten toonden aan dat de gemiddelde score op de 
QBPDS afnam van 51,7 (SD 15,6) op baseline tot respectievelijk 31,7 (SD 15,2), 31,1 
(SD 18,2) en 29,1 (SD 20,0) op 2, 5 en 12 maanden. Dertig procent verbetering op de 
QBPDS-score is gerapporteerd bij 63% van de patiënten na 12 maanden follow-up. 
Het absolute herstel (QBPDS  20 punten) nam toe van 24% op 2 maanden follow-up, 
naar respectievelijk 31% en 38% in de follow-up na 5 en 12 maanden.
 De prognostische factoren geïdentificeerd voor 30% verbetering op 5 en 12 
maanden follow-up waren: jongere leeftijd, getrouwd/samenwonend met een 
volwassene, hoge QBPDS-score, hogere score op de SF-36 (PCS en MCS) en geen 
eerdere revalidatie behandeling. Hierbij waren toegevoegd in het model, op 5 
maanden follow-up: hogere werkparticipatie, afname van de pijn in het beloop van 
drie maanden voor de start van de therapie en kortere duur van lage rug klachten; 
dit waren positieve voorspellers (verklarende variantie 12,8% en AUC 0,68). Op 
12 maanden follow-up waren de aanvullende factoren in het model: geen comorbi-
diteit, hogere opleiding en lagere rugpijnintensiteit (verklarende variantie 10,7% 
en AUC 0,66).
 Voor de uitkomstmaat absoluut herstel (QBPDS  20 punten) waren jongere 
leeftijd, kortere duur van de rugpijn, lagere QBPDS-score en hogere score op de 
SF-36 (PCS en MCS) opgenomen in het model op 5 en 12 maanden follow-up. Het 
model op 5 maanden follow-up had een verklarende variantie van 2,7% en een AUC 
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van 0,66 met de toevoeging van de factor ‘geen psychische/lichamelijke dysfunctie’. 
Op 12 maanden follow-up zijn in de analyse de factoren van geen comorbiditeit, 
lagere rugpijnintensiteit, duur van wandelen  60 minuten en spierkracht in de romp 
toegevoegd aan het model, met een verklarende variantie van 10,7% en een AUC 
van 0,66.
 Voor de interne validatie van de modellen en de sensitiviteitsanalyse (o.a. 
QBPDS-scores van  10 en  39) waren de resultaten ongeveer gelijk. 
In hoofdstuk 6 is het klinisch beloop beschreven en de identificatie van prognos-
tische factoren voor het herstel aangaande werkparticipatie van patiënten met 
chronische aspecifieke lage rugpijn. In deze studie zijn 1.608 van de 1.760 patiënten 
geïncludeerd; dit waren de patiënten die – als extra inclusiecriterium op baseline – 
een arbeidscontract hadden. De uitkomstmaat werkparticipatie is bepaald door 
het delen van ‘het huidige aantal werkuren’ door ‘het voormalige aantal werkuren, 
voorafgaand aan de chronische aspecifieke lage rugpijn’. 
 Patiënten rapporteerden een stijging van de werkparticipatie van gemiddeld 
38,3% (SD 43,1) op baseline tot 82% (SD 52,9) na 5 en 12 maanden follow-up. Op 
5 maanden follow-up rapporteerde 30,3% van de patiënten 30% verbetering op 
de score werkparticipatie en op 12 maanden follow-up 60,5% van de patiënten. 
Op baseline werkte 25,4% van de patiënten voor 90% of meer (absoluut herstel); 
dit aantal nam toe van baseline naar respectievelijk 43,2% tot 52,0% op 5 en 12 
maanden follow-up. 
 Baseline-factoren die voorspellend zijn voor de uitkomst 30% verbetering 
in werkparticipatie op 5 maanden follow-up waren: minder rugpijnintensiteit, 
lagere werkparticipatie, duur van kunnen staan (31–60 minuten) en oorzaak van 
het ontstaan van de klacht (ongeval of verkeerde beweging), met een verklarende 
variantie van 59% en een AUC van 0,89. In de follow-up na 12 maanden liet het 
multivariabele regressiemodel (AUC 0,90) 4 prognostische factoren zien met een 
verklarende variantie van 60%: jongere leeftijd, hoger opleidingsniveau, lagere 
werkparticipatie en hogere score op de mentale component (MCS) van de SF-36 
op baseline. Prognostische factoren voor absoluut herstel (  90% werkparticipatie) 
op 5 maanden follow-up waren: getrouwd/samenwonen met een volwassene, 
vrouwelijk geslacht, een hoge QBPDS-score, een hoge score op de fysieke component 
schaal (PCS) van kwaliteit van leven (SF-36), eerder hebben gevolgd van een 
revalidatietraject, geen ziektewetuitkeringen en hogere werkparticipatie op 
baseline. Hogere werkparticipatie en vrouwelijk geslacht waren ook prognostische 
factoren voor absoluut herstel op 12 maanden follow-up. Het model voor absoluut 
herstel op 5 maanden follow-up had een verklarende variantie van 30% en een 
AUC van 0,78 tegen 17% en 0,70 op 12 maanden follow-up. De interne validatie van 
de modellen en de sensitiviteitsanalyse (cut-off waarden van 80% werkend en 
100% werkend) rapporteerden vergelijkbare resultaten.
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In hoofdstuk 7 is het klinisch beloop beschreven en de identificatie van de prognos-
tische factoren voor ‘’kwaliteit van leven’’ en ‘’door de patiënt ervaren herstel’’ (Global 
Perceived Effect, GPE) in de follow-up na 5 en 12 maanden bij patiënten (n = 1760) 
die behandeld waren voor chronische aspecifieke lage rugpijn. 
 Kwaliteit van leven is gemeten met de Short Form 36-items Health Survey 
(SF-36). Patiënten rapporteerden een stijging van de MCS en PCS (SF-36) van 
gemiddeld 46,6 (SD 10,3) op baseline tot 49,2 (SD 9,4) op 5 maanden follow-up 
op de MCS in vergelijking met 31,9 (SD 7,1) op baseline tot 40,7 (SD 8,2) op de PCS. 
Tien procent verbetering van de MCS en PCS werd gerapporteerd door 39,6% en 
76,6% van de patiënten op 2 maanden follow-up en door 20,6% en 76,3% van de 
patiënten op 5 maanden follow-up. Op 2 maanden follow-up rapporteerde 45,1% van 
de patiënten een klinische verbetering op de GPE-schaal en dit nam toe tot respec-
tievelijk 53,0% en 60,3% op 5 en 12 maanden follow-up.
 Baseline variabelen die 10% verbetering op de uitkomstmaat PCS (SF-36) op 
5 maanden follow-up voorspelden, waren: jongere leeftijd, BMI van  30 kg/m2, lagere 
score op de PCS (SF-36), hogere score op de MCS (SF-36), psychische/lichamelijke 
dysfunctie, ontvangen van een ziektewetuitkering, hogere werkparticipatie en 
duur van het wandelen tussen de 16–30 minuten. De volgende baseline variabelen 
werden geassocieerd met 10% verbetering op de MCS (SF-36) in de follow-up na 
5 maanden: vrouwelijk geslacht, hogere score op de PCS (SF-36), lagere score op 
de MCS (SF-36) en geen psychische/fysieke dysfunctie. De AUC was respectieve lijk 
0,69 en 0,88 met een verklarende variantie van 11% voor de PCS en 44% voor 
de MCS van de SF-36. De factoren jongere leeftijd, getrouwd/samenlevend met 
een volwassene, op baseline kortere duur van de rugpijn, lagere rugpijnintensiteit 
en hogere werkparticipatie werden geassocieerd met 30% verbetering op de 
GPE-schaal op 5 en 12 maanden follow-up. De verklarende variantie was 11% en de 
AUC 0,66 bij 5 maanden follow-up. Aanvullende factoren op 5 maanden follow-up 
waren vermindering van rugpijn in de voorgaande drie maanden voor baseline, 
meer beperkingen, geen angst om te bewegen, hogere score op de MCS en PCS 
SF-36, ontvangen van een ziektewetuitkering en spierkracht. Vrouwelijk geslacht en 
duur van lopen (16-30 minuten) waren aanvullende factoren in de follow-up na 12 
maanden, met een verklarende variantie van 9,0% en een AUC van 0,65. De interne 
validatie en sensitiviteitsanalyse (30% verbetering op de MCS en PCS) vertoonden 
resultaten die vergelijkbaar waren met eerdere bevindingen.
 
Hoofdstuk 8 gaat in op de belangrijkste bevindingen en beperkingen van de studies 
in dit proefschrift, beschrijft de belangrijkste implicaties voor de dagelijkse praktijk 
en geeft aanbevelingen voor toekomstig wetenschappelijk onderzoek.
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DANKWOORD
 
De Hogeschool Rotterdam, Instituut voor Gezondheidzorg (opleiding fysiotherapie) 
en kenniscentrum Zorginnovaties ben ik speciale dank verschuldigd voor de 
mogelijk heid om via een promotie voucher twee dagen per week te werken aan 
het onderzoek naar het klinische beloop en prognostische factoren voor herstel 
bij patiënten met chronische aspecifieke lage rugpijn, die een behandeling volgde 
bij het revalidatie centrum Spine & Joint Centre, te Rotterdam. 
Hogeschool Rotterdam
Toenmalig directeur drs. Claire Kornaat-Schroder, onderwijsmanager fysiotherapie 
Rob Tijssen en lector drs. Harald Miedema wil ik bedanken voor de mogelijkheid en 
het vertrouwen om mijn eigen ingebrachte onderzoeksidee te realiseren. 
Claire, in de afgelopen jaren (vanaf student zijnde) en hopelijk in de komende jaren 
heb jij mij altijd gestimuleerd en gesteund om mijzelf professioneel verder te ontwik-
kelen. 
Rob, je gaf mij de ruimte om onderwijs- en onderzoektaken op een goede wijze in te 
vullen en te combineren, dat is nodig om een promotie traject af te kunnen ronden. 
Tevens draag je op deze wijze ook bij aan de cultuur dat fysiotherapeutische zorg 
aan patiënten op een wetenschappelijke verantwoorde wijze verder wordt verbeterd 
voor de praktijk als het onderwijs.     
Harald, als lid van het onderzoeksteam en co-auteur nam je de rol in om voorwaarden 
te blijven scheppen voor de voortgang, professionalisering te borgen en op bepaalde 
momenten een kritische vraag te stellen waardoor het product verbeterde. 
Alle collega’s van secretarieel tot directie in de loop der jaren bedankt voor je 
getoonde interesse, luisterend oor en op bepaalde momenten mooie afleiding of 
gesprekken. Speciale dank aan afdeling concernstrategie, Josephine Lappia voor 
alle tips en adviezen rondom de organisatie van een promotie voucher en Corinne 
Lamme en Sabine van Beekhof voor de vormgeving van het proefschrift.
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Erasmus MC, afdeling huisartsgeneeskunde  
De totstandkoming van dit proefschrift heeft niet kunnen plaatsvinden zonder de 
bereidheid van medewerking, inzet en betrokkenheid van promotor prof. dr. Bart 
Koes, co-promoter dr. Pim Luijsterburg en co-promoter dr. Annelies Pool-Goudzwaard. 
Pim, met jou als co-promoter heb ik het niet beter kunnen treffen. Jouw focus, 
prettige overlegstructuur (via de mail altijd een reactie!), je opmerkingen in alle 
artikelen waarmee ik verder kon, hebben veel bijgedragen aan dit schriftelijk 
eindproduct.  
Bart, in ons ‘onderzoeksteam’ bijeenkomsten borgde jij de hoofdlijnen, het positieve 
advies en een heldere kijk welke opties er mogelijk zijn.  
Annelies, ik waardeer het zeer dat wanneer het nodig was, je tijd had voor een 
luisterend en adviserend moment dat bijdroeg aan de vorderingen van het 
onderzoek. Jouw inhoudelijke kennis over aspecifieke lage rugpijn heeft mijn kennis 
doen verbreden.
Op een later moment binnen het onderzoekstraject is dr. Martijn Heymans, verbonden 
aan de EMGO, VU Universiteit medisch centrum te Amsterdam ‘aangetrokken’ aan 
ons onderzoeksteam.    
Martijn, gefascineerd door jouw publicaties over prognostische modellen kwam ik 
met je in contact. De vele overlegmomenten over deze boeiende materie en de 
deskundigheid die jij telkens ten toon spreidt, hebben mij vele leermomenten 
gegeven en het enthousiasme om mij verder te ontwikkelen. 
 
Rene Suurland en Marlies Luiten, bedankt voor de administratieve ondersteuning 
en adviezen. 
 
Lariane Visser-Isles, bedankt voor de snelle reacties en duidelijke opmerkingen op 
de concept artikelen.  
 
Spine & Joint Centre
Ten eerste alle patiënten en collega’s die in de loop der jaren de data om het 
onderzoek mogelijk te maken hebben aangereikt en/of verzameld wil ik bedanken. 
Het revalidatie centrum draagt een warme, vriendelijke, professionele ‘hartstocht’ 
uit voor chronische aspecifieke lage rugpijn patiënten.    
Dr. Jan-Paul van Wingerden, directeur en drs. Inge Ronchetti, functie onderzoeker 
bij het revalidatie centrum zijn mede co-auteurs bij bepaalde studies.
Jan-Paul, jij gunt het dat iemand zich kan ontwikkelen en kansen kan krijgen om 
het dan ook vorm te geven. Dit doe je voor mij al vanaf mijn studietijd fysiotherapie, 
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opleiding gezondheidswetenschappen en dit huidige promotie traject. Met jou in 
gesprek zijn, door ‘’jouw andere kijk op diverse onderwerpen’’ is enerverend maar 
verfrissend tegelijkertijd.   
Inge, vele gezellige woensdagen samen doorgebracht de afgelopen jaren, om 
steeds meer inzicht te krijgen in de patiënt met chronische aspecifieke lage 
rugpijn. Jouw logische nadenken en aanspreekpunt als ik iets wilde verifiëren 
uit de baseline data waardeer ik ten zeerste.  
Ik kijk uit naar de voortzetting van de samenwerking van alle betrokkene binnen 
dit huidige onderzoek om verder verdieping en nieuwe onderzoeksterreinen te 
verkennen.  
Vincent Hoogstad en Inge Ronchetti mijn paranimfen: ‘’A friend is one that knows 
you as you are, understands where you have been, accepts what you have become 
and still, gently allows you to grow’’ (Willem Shakespeare). 
Bedankt aan een ieder die ik niet noem bij naam maar wel de afgelopen jaren 
interesse toonde, kennis deelde, raad en advies gaven, steun, gezelligheid, vriend-
schap, begrip en mij inspirerende.    
Als laatste maar bij alles aan het begin staan, mijn familie, mijn ouders, mijn zus 
Annelise en hond Yenthe, partner Alexander en onze lieve dochter Sofie ben 
ik dankbaar voor de kansen die ik heb gekregen, het bijstaan, jullie liefde en tijd 
die ik kon besteden aan mijn ontwikkeling. ‘’Family faces are magic mirrors. Looking 
at people who belong to us, we see the past, present, and future” (Gail Lumet 
Buckley).
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Karin Verkerk
Chronic Non-Specifi c Low Back Pain
Chronic non-specifi c low back pain is assumed to be a multi-factorial 
affl iction, implying that a number of different risk factors contribute to its 
development and persistence. After onset, prognostic factors can poten-
tially predict the future course. Risk factors for the development of chronic 
pain (i.e. transition from acute to chronic pain) are well documented in 
the literature. However, when pain becomes persistent, less knowledge is 
available on the risk factors for future outcome. Increased knowledge on 
the prognostic factors for chronic complaints will allow to better inform 
and advise patients, by supporting clinical decisions about the type of 
treatment and identifying patients at risk of a poor outcome.
The objective of this thesis was to describe the clinical course of chronic 
non-specifi c low back pain in patients referred to a rehabilitation centre 
in tertiary care, to identify prognostic factors for recovery, and to analyse 
the infl uence of various outcomes and statistical techniques on the 
development of a prognostic model. This study included 1,760 patients 
with chronic non-specifi c low back which completed a 2-month multi-
disciplinary treatment and were followed up at 5- and 12-months.
In summary, the clinical course of patients with chronic non-specifi c low 
back pain who did not recover during primary and secondary care seemed 
to improve after a rehabilitation program, with success rates up to 60% 
at 12-months follow-up depending on the defi nition of recovery. 
Younger age, being female, being married or living with one adult, lower 
pain intensity and disabilities, higher quality of life (physical and mental) 
and a higher work participation increased the change for recovery.    
Karin Verkerk is senior lecturer and researcher at the Department of Health 
Care of the Rotterdam University of Applied Sciences.
